Noninvasive Mechanical Ventilation
Antonio M. Esquinas (Editor)
Noninvasive Mechanical Ventilation Theory, Equipment, and Clinical Applications
AntonioM.Esquinas AvenidadelParque,2,3B 30500Murcia MolinaSegura Spain e-mail:
[email protected]
ISBN:978-3-642-11364-2
e-ISBN:978-3-642-11365-9
DOI:10.1007/978-3-642-11365-9 SpringerHeidelbergDordrechtLondonNewYork LibraryofCongressControlNumber:2010925792 ©Springer-VerlagBerlinHeidelberg2010 Thisworkissubjecttocopyright.Allrightsarereserved,whetherthewholeorpartofthematerialis concerned,speci callytherightsoftranslation,reprinting,reuseofillustrations,recitation,broadcasting, reproductiononmicro lmorinanyotherway,andstorageindatabanks.Duplicationofthispublication orpartsthereofispermittedonlyundertheprovisionsoftheGermanCopyrightLawofSeptember9, 1965,initscurrentversion,andpermissionforusemustalwaysbeobtainedfromSpringer.Violations areliabletoprosecutionundertheGermanCopyrightLaw. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply,evenintheabsenceofaspeci cstatement,thatsuchnamesareexemptfromtherelevantprotective lawsandregulationsandthereforefreeforgeneraluse. Productliability:Thepublisherscannotguaranteetheaccuracyofanyinformationaboutdosageand applicationcontainedinthisbook.Ineveryindividualcasetheusermustchecksuchinformationby consultingtherelevantliterature. Coverdesign:eStudioCalamar,Figueres/Berlin Printedonacid-freepaper SpringerispartofSpringerScience+BusinessMedia(www.springer.com)
Contents
SectionI InterfaceTechnologyinCriticalCareSettings 1 FullMaskVentilation.......................................................................................... FrancisCordovaandManuelJimenez
3
2 HelmetContinuousPositiveAirwayPressure:TheoryandTechnology........ GiacomoBellani,StefanoIsgrò,andRobertoFumagalli
7
3 HelmetContinuousPositiveAirwayPressure:ClinicalApplications............ 13 AlbertoZanella,AlessandroTerrani,andNicolòPatroniti SectionII V entilatoryModesandVentilators: Theory,Technology,andEquipment 4 PressureSupportVentilation.............................................................................. 21 EnricaBertellaandMicheleVitacca 5 VentilatorsforNoninvasiveMechanicalVentilation........................................ 27 RaffaeleScala 6 N oninvasivePositivePressureVentilationUsingContinuous PositiveAirwayPressure..................................................................................... 39 PedroCaruso 7 HomeMechanicalVentilators............................................................................. 45 FrédéricLofaso,BrigitteFauroux,andHélènePrigent 8 MaintenanceProtocolforHomeVentilationCircuits...................................... 51 MichelToussaintandGregoryReychler 9 NocturnalNoninvasiveMechanicalVentilation................................................ 59 DavidOrlikowski,HassanSka ,andDjillaliAnnane
v
vi
Contents
SectionIII Patient VentilatorInteractions 10 P atient VentilatorInteractionDuringNoninvasive Pressure-SupportedSpontaneousRespirationinPatients withHypercapnicChronicObstructivePulmonaryDisease........................... 67 WulfPankow,AchimLies,andHeinrichBecker 11 AsynchronyandCyclicVariabilityinPressureSupportVentilation.............. 73 AntoineCuvelierandJean-FrançoisMuir 12 C arbonDioxideRebreathingDuring NoninvasiveMechanicalVentilation.................................................................. 77 FrancescoMojoliandAntonioBraschi 13 C arbonDioxideRebreathingDuringPressureSupport VentilationwithAirwayManagementSystem(BiPAP)Devices..................... 83 FrédéricLofasoandHélènePrigent 14 CarbonDioxideRebreathinginNoninvasiveVentilation................................ 87 DanielSamolskiandAntonioAntón 15 N ewAdaptiveServo-Ventilation DeviceforCheyne StokesRespiration.............................................................. 93 Ken-ichiMaenoandTakatoshiKasai SectionIV MonitoringandComplications 16 N octurnalMonitoringintheEvaluationofContinuous PositiveAirwayPressure.....................................................................................101 OresteMarrone,AdrianaSalvaggio, AnnaLoBue,andGiuseppeInsalaco 17 ComplicationsDuringNoninvasivePressureSupportVentilation.................107 MicheleCarron,UldericoFreo,andCarloOri SectionV C hronicApplicationsofNoninvasive MechanicalVentilationandRelatedIssues 18 E f cacyofContinuousPositiveAirwayPressure inCardiovascularComplicationsofObstructiveSleepApnea.......................121 AhmedS.BaHammamandMohammedK.A.Chaudhry 19 ObstructiveSleepApneaandAtherosclerosis...................................................131 R.Schulz,F.Reichenberger,andK.Mayer 20 T ransnasalInsuf ation ANewApproachin theTreatmentofOSAs........................................................................................135 GeorgNilius,BrianMcGinley,andHartmutSchneider
Contents
vii
21 C ardiopulmonaryInterventionstoProlongSurvival inPatientswithDuchenneMuscularDystrophy..............................................143 YukaIshikawa 22 N oninvasiveVentilationPressureAdjustments inPatientswithAmyotrophicLateralSclerosis................................................149 KirstenL.Gruis 23 N oninvasivePositivePressureVentilation inAmyotrophicLateralSclerosis.......................................................................153 DanieleLoCoco,SantinoMarchese,andAlbinoLoCoco 24 N oninvasiveMechanicalVentilationasanAlternative toEndotrachealIntubationDuringTracheotomy inAdvancedNeuromuscularDisease.................................................................161 DavidOrlikowski,HélènePrigent,andJésusGonzalez-Bermejo 25 N oninvasiveMechanicalVentilationinPatients withMyasthenicCrisis........................................................................................167 CristianeBrennerEilertTrevisan,SilviaReginaRiosVieira, andRenataPlestch 26 P redictorsofSurvivalinCOPDPatientswithChronic HypercapnicRespiratoryFailureReceivingNoninvasive HomeVentilation..................................................................................................171 StephanBudweiser,RudolfA.Jörres,andMichaelPfeifer 27 W ithdrawalofNoninvasiveMechanicalVentilation inCOPDPatientswithHypercapnicRespiratoryFailure...............................179 JacoboSellares,MiquelFerrer,andAntoniTorres 28 N oninvasiveVentilationinPatientswithAcute ExacerbationsofAsthma....................................................................................185 SeanP.Keenan 29 N oninvasivePositivePressureVentilation DuringAcuteAsthmaticAttack.........................................................................191 ArieSoroksky,IsaacShpirer,andYuvalLeonov 30 N oninvasivePositivePressureVentilation forLong-TermVentilatoryManagement..........................................................199 AkikoTokiandMikioSumida 31 HomeVentilationforChronicObstructivePulmonaryDisease......................205 Georg-ChristianFunk
viii
Contents
SectionVI C riticalCareApplicationsofNoninvasiveMechanical VentilationandRelatedIssues 32 C urrentStrategiesandEquipment forNoninvasiveVentilationinEmergencyMedicine.......................................217 KeisukeTomii 33 NoninvasiveVentilationOutsideofIntensiveCareUnits................................223 DavideChiumello,GaetanoIapichino,andVirnaBerto 34 N oninvasivePositiveAirwayPressureandRisk ofMyocardialInfarctioninAcuteCardiogenicPulmonaryEdema...............231 GiovanniFerrari,AlbertoMilan,andFrancoAprà 35 T heRoleofContinuousPositiveAirwayPressureinAcute CardiogenicPulmonaryEdemawithPreservedLeftVentricular SystolicFunction:APreliminaryStudy............................................................237 AndreaBellone 36 N oninvasiveVentilationinAcuteLungInjury/ AcuteRespiratoryDistressSyndrome...............................................................241 RiteshAgarwal 37 N oninvasivePositivePressureVentilationinAcute HypoxemicRespiratoryFailureandinCancerPatients.................................249 S.EgbertPravinkumar 38 NoninvasiveVentilationasaPreoxygenationMethod.....................................257 ChristopheBaillard 39 I n uenceofStaffTrainingontheOutcomeofNoninvasive VentilationforAcuteHypercapnicRespiratoryFailure..................................263 JoséLuisLópez-CamposandEmiliaBarrot SectionVII TheRoleofSedation 40 SedationforNoninvasiveVentilationinIntensiveCare...................................269 Jean-MichelConstantin,RenauGuerin,andEmmanuelFutier 41 UseofDexmedetomidineinPatientswithNoninvasiveVentilation................273 ShinhiroTakeda,ShinjiAkada,andKeikoNakazato SectionVIII W eaningfromConventional MechanicalVentilationandPostextubationFailure 42 E xtubationandDecannulationofUnweanablePatients withNeuromuscularWeakness...........................................................................279 JohnRobertBach
Contents
ix
43 M echanicallyAssistedCoughingandNoninvasive VentilationforExtubationofUnweanablePatients withNeuromuscularDiseaseorWeakness........................................................287 JohnRobertBach 44 N oninvasivePositivePressureVentilationin thePostextubationPeriod...................................................................................295 HasanM.Al-DorziandYaseenM.Arabi 45 NoninvasiveVentilationinPostextubationRespiratoryFailure.....................305 RiteshAgarwal SectionIX I ntraoperativeandPostoperative IndicationsforNoninvasiveMechanicalVentilation 46 IntraoperativeUseofNoninvasiveVentilation.................................................317 FabioGuarracinoandRubiaBaldassarri 47 NoninvasiveVentilationinAdultLiverTransplantation.................................321 PaoloFeltracco,StefaniaBarbieri,andCarloOri 48 N oninvasivePositivePressureVentilation inPatientsUndergoingLungResectionSurgery..............................................327 ChristophePerrin,ValérieJullien,YannickDuval, andFabienRolland SectionX NoninvasiveMechanicalVentilation inNeonatesandChildren 49 E quipmentandTechnologyforContinuousPositive AirwayPressureDuringNeonatalResuscitation..............................................335 GeorgM.SchmölzerandColinJ.Morley 50 A irLeakageDuringContinuousPositiveAirway PressureinNeonates............................................................................................343 GerdSchmalisch 51 TheUseofNoninvasiveVentilationintheNewborn........................................357 DebbieFraserAskin 52 N asalHigh-FrequencyVentilation: ClinicalStudiesandTheirImplications............................................................363 KatarzynaDabrowskaandWaldemarA.Carlo 53 BubbleContinuousPositiveAirwayPressure...................................................369 J.JanePillow
x
Contents
54 N oninvasiveMechanicalVentilationwithPositive AirwayPressureinPediatricIntensiveCare....................................................377 GiancarloOttonello,AndreaWol er,andPietroTuo 55 H omeMechanicalVentilationinChildren withChronicRespiratoryFailure......................................................................387 SedatOktem,Re kaErsu,andElifDagli Index.............................................................................................................................397
Abbreviations
ACPE AHI AHRF ALI ALS ARDS ARF ASV BiPAP BNP BPD CAD CCHS CF CHF CHRF CO2 COPD CPAP CPE CPF CRF CSA CSR CSR-CSA DMD DR ED EELV EPAP ETCO2
Acutecardiogenicpulmonaryedema Apneahypopneaindex Acutehypercapnicrespiratoryfailure Acutelunginjury Amyotrophiclateralsclerosis Acuterespiratorydistresssyndrome Acuterespiratoryfailure Adaptiveservo-ventilation Bi-levelpositiveairwaypressure Brainnatriureticpeptide Bronchopulmonarydysplasia Coronaryarterydisease Congenitalcentralhypoventilationsyndrome Cystic brosis Congestiveheartfailure Chronichypercapnicrespiratoryfailure Carbondioxide Chronicobstructivepulmonarydisease Continuouspositiveairwaypressure Cardiogenicpulmonaryedema Coughpeak ows Chronicrespiratoryfailure Centralsleepapnea Cheynestokesrespiration Cheyne-stokesrespirationwithcentralsleepapnea Duchennemusculardystrophy Deliveryroom Emergencydepartment Endexpiratorylungvolume Expiratorypositiveairwaypressure CO2attheendofexpiration
xi
xii
ETI ETO2 EV f f/Vt FAO2 FiCO2 FiO2 FRC Ftot FVC GPB hCO2 HTN HVC ICU IMT IPAP IPPV ITE Leaki LVEF MAC MEP MIC MIP MMRC MRSA MV MWD N NIMV NIPPV NIPSV NIV NMD NNPV NO NPPV NPSV ON OLTx OSA P[A=a]O2
Abbreviations
Endotrachealintubation End-tidalO2 Exhaustvent Respiratoryrate Respiratoryfrequency/tidalvolume Alveolarfractionofoxygen CO2inspiredfraction Inspiratedfractionofoxygen Functionalresidualcapacity Totalgas owpassingthroughthehelmet Forcedvitalcapacity Glossopharyngealbreathing Meancarbondioxideconcentrationinsidethehelmet Hypertension Homeventilationcircuits Intensivecareunit Intimamediathickness Inspiratorypositiveairwaypressure Intermittentpositivepressureventilation Inspiratorytriggeringefforts Differentde nitionsofairleakage(i=1,2,3) Leftventricularejectionfraction Mechanicallyassistedcoughing Maximalexpiratorypressure Maximuminsuf ationcapacity Maximalinspiratorypressure Modi edmedicalresearchconcil MethicillinresistantStaphylococcusaureus Mechanicalventilation 6-minutewalkingdistance Nasal Noninvasivemechanicalventilation Noninvasivepositivepressureventilation Noninvasivepressuresupportventilation Noninvasiveventilation Neuromuscularweakness Noninvasivepositivepressure Nasaloral Noninvasivepositivepressureventilation Noninvasivepressuresupportventilation Oronasal Livertransplantation Obstructivesleepapnea Arterialoxygenpressuregradient
Abbreviations
PaCO2 PaO2 PAP PAV PCV PEEP PPO PSV PTP RASSScore RCPAP RCTs RDI RDS REM RLeak RR SBT SCI SDB SGRQ SINP SMA1 SMT SNIPPV SpO2 Texp TFM Ti Ti/Ttot Ti Tinsp TNI TPPV TV Vinsp VAP V/CO2 V/Q VC VD/VT Vexp VFBA VFBT VT
xiii
Carbondioxidetension Arterialpressureofoxygen Positiveairwaypressure Proportionalassistventilation Pressurecontrolledventilation Positiveendexpiratorypressure Potentiallypathogenicorganism Pressuresupportventilation Dipressuretimeproduct Richmondagitationsedationscalescore ResistanceoftheCPAPinterface Randomizedcontrolledtrials Respiratorydisturbanceindex Respiratorydistresssyndrome Rapideyemovement Airleakageresistance Respiratoryrate Spontaneousbreathingtrial Spinalcordinjury Sleepdisorderedbreathing St.George srespiratoryquestionnaire Sniffnasalinspiratorypressure Spinalmuscularatrophytype1 Standardmedicaltreatment Synchronizednasalintermittentpositivepressureventilation Oxygenhemoglobinsaturation Expiratorytime Totalfacemask Inspiratorytime Inspiratorytime/totaltime Inspiratorytime Inspiratorytime Treatmentwithnasalinsuf ation Tracheostomypositivepressureventilation Tidalvolume Inspiredvolume Ventilation-associatedpneumonia Patient scarbondioxidemetabolicproduction Ventilation/perfusionratio Vitalcapacity Vitalvolumeratio Expiredvolume Ventilator-freebreathingability Ventilatorfreebreathingtime Tidalvolume
xiv
VPat Vmeas VLeak VE δVexp maxVCPAP V Pat, means
QOL WOB
Abbreviations
Air owofthepatient Flowmeasuredbythe owsensor Leakage ow Minuteventilation Volumeerrorofthedisplayedexpiratoryvolume MaximalCPAP ow Measuredpatient ow Qualityoflife Workofbreathing
Section I Interface Technology in Critical Care Settings
Full Mask Ventilation
1
FrancisCordovaandManuelJimenez
1.1 Introduction Noninvasivepositivepressureventilation(NPPV)hasbecomeanintegralpartofventilator supportinpatientswitheitheracuteorchronicrespiratoryfailure.NPPVhasbeenshown toavoidtheneedforinvasivemechanicalventilation,it sassociatedcomplicationsand facilitate successful extubation in patients with chronic obstructive pulmonary disease (COPD) who have marginal weaning parameters. In addition, some studies [1 3] have shown that NPPV improves survival compared with invasive mechanical ventilation in patientswithacuterespiratoryfailure.Moreover,NPPVhasbeenshowntobeaneffective modalityforthetreatmentofchronicrespiratoryfailureinpatientswithrestrictiveventilatorydisorders[4 6]andinselectedpatientswithCOPD[7,8].Comparedwithinvasive ventilation,NPPVdecreasedtheriskofventilator-associatedpneumoniaandoptimized comfort.Becauseofitsdesign,successdependslargelyonpatientcooperationandacceptance.SomefactorsthatmaylimittheuseofNPPVaremask-(orinterface-)relatedproblems such as air leaks, mask intolerance due to claustrophobia and anxiety, and poorly ttingmask.Approximately10 15%ofpatientsfailtotolerateNPPVduetoproblems associatedwiththemaskinterfacedespiteadjustmentsinstraptension,repositioning,and trialofdifferenttypesofmasks.Othermask-relatedproblemsincludefacialskinbreakdown,aerophagia,inabilitytohandlecopioussecretions,andmaskplacementinstability. Themostcommonlyusedinterfacesinbothacuteandlong-termsettingsarenasaland nasal-oral(NO)masks.Thefollowingreviewstheapplicationsoffull-facemaskinpatients whoareunabletotolerateaconventionalmaskduringNPPV.
F.Cordova()andM.Jimenez DivisionofPulmonaryMedicineandCriticalCareMedicine, TempleUniversityHospital,3401NBroadStreet,Philadelphia,PA19140-5103,USA e-mail:
[email protected];
[email protected] A.M.Esquinas(ed.), NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_1,©Springer-VerlagBerlinHeidelberg2010
3
4
F. Cordova and M. Jimenez
1.2 Total-Face Mask During NPPV AwidevarietyofmaskinterfaceshasbecomeavailabletodeliverNPPV.ThemostcommoninusearenasalandNO(orfull-face)masks.AlargerversionoftheNOmask,the total-facemask(TFM;Fig.1.1)couldbeusedasanoptiontoimprovepatientacceptance andpossiblyimprovegasexchangeandavoidintubationandmechanicalventilation.This maskcoversthewholeanteriorsurfaceofthefaceanddeliverseffectiveventilationviathe nasalandoralroutes.Crinerandcolleagues[9]comparedtheef cacyofNPPVviaTFM maskversusnasalorNOmasksinpatientswithchronicrespiratoryfailure.Theirstudy showed that NPPV via TFM in selected patients with chronic respiratory failure may improvecomfort,minimizeairleakfromthemaskinterface,andimprovealveolarventilation.Theyalsosuggestedthatthisformofmaskmaybeeffectiveinpatientssufferingfrom acuterespiratoryfailurewhoarecandidatesfornoninvasivemechanicalventilationina controlledenvironmentsuchastheintensivecareunit(ICU).We[10]alsoreviewedretrospectively13casesofacuterespiratoryfailure;thisanalysisshowedthatNPPVwassuccessfullyaccomplishedviaTFMinpatientswhowerepreviouslyunabletotolerateNPPV viaconventionalnasalorNOmasks.NPPVviaTFMimprovedgasexchangewithincreased pH,improvedgasoxygenationlevels,anddecreasedhypercapnia.Inthemajorityofthe patients,NPPVwaswelltoleratedwithoutdislodgementofthemaskorsigni cantneed forreadjustment.Complicationsfromtreatmentwereminimalandgenerallydidnotlead toaninterruptionintherapy.Thistypeofmaskwasalsoratedbypatientsasmorecomfortablethanthestandardfull-facemaskinapreliminaryreport[11]. BecausetheTFMcoverstheentireface,onewouldthinkthatthiswouldworsenfeelings of claustrophobia rather than improve them. However, Criner and colleagues [9] observedthatthissensationwasavoidedwiththeuseofTFMinsomeofthepatientswho werenotabletotolerateanNOmask.Potentialexplanationsforthisincludeunobstructed eldofvisionforthepatient;theabilitytocommunicateverbally;andthesensationofair owingovertheentirefacewhileusingthemask.
Fig.1.1 Differenttypes ofmaskavailablefor theNPPVinterface. Notethelargersizeof theTFM
1
Full Mask Ventilation
5
Concerns have been raised about the TFM. Since this form of face mask has much largervolume,ithasasigni cantlygreateramountofdeadspacecomparedwithother commerciallyavailableformsofnasalandNOmasks,butstreamingofair owdirectly fromtheinlettothepatient snoseandmouthappearstominimizethisproblem. Othercomplications,suchaseyeirritationandgastricdistention,wouldbeexpectedto bemorecommonduringNPPVwithaTFM.However,anincreaseintheseproblemshas notbeenreportedinanyofthestudies. The ef cacy of nasal and NO masks has been compared in a controlled trial of 26patientswithCOPDandrestrictivethoracicdisease.TheNOmasksweremoreeffectiveinloweringPaco2,perhapsbecauseofthegreaterairleakassociatedwiththenasal mask[12].Thissupportsthebeliefthat,intheacutesetting,nasal-oralmasksarepreferabletonasalmasksbecausedyspneicpatienttendtobemouthbreathers,predisposingto greaterairleakage.
1.3 Discussion Full-facemaskshavebeenusedmainlyonpatientswithacuterespiratoryfailurebutmay alsobeusefulforchronicventilatorysupport.Full-facemasksmaybepreferredforpatients withcopiousairleakingthroughthemouthduringnasalmaskventilation.Asnoted,the TFMisanoptionforpatientswhofailNPPVviamoreconventionalnasalorNOmasks. Patient traits or preferences may still favor the selection of one particular device over another.Regardlessofthemaskselected,proper tisofparamountimportanceinoptimizingthecomfortandsuccessofNPPV.Practitionersmustbepreparedtotrydifferentmask sizesandtypesinanefforttoenhancepatientcomfort. Insummary,NPPVviaaTFMinselectedpatientswithacuteorchronicrespiratory failure may improve comfort, minimize air leaking from the mask face interface, and improve alveolar ventilation in patients who fail NPPV with conventional oral or NO interface.
Key Recommendations
› › ›
AirleakageandclaustrophobiaassociatedwithNPPVmaybeovercomebyusing afull-facemask. TFMisaninterfaceoptiontoprovideNPPVinpatientswhofailtheuseof conventionaltypesofmasks(nasalornasal-oral). Practitionersmustbepreparedtotrydifferentmasktypesandsizesinaneffortto enhancethecomfortandsuccessofNPPV.
6
F. Cordova and M. Jimenez
References 1. AuriantI,JallotA,HervePetal(2001)Noninvasiveventilationreducesmortalityinacute respiratoryfailurefollowinglungresection.AmJRespirCritCareMed164:1231 1235 2. CarlucciA,RichardJC,WysockiM,LepageEetal(2001)Noninvasiveversusconventional mechanicalventilation.Anepidemiologicsurvey.AmJRespirCritCareMed163:874 880 3. BottJ,CarrollMP,ConwayJHetal(1993)Randomizedcontrolledtrialofnasalventilationin acuteventilatoryfailureduetochronicobstructiveairwaysdisease.Lancet341:1555 1557 4. KerbyGR,MayerLS,PingletonSK(1987)Nocturnalpositivepressurevianasalmask.Am RevRespirDis135:738 740 5. BachJR,AlbaAS(1990)Managementofchronicalveolarhypoventilationbynasalventilation.Chest97:148 152 6. LegerP,JennequinJ,GerardMetal(1989)Homepositivepressureventilationvianasalmask for patients with neuromuscular weakness or restrictive lung or chest wall disease. Respir Care34:73 79 7. GayPC,PatelAM,ViggianoRW,HubmayerRD(1991)Nocturnalnasalventilationfortreatmentofpatientswithhypercapnicrespiratoryfailure.MayoClinProc66:695 703 8. CarreyZ,GottfriedSB,LevyRD(1990)Ventilatorymusclesupportinrespiratoryfailurewith nasalpositivepressureventilation.Chest97:150 158 9. CrinerGJ,TravalineJM,BrennanKJetal(1994)Ef cacyofanewfullfacemaskfornon invasivepositivepressureventilation.Chest106:1109 1115 10. BruceRoyMD,CordovaF,TravalineJetal(2007)Fullfacemaskfornoninvasivepositive pressure ventilation in patients with acute respiratory failure. J Am Osteopath Assoc 107(4):148 156 11. LieschingTN,CromierK,NelsonDetal(2003)TotalfacemaskTMvsstandardfullface mask for noninvasive therapy of acute respiratory failure. Am J Respir Crit Care Med 167:A996 12. NavalesiP,FanfullaF,FrigeiroPetal(2000)Physiologicevaluationofnoninvasivemechanicalventilationdeliveredwiththreetypesofmasksinpatientswithchronichypercapnicrespiratoryfailure.Chest28:1785 1790
Helmet Continuous Positive Airway Pressure: Theory and Technology
2
GiacomoBellani,StefanoIsgrò,andRobertoFumagalli
2.1 Introduction Continuouspositiveairwaypressure(CPAP)isadministeredtopatientstomaintainthe airwayataselectedpressure(usuallynamedthepositiveend-expiratorypressure,PEEP) higherthanthatoftheatmosphereone.PEEPapplicationhasseveralwell-knowneffects ontherespiratorysystemandhemodynamics,whosedescriptionisnotamongtheaimsof thischapter.Theappliedpressureiskeptconstantthroughoutthewholerespiratorycycle sothatintrapulmonarypressureswingsaroundthesetlevel.Patientscanbreathspontaneously at the selected pressure without any active support of inspiration; it follows that CPAPcannotbestrictlyconsideredaformof ventilation.
2.2 Helmet Technology Thehelmetinterface[1]wasconceivedtodeliverhighoxygenconcentrationsduring hyperbarictherapy.Sincetheninetiesithasbeenincreasinglyused,particularlyinthe southernEuropeancountries,todelivernoninvasiveventilation.Thehelmetconsistsof asofttransparentplastichoodbuiltonahardplasticring.Asilicon/polyvinylchloride softcollarbuiltontheringprovidesapneumaticsealattheneck,whilethehoodcontainsthepatient sentirehead.Thepresenceoftwoormoreinletsandoutletsenables connectionofstandardventilatortubingfortheexpiratoryandinspiratoryportsofthe circuitandtheinsertionofnasogastrictubesandstraws.Thecollarprovidesagood sealwithoutmajorcompressionatcontactpoints.Thelackofpressurepointsonthe
G.Bellani(),S.Isgrò,andR.Fumagalli DepartmentofExperimentalMedicine,Milano-BicoccaUniversity,Monza,Italyand DepartmentofPerioperativeandIntensiveCareMedicine,SanGerardoHospital,Monza,Italy e-mail:
[email protected];
[email protected];
[email protected] A.M.Esquinas(ed.), NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_2,©Springer-VerlagBerlinHeidelberg2010
7
8
G. Bellani et al.
faceavoidsskinnecrosisandpain,reducesdiscomfort,andimprovespatienttolerance. The seal around the neck allows the use of the helmet also in patients with dif cult anatomicalsituationsthatcommonlydonotallowtheuseofafacemask,suchasin edentulouspatients,patientswithafullbeard,orpatientswithfacialtrauma.Thehelmet allows the patients to see, read, talk, and interact more easily than with other devices. Differentcompaniesproducevariousadult,pediatric,andneonataltypesandsizesof helmets,eachprovidedwithvarious xingandsafetyfeatures.Adulthelmetsareeasily heldinplacebytwostrapspositionedundertheaxillae.Codazzietal.[2]introducedan interestingtechniquetoprovidehelmetCPAPtopreschoolchildrenbyemployinga babybody wornunderthepubicregionasadiaperand xedtotheplasticring.Inasinglecenter prospective study, this system was effective in delivering CPAP and was well tolerated.Amodi edhelmethasbeendevelopedtodeliverCPAPtopreterminfants[3]; thesealedhoodismountedontheupperpartofthebed,towhichtheinspiratorylineofthe circuit is connected. Another port is provided for expiratory exit; a threshold valve is mountedheretogeneratePEEP.Inaddition,intheupperpartofthehoodthereisapressure release valve that prevents excessive pressure in the system. Pressure, inspiratory fractionofoxygen,andtemperatureinthechamberarecontinuouslymonitored.Thepressurechamberiskeptseparatefromtherestofthebedbyatransparent,latex-free,polyurethanemembrane.Thecone-shapedmembranehasaholeinthemiddletoallowthepatient s headtopassthrough.Duetothepressureinthechamber,thesoftmembranebecomesa loosecollararoundtheneck,adheringtotheshouldersofthepatientwithasealingand nontraumaticeffect.
2.2.1 Helmet to Deliver Noninvasive CPAP Whileahelmethasbeenusedtodeliverpressuresupportventilationbyconnectingthe inspiratoryandexpiratorylineofthehelmettoaventilator,theef cacyofsuchasystem indeliveringpressuresupportisquestionable[4].Theanalysisofthepatient ventilator interaction becomes quite complicated and is not the subject of this chapter, which focusesonCPAP. A typical circuit setup to deliver noninvasive CPAP by a helmet consists of an inspiratorybranch thatsuppliesaconstant owoffreshgastothehelmet.Gas ow (typically30 60l/min)isprovidedtypicallythroughanO2/air owmeterwithananalog scalethatallowsthecliniciantoregulateoxygenandair owseparatelyandaccordingly Fio2.The owmeterisinterposedbetweenthesourceoffreshgases(wall,tanks)andthe gasinletofthehelmet.The expiratorybranch disposesthegasthroughathreshold spring-loadedorwater-sealvalve(seeFig.2.1),whichkeepsthesystemunderpressure. ThehelmethasbeensuccessfullyusedtodeliverCPAPinseveralclinicalstudies(see chapter3). Patronitietal.[5]comparedtheef cacyofthehelmetversusthefacemaskindeliveringCPAPtoeighthealthyvolunteers.AcombinationofthreePEEPlevels(5,10,and 15cmH2O)andthreegas owswastestedinrandomorder;theincreaseinend-expiratory
2
Helmet Continuous Positive Airway Pressure: Theory and Technology
9
Fig. 2.1 Continuous owCPAPsystemwiththresholdspring-loadedPEEP;seetextfordetails
lungvolume,theswingsinairwaypressureduringthebreathingcycle,andtheworkof breathingweresimilarateachPEEPlevelbetweenthetwointerfaces,thusdemonstrating that CPAP delivered by helmet is at least as effective as CPAP by face mask. It shouldbenotedthatduetoitsextremelyhighcompliance,helmetsactasareservoir; evenifthepeakinspiratory owrateofthepatientexceedsthefreshgas owrate,the pressurewillremainalmostconstant.ThisisnotthecasewhenusingafacemaskCPAP, whichrequireseitherthepresenceofareservoirabletodumpthepressureswingorthe presence of a mechanical ventilator able to generate as much ow as the patient demands. The helmet CPAP system is effective, cheap, and easy to set up also outside the intensivecareunits(ICUs),suchasinthehospitalsetting[6],intheemergencydepartment,inthepostanesthesiacareunit[7],andevenintheward.Themaindisadvantages ofthissystemaretheinabilitytoprovideventilatoryassistanceorlungrecruitmentif neededandtheabsenceofanacousticalarmsystemforinadvertentpressure/gasdrop.
2.3 Limitations of the Technique 2.3.1 Carbon Dioxide Rebreathing Oneofthemainconcernswhentheheadofthepatientisinaclosedsystemisthepotential forCO2rebreathing,whichisobviouslyavoidedbyprovidinganadequatefreshgas ow rate.Indeed,incomparisonwithfacemaskCPAP,theuseofthehelmetwasassociated
10
G. Bellani et al.
withhigherinspiratoryconcentrationofCO2,whichdecreasedatincreasing owrates[5]. Similar ndingswerereportedinabenchandhealthyvolunteersstudywithanincreasein inspiredconcentrationofCO2whenthegas owratewasreducedbelow30l/min.Itis noteworthy that the study also showed the inadequacy of delivering CPAP via helmet employingamechanicalventilator,which,becauseitisonlyaimedatkeepingtheairway pressure constant, lackscontinuousdeliveryofgas owtothehelmetandprovidesa freshgas owtothehelmetequaltoorslightlysuperiorthanthepatient sminuteventilationandwellbelowthelimitof30l/minsuggestedaseffectiveinmaintainingtheinspiratoryconcentrationofCO2inareasonablerange[8]. Forthisreason,wehighlydiscourageconnectingthehelmettoamechanicalventilator to provide CPAP. This result has been con rmed by Racca and coworkers, who also showedthatelevatedCO2rebreathingoccursifthePEEPvalveismountedontheinspiratorybranchasopposedtotheexpiratoryone[9]. Furthermore,astudy[10]byPatronitietal.addressedtheissueofthepotentialdanger derivingfromthediscontinuationoffreshgas ow.Thestudytestedthreedifferenthelmet models;oneofthehelmetsboreanantisuffocationvalve.Afterjust4minfromthedisconnectionofthefreshgas ow,theFio2dropped,andtheinspiratoryCO2rosetoextremely highlevels(upto70mmHg),withafourfoldincreaseintheminuteventilation.These effectsweregreatlydiminishedinthepresenceofanantisuffocationvalve.Theauthors concluded that some features of the helmet design (a high-volume, low-resistance inlet portandtheadjunctofasafetyvalve)caneffectivelylimitanddelaytheconsequencesof freshgassupplyinterruptionandthat,whendeliveringhelmetCPAP,thereisaclearneed to include a monitoring and alarm system along with a clinical control, even in ICU settings.
2.3.2 Noise Cavaliereetal.[11]addressedtheissueofthenoise(arisingfromtheturbulent owat thegasinletduringhelmetCPAP)asapossiblesourceofdiscomfortforpatients.The reportednoiselevelsinthehelmetduringnoninvasiveventilationequal100dB,andthe noise perceived by the subjects (assessed by a visual analog scale) was signi cantly greaterwiththehelmetthanwithafacemask;nonetheless,thehelmetwasoverallbetter tolerated than the face mask. Finally, the presence of a simple lter for heat and moistureexchangeontheinletlinesigni cantlydecreasedthesubjectivenoiseperception.Thesameauthorsreported,after1hofpressuresupportventilationdeliveredby helmettohealthyvolunteers,areversibleincreaseinacousticcompliance(indicatinga less-stiff tympanic membrane) that could predispose the middle and inner ear to mechanicaldamage.Althoughtheclinicalrelevanceofthesedataisunknown,particularlyafterprolongedtreatment,theauthorssuggestedtheuseofprotectivedevicessuch asearplugs.
2
Helmet Continuous Positive Airway Pressure: Theory and Technology
11
2.3.3 Pressure Monitoring and Generators As an important factor affecting the pressure generated into the helmet is the ow rate passingthroughthePEEPvalvegenerator,specialattentionmustbereservedforproviding adequategas owandavoidingmajorleaks.Asimplewaytoassessifthepressureinside thehelmetdoesnotdropbelowthePEEPistoascertainthatgasis owingthroughthe expiratoryvalvethroughouttherespiratorycycle:Ifduringinspirationthegas owstops, thisindicatesthatpressureinthehelmetisbelowthePEEPandthatahigherfreshgas ow rate is necessary. Moreover, it could be recommended to frequently measure pressure insidethehelmet,especiallywhenhelmetCPAPisperformedinahighlytechnological environment(suchasICUs). Somecompaniesemploypressurereliefvalvepressure,whichopenswhenthepressure risesaboveasafetylevel(e.g.,ifthepatientscoughs). Furthermore,togeneratePEEPathreshold(orplateau)valveisusuallyemployed.This valveisdesignedtoopenatathresholdpressureandabovethisleveltogenerateaconstant pressureindependentlyfromvariationsof ow.Themostemployedarespring-loadedand water-seal valves. Several different technologies have been developed to grant the rst kindofvalvesaconstantresistanceinthewiderrangeofgas ow,butdependingonthe manufacturer,when owishightheycouldshowsomedegreeof owdependency,thus increasingthepressuregeneratedinsidethehelmet.Thesecondkindiseasytoprovide alsoinanontechnologicalenviromentandcheap;itneedsaventilatortubetoconnectthe helmetandthewaterrepository.
Key Recommendations
› ›
› › ›
Duetoitslowinvasivenessandsimplicityofuse,ahelmetshouldbetakeninto considerationwhenconsideringapplicationofnoninvasiveCPAP. Adequatefreshgas ow(certainlynotlowerthan30l/min,buthighermightbe necessary)mustbeprovidedtoavoidrebreathingandpressuredropbelowPEEP. MechanicalventilatorssetinCPAPmodalityshouldnotbeconnectedtohelmets asfreshgas owrateisinadequate. A lterforheatandmoistureexchangeandearplugsmightbeusefultoolsto reducenoiseanddiscomfort. PressuremeasurementinsidethehelmetisrecommendedtotitratethePEEP atthecorrecttherapeuticlevel.Apressure/ ow/CO2alarmingsystemisstill desirabletoimprovesafety. Thepresenceofasafetyvalveavoidstheriskofchokingduetofreshgas owsupplyinterruption.
12
G. Bellani et al.
References 1. BellaniG,PatronitiN,GrecoMetal(2008)Theuseofhelmetstodelivercontinuouspositive airwaypressureinhypoxemicacuterespiratoryfailure.MinervaAnestesiol74:651 656 2. CodazziD,NacotiM,PassoniMetal(2006)Continuouspositiveairwaypressurewithmodiedhelmetfortreatmentofhypoxemicacuterespiratoryfailureininfantsandapreschool population:afeasibilitystudy.PediatrCritCareMed7(5):455 460 3. TrevisanutoD,GrazzinaN,DoglioniNetal(2005)Anewdeviceforadministrationofcontinuouspositiveairwaypressureinpreterminfants:comparisonwithastandardnasalCPAP continuouspositiveairwaypressuresystem.IntensiveCareMed31:859 864 4. NavalesiP,CostaR,CerianaPetal(2007)Non-invasiveventilationinchronicobstructive pulmonarydiseasepatients:helmetversusfacialmask.IntensiveCareMed33(1):74 81 5. PatronitiN,FotiG,Man oAetal(2003)Headhelmetversusfacemaskfornon-invasive continuous positive airway pressure: a physiological study. Intensive Care Med 29: 1680 1687 6. FotiG,SangalliF,BerraLetal(2009)IshelmetCPAP rstlinepre-hospitaltreatmentof presumedsevereacutepulmonaryedema?IntensiveCareMed35(4):656 662 7. SquadroneV,CohaM,CeruttiEetal(2005)Continuouspositiveairwaypressurefortreatmentofpostoperativehypoxemia arandomizedcontrolledtrial.JAMA293(5):589 595 8. TacconeP,HessD,CaironiPetal(2004)Continuouspositiveairwaypressuredeliveredwith a helmet :effectsoncarbondioxiderebreathing.CriticalCareMed32:2090 2096 9. Racca F, Appendini L, Gregoretti C et al (2008) Helmet ventilation and carbon dioxide rebreathing: effects of adding a leak at the helmet ports. Intensive Care Med 34(8): 1461 1468 10. PatronitiN,SainiM,ZanellaAetal(2007)Dangerofhelmetcontinuouspositiveairwaypressureduringfailureoffreshgassourcesupply.IntensiveCareMed33:153 157 11. CavaliereF,ContiG,CostaR,ProiettiR,SciutoA,MasieriS(2004)Noiseexposureduring noninvasiveventilationwithahelmet,anasalmask,andafacialmask.IntensiveCareMed 30:1755 1760
Helmet Continuous Positive Airway Pressure: Clinical Applications
3
AlbertoZanella,AlessandroTerrani,andNicolòPatroniti
3.1 Introduction Duringnoninvasivecontinuouspositiveairwaypressure(CPAP)thepatient srespiratory systemismaintainedthroughoutthewholerespiratorycycleataconstantpressurehigher thantheatmosphericpressure,usuallytermedthepositiveend-expiratorypressure(PEEP). NoninvasiveCPAPisvoidofanyactivesupportforthepatient sworkofbreathingand thereforecannotbeconsideredaformof ventilation. NoninvasiveCPAPisfrequentlyusedtoimprovegasexchangeandrespiratorymechanics in cooperative patients with an intact neuromuscular function with acute respiratory failure(ARF),includingacutecardiogenicpulmonaryedema(ACPE)[1].Ifononehand theuseoftechniqueswithanactivesupporttoinspiration,likepressuresupportventilation, mightdeterminefurtherbene tstopatientswithARF,ontheotherhandCPAPiseasily deliveredbysimplecontinuous owsystemswithouttheneedforamechanicalventilator, evenoutsideintensivecareunits(ICUs). Inthepast,noninvasiveCPAPhasbeenmostlydeliveredbyafacemask,combined either with a traditional CPAP circuit, equipped with a large reservoir bag on the inspiratory limb (with the purpose of minimizing the pressure swings) and a PEEP valve,orcombinedwitha Boussignacvalve. Whenusingafacemask,toavoidleaks (thusmaintainingaconstantairwaypressure),atightsealbetweenthepatient sface andthedeviceiscrucialbutoftenisdif culttoobtain,especiallywithpatientswith peculiarcharacteristics(e.g.,inanedentulouspatientorinthosewithabeard);moreover, the elevated pressure exerted by the mask on the patient s face can potentially lead to patient discomfort and skin lesions, usually limiting the application of this devicetoshort-termtreatmentsorperiodicapplications.Thecorrectapplicationofthe
A.Zanella(),A.Terrani,andN.Patroniti PerioperativeandIntensiveCareMedicine,Milano-BicoccaUniversity,Milan,Italy e-mail:
[email protected];
[email protected];
[email protected]
A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_3,©Springer-VerlagBerlinHeidelberg2010
13
14
A. Zanella et al.
facemaskisthereforesomehowdif cultandrequiresanexperiencedteamandacollaborativepatient. The head helmet has been introduced with success as a tool to deliver noninvasive CPAP. It seems to offer some signi cant advantages compared to a face mask, mainly highertolerabilitybythepatient,preventionofpressuresores,andsuperioref ciencyin keepingthePEEPlevelconstantthroughouttherespiratorycycle.
3.1.1 Acute Cardiogenic Pulmonary Edema During ACPE, the application of a CPAP improves the arterial oxygenation and the respiratorymechanicsandmayreducethepatient srespiratorydriveandeffort.Since theinspiratoryeffortdecreasestheintrathoracicpressure,theafterloadoftheleftventricle increases; for example, if the arterial systolic pressure is 120 mmHg and the intrathoracicpressure(surroundingtheheart)is 20mmHg,theventriclehastogenerateapressureof140mmHg.Forthisreason,adecreaseintheinspiratoryeffortimplies areductionoftheleftventricleafterload.Moreover,CPAPreducesthevenousreturn andtheventriclesize,diminishingthewalltensionandmyocardialoxygenconsumption.ProbablybecauseofthesemultiplemechanismsCPAPiseffectiveinreducingthe needforintubationandthedeathofpatientswithACPE.Inaclinicalstudy[2],acohort ofpatientswithARFfollowingACPEwassuccessfullytreatedwithhelmetCPAP,with ameandurationoftreatmentof13h;asigni cantreductioninrespiratoryandpulse rateandanimprovementingasexchangewereobservedafter1hfrominstaurationof treatment. HelmetCPAPhasbeensuccessfullyusedasaprehospitaltherapyinpatientswithpresumedACPE.Inourexperience[3],prehospitalapplicationofhelmetCPAPwasextremely effective in improving the respiratory function and decreased intrahospital mortality in patientswithACPE.PrehospitalhelmetCPAPwasfeasible,safe,andeffectiveasanaddition to standard medical therapy or as a stand-alone treatment. A similar approach to patientswithACPEhasbeendescribedbyPlaisanceandcoworkers[4].
3.1.2 Acute Noncardiogenic Respiratory Failure In patients with acute noncardiogenic respiratory failure, CPAP, increasing the end- expiratorylungvolume(EELV)andpreventingalveolarcollapse,canimprovethegas exchangeandrespiratorymechanics,decreasingtheworkofbreathing.InFig.3.1,curve A represents a normal respiratory system pressure volume relationship, and P1 is the pressureneededtoinspireatidalvolume(TV).Arightwardshiftofthepressure volume curveB,whichmayoccurwithareductioninrespiratorysystemcompliance,resultedin a decrease in functional residual capacity (FRC) and an increase in work of breathing because, to inspire the same TV, a higher pressure (P2) is required. An application of
B
60
80
A
40
TV P1
TV P3 TV
20
P2
0
Fig.3.1 CurveArepresentsa normalrespiratorysystem pressure volume relationship,andP1isthe pressureneededtoinspirea tidalvolume(TV).A rightwardshiftofthe pressure volumecurveB resultsinadecreasein functionalresidualcapacity andincreasestheworkof breathingsince,toinspire thesameTV,ahigher pressure(P2)isrequired.An applicationof10cmH2Oof CPAPreestablishesthe normalend-expiratorylung volumeandreducesthe workofbreathing(P3=P1)
15
100
Helmet Continuous Positive Airway Pressure: Clinical Applications
Total lung capacity(%)
3
−10
0
+10
+20
+30
Airways pressure (cmH2O)
CPAP (in the gure, 10 cmH2O), reestablished the normal EELV and the reduced the workofbreathing(P3=P1). TheeffectivenessofCPAPinpatientswithARFhasbeenproveninmanystudies[5], especiallyinARFcomplicatinghematologicalmalignancy,giventheimportanceinthose patientsofavoidingendotrachealintubation.Principietal.[6]comparedacohortofpatients withhematologicalmalignancywithARFtreatedwithCPAPdeliveredbyhelmetwitha cohortofhistoricalcontrolstreatedbyfacemaskCPAP.Despiteasimilarimprovementin oxygenationat2and6hfromtheinitiationofthetreatment,inthehelmetgroupthemean duration of continuous application of CPAP without disconnection and the total duration ofCPAPwerelongerthaninthefacemaskgroup(28.4±0.2vs7.5±0.4hand34.1±0.1 vs28.1±0.3h,respectively),withbetterpatienttolerance.Theauthorsalsoreportedstatisticallysigni cantlowerratesofdeathandintubationbetweenthetwogroups,whichcan hardlybeexplainedbyagreateref cacyofthehelmet(astheinitialimprovementinoxygenationwassimilar);rather,thesecouldbeattributabletoamorecontinuativetherapy. Despiteitslimitations,thisstudyprovidedastrongsuggestionthattheheadhelmet,allowingtreatmentofpatientsforalongerperiodoftime,mightbearasubstantialadvantagein comparisontothefacemask,atleastinthesubsetofpatientsrequiringlong-term(days ratherthanhours)intervention,likethoseaffectedbyhematologicmalignancies.Thecapabilityofdeliveringnoninvasiveventilationforamoreprolongedperiodwithbetterpatient tolerancehasbeenreportedalsoinsubsequentstudies[7]. AheadhelmethasbeensuccessfullyappliedtodeliverCPAPduringhypoxicrespiratoryfailurefollowingmajorabdominalsurgery[8].PatientswithaPaO2/FiO2lower than300mmHgwhilebreathingoxygenthroughaVenturimaskataninspiratoryfractionof0.3,wererandomlyassignedtobetreatedfor6hwithoxygenthroughaVenturi
16
A. Zanella et al.
maskatanFiO2of0.5(controlpatients)orwithoxygenatanFiO2of0.5plusaCPAP of 7.5 cmH2O, delivered by the head helmet. The patients treated with head helmet CPAPshowedalowerintubationrate(1%vs10%)andashorterdurationofICUstay. Inthisstudy,thehelmetwasnotcomparedtootherCPAPdevices;however,therateof intoleranceofthehelmetCPAPreportedbytheauthors(4%)waslowerthanwhathas beenreportedforthefacemaskinotherstudies(14%). Finally,inpatientswithchronicobstructivepulmonarydisease(COPD),CPAPisable tosubstantiallydecreasetheworkofbreathingbycompensationforthepatient sintrinsic PEEP.
3.2 Experience with Helmet CPAP at Our Institution Forseveralyearsatourinstitution,thenumberofavailableICUbedswasnoticeably undersized in proportion to the total number of beds of the hospital. To reduce the requirementtotransferpatientstootherhospitalICUsandtopreventtheICUadmission of certain patients categories (e.g., patients affected by hematological malignancies), theuseoftheheadhelmetinthegeneralwards(medicalandsurgical)wasimplemented. The outreach team for intrahospital urgencies and emergencies, including one staff intensivist and one resident, is alerted by the ward physician when a patient might require the application of noninvasive CPAP (nCPAP). If this is considered to be the case,atreatmentwithhelmetCPAPisinstitutedandmanagedbythewardnurses,who arespeci callytrainedfortheuseofthesystem.Decisionsonthetitrationofthetherapy aswellasitsdiscontinuationortheneedforamoreaggressivetherapyaremadebythe wardphysicianandtheoutreachteam,whoevaluatethepatientstwiceaday.Inthelast 15 years, hundreds of patients have been managed in this way at our institution. We reportdatafromacohortof39consecutivepatientswithARF(26ARFand13ACPE) managed by helmet CPAP in general wards [9]. We included patients with hypoxia refractorytoadministrationofoxygenbyreservoirmaskandwithin ltratesonchest X-rays.Patientsneedingimmediateintubation,withahistoryofCOPD,andwithmore thantwoneworganfailureswereexcluded.TheaveragelengthofCPAPtreatmentwas 2.9±2.3dayswithPEEPlevelsbetween8and12cmH2O.Ninepatients(23%)were subsequentlyintubated,andsix(15%)ultimatelydied.Inallpatients,Pao2/Fio2improved after 1 h of CPAP administration (from 113 ± 36 to 200 ± 83 mmHg). Patients who recoveredfromARFwithoutintubationshowed,from1to24hoftreatment,asigni cantimprovementinPao2/Fio2(from205±84to249±98mmHg,p<0.05)andasigni cantdecreaseinrespiratoryratefrom29.2±7.3to26.2±6.5breathsperminute, p < 0.05). On the contrary, patients who needed intubation did not show any further improvementinPao2/Fio2andrespiratoryrate. Again,wedidnotreportanyintoleranceforthehelmet,andwewereabletoeasily obtainagoodairsealinallpatients,whilepatientdiscomfort,facemaskintolerance,and
3
Helmet Continuous Positive Airway Pressure: Clinical Applications
17
inabilitytoobtainasuf cientsealarethemostimportantcausesoffailureofnoninvasiveCPAPaswellasofnoninvasivepositivepressureventilation(NPPV).Byavoiding thesetwomajorproblems,theuseofthehelmetmayextendtheuseofCPAPtoamuch largerpatientpopulation.Second,tolimitpatientdiscomfortandpossibleskinlesions, facemaskNPPVcannotbeadministeredcontinuouslyforlongperiods.Inastudyby Delclauxetal.[10]thatdidnotshowanybene toffacemaskCPAPcomparedtostandardoxygentherapy,thelengthofCPAPapplicationrequiredbyprotocolwasonly6h perday.TheshortdurationofCPAPtreatmentmayhavegreatlyaffecteditsef cacy, accountingatleastinpartforthelackofef ciencyshowninthisstudy.Theseresults corroboratethe ndingsofPrincipietal.[6]andsuggestthatthepossibilityofapplying CPAPtreatmentwithoutdisconnectionforlongerperiodsisthemostpromisingadvantageofthehelmet.
3.3 Conclusion TheapplicationofCPAPbyhelmetappearstobeeasy,ef cient,andcheap.Someessential monitoringshouldbeprovidedtowarrantsafetystandards.Despiteasimilarpneumatic performance,helmetCPAPmightbesuperiortofacemask,atleastinpatientsrequiring long-termtreatments,giventhepossibilityofdeliveringCPAPmoreeasilyandformore prolonged periods with greater patient tolerance and with less harm for the patients. A largeproportionofhypoxicpatients,includingthosewithACPE,CAP,postsurgicalrespiratoryfailure,ARFinimmunocompromisedpatients,andsoonmaypotentiallybene t fromearlyapplicationofCPAP.
Key Recommendations
› › › ›
Theheadhelmetisanef cienttooltodelivernoninvasiveCPAP,anditseems tooffersomesigni cantadvantagescomparedtoafacemask. CPAPisveryeffectiveinreducingtheneedforintubationandthedeathof patientswithACPE. PrehospitalapplicationofhelmetCPAPimprovestherespiratoryfunctionand decreasesintrahospitalmortalityinpatientswithACPE. Inpatientswithacutenoncardiogenicrespiratoryfailure,CPAPimproves oxygenationbyincreasingtheEELFandpreventingalveolarcollapse.
18
A. Zanella et al.
References 1. MasipJetal(2005)Noninvasiveventilationinacutecardiogenicpulmonaryedema:systematicreviewandmeta-analysis.JAMA294(24):3124 3130 2. TonnelierJMetal(2003)Noninvasivecontinuouspositiveairwaypressureventilationusing a new helmet interface: a case-control prospective pilot study. Intensive Care Med 29(11): 2077 2080 3. FotiGetal(2009)IshelmetCPAP rstlinepre-hospitaltreatmentofpresumedsevereacute pulmonaryedema?IntensiveCareMed35(4):656 662 4. PlaisancePetal(2007)Arandomizedstudyofout-of-hospitalcontinuouspositiveairway pressure for acute cardiogenic pulmonary oedema: physiological and clinical effects. Eur HeartJ28(23):2895 2901 5. HilbertGetal(2001)Noninvasiveventilationinimmunosuppressedpatientswithpulmonary in ltrates,fever,andacuterespiratoryfailure.NEnglJMed344(7):481 487 6. PrincipiTetal(2004)Noninvasivecontinuouspositiveairwaypressuredeliveredbyhelmet in hematological malignancy patients with hypoxemic acute respiratory failure. Intensive CareMed30(1):147 150,Epub2003Oct31 7. RoccoMetal(2004)Noninvasiveventilationbyhelmet or face mask in immunocompromisedpatients:acase-controlstudy.Chest126(5):1508 1515 8. SquadroneVetal(2005)Continuouspositiveairwaypressurefortreatmentofpostoperative hypoxemia:arandomizedcontrolledtrial.JAMA293(5):589 595 9. BellaniGetal(2008)Theuseofhelmetstodelivernon-invasivecontinuouspositiveairway pressureinhypoxemicacuterespiratoryfailure.MinervaAnestesiol74(11):651 656 10. DelclauxCetal(2000)Treatmentofacutehypoxemicnonhypercapnicrespiratoryinsuf ciencywithcontinuouspositiveairwaypressuredeliveredbyafacemask:arandomizedcontrolledtrial.JAMA284(18):2352 2360
Section II Ventilatory Modes and Ventilators: Theory, Technology, and Equipment
Pressure Support Ventilation
4
EnricaBertellaandMicheleVitacca
4.1 Introduction Noninvasive ventilation (NIV) refers to the provision of mechanical ventilation (MV) through the patient s upper airway by means of a mask without the use of an invasive arti cialairway(endotrachealtubeortracheostomy)[1]. NIVhaslongbeenusedasthestandardmethodtotreatpatientswithchronicrespiratory failure(CRF)relatedtochestwalldiseases,neuromusculardisorders,orcentralhypoventilation.Ithasbeenshowntobeeffectiveintreatmentofdifferentformsofacuterespiratoryfailure(ARF)[2,3]. Respiratoryfailuredependsontwomainprocesses:lungfailure,whichleadsmainlyto hypoxemia, and pump failure, which leads mainly to hypercapnia. Causes of hypoxemic respiratory failure can be airway collapse, alveolar lling, low ventilation/perfusion ratio (V/Q), and shunt. Causes of hypercapnic respiratory failure can be depression of central inspiratorydrive(centralalveolarhypoventilation,decreasedchemosensitivity,hypothyroidism,useofdiuretics,metabolicalkalosis,narcoticsabuse);increasedinspiratoryload(increased airwayresistance,reducedchestwallorlungcompliance,dynamichyperin ation);orinspiratorymuscleimpairment(staticordynamichyperin ation,muscleweakness). Carbon dioxide (CO2) retention is mainly related to alveolar hypoventilation; thus, hypercapniasuggeststhatalveolarventilationisinadequatetocounterbalanceCO2production.Usually,patientswithCO2retentionhaveahigherrespiratoryrate,shorterinspiratorytime(Ti),andsmallertidalvolume(Vt)thanpatientswithnormalCO2levels. ThemaingoalsofMVare 1. Improvementofarterialbloodgases 2. Improvementofminuteventilation
M.Vitacca()andE.Bertella RespiratoryDivisionandWeaningCenter,FondazioneS.MaugeriIRCCS, Lumezzane(BS),Italy e-mail:
[email protected];
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_4,©Springer-VerlagBerlinHeidelberg2010
21
22
E. Bertella and M. Vitacca
3. Unloadingofinspiratorymuscles 4. Achievingoptimalventilator patientinteractionwithmaximalcomfort DifferentmodesofMVexisttoachievethesegoals;amongtheassistedmodalities,the mostusedispressuresupportventilation(PSV),amodeofpartialventilatorsupportthat duringspontaneousinspiratoryeffortsimposesasetlevelofpositivepressureinapatient withintactrespiratorydrive[4].
4.2 Mechanisms of Action PSVispressurelimitedandpatienttriggered,anditsuseassumesthatthepatientisableto initiateaninspiratoryeffort[5].Expirationispassive. PSV allows patients to control inspiratory and expiratory times while the ventilator providesasetpressure.Thismechanism,inconjunctionwithpatienteffortandrespiratory mechanics,determinestheinspiratory owandVt[6]. Theinspiratoryeffortisdetectedbyapressureor owsensorwithadjustabletrigger sensitivity.Thepressuretriggerrequiresadecreaseinairwaypressurefromend-expiratory leveltoasetthreshold.The owtriggerrequiresa owchangesuf cienttoreachapredeterminedthreshold[5]. Flow-triggered ventilators have been shown to be more sensitive than pressure- triggeredventilators.Triggersensitivityshouldbeoptimizedaccordingtopatientneed; atoosensitivetriggercausesautotriggering;aninsensitivetriggerincreasestheworkof breathing[6]. PSVisgenerally owcycled,meaningthattheexpiratorytriggerisdeterminedbya decreaseininspiratory owandwhen owfallsbelowaventilator-determinedthreshold level,theexhalationstarts[5].Someventilatorshavethepossibilitytosetatimelimitfor inspiration,atwhichtimethedevicewillcycleintoexpirationregardlessofthe ow[6]. PSVhasthemajortargetofassistingrespiratorymuscles,improvingtheef cacyof inspiratoryeffortandreducingworkload. InpatientswithARF,PSVreducestheworkofbreathingbyincreasingtranspulmonary pressure, the in ation of the lungs, the increase of Vt, and the reduction of inspiratory muscleworkload.PSVimprovesgasexchange rstlybyincreasingalveolarventilation and increases functional residual capacity (FRC), opening collapsed alveoli, reducing shunt,andimprovingtheV/Qratio(Fig.4.1). Pressuredeliverycanbeimprovedandtheworkofbreathingdecreasedbyincreasing inspiratorypressuresupportandreducingthepressurerisetime(thetimesettoreachthe presetinspiratorylevelthatcanbeindividuallyadjusted)[6]. Patientswithseverechronicobstructivepulmonarydisease(COPD)mustovercome thepresenceofintrinsicpositiveend-expiratorypressure(PEEP)totriggertheventilator;thus,theworkofbreathingisfurtherreducedbytheadditionofappliedPEEPthat counterbalancestheintrinsicPEEP[5].Theresultsaretheimprovementofdyspnoea
4
Pressure Support Ventilation
Fig.4.1 Fromtoptobottom: effectsofPSVon ow, airwaypressure(Pao), esophagealpressure(Pes), transdiaphragmaticpressure (Pdi),andtidalvolume(Vt). Leftpanel:patientbreathing spontaneously(SB);right panel:underpressure supportventilation(PSV)
23
SB
PSV
Flow (L/sec)
Pao (cmH2O)
Pes (cmH2O)
Pdi (cmH2O)
VT (L)
Time (sec)
andthereductionoftherespiratoryrate,CO2retention,andsternocleidomastoidmuscle activity[2]. Success with assisted ventilation is critically related to the adaptation of MV to the patient s needs. This is particularly true for NIV because the patient is conscious, and ventilationisineffectiveoruncomfortablewhenthepatientrejectsit. ThevariabilityinresponsetoPSVappearstobeparticularlypronouncedinpatients withCOPDduringARF.Thesepatientsusuallyshowwiderangesofairwayresistance, elastance,andintrinsicPEEP. Quitefewstudieshavebeenperformedtocomparedifferentventilatorymodesapplied noninvasivelyinCOPDpatientswithhypercapnicARF[7,8].Assistcontrolventilation seemstolowerrespiratoryworkloadbetterthanPSV,butitcausesgreaterpatientdiscomfort,morefrequentlossofbreathingcontrol,andlesspossibilitytocompensateformask leaks. Pressure-targeted ventilators have several advantages compared to volume-targeted ventilatorsandarethepreferredNIVdevicesinthetreatmentofARF.
4.3 Patient–Ventilator Interaction Patient ventilatorsynchronyisparamountforthesuccessoftheventilation.Thepresenceofasynchronydeterminesthepatient sdiscomfortandunnecessarilyincreasesthe workofbreathing. Patient ventilatorinteractionhasbeendescribed[9]asanexpressionoftwocontrollers:theventilator(controlledbythephysician)andthepatient srespiratorymusclepump. Thesecontrollersshouldbeinharmonytoobtainventilationappropriateforthepatient.
24
E. Bertella and M. Vitacca
Vignauxetal.[10]studiedtheprevalenceofpatient ventilatorasynchronyinpatients receivingnoninvasivePSVforARF.Autotriggeringwaspresentin13%ofpatients,double triggering in 15%, ineffective breaths in 13%, premature cycling in 12%, and late cyclingin23%. Autotriggeringoccurswhenarespiratorycycleisfalselytriggeredbyasignalnotproducedbythepatienteffort.ThemorefrequentcausesofautotriggeringduringPSVare expiratoryleaksfromthemask,settingtoosensitiveatrigger,patientmovement,ormotion ofwaterinthecircuit[4,5,10]. Autotriggeringcanbedif culttodetectonventilatorcurves.Itissuggestedbyasudden increaseorapersistentlyhighrespiratoryrate[4]. Doubletriggeringoccurswhenpatientdemandoreffortexceedsthe owdeliverysetting on the ventilator. If the level of pressure support is not suf cient, one pronounced inspiratoryeffortretriggerstheventilatoraftertheterminationofpressurization.Thishappens if the ventilator setting has not been adjusted to meet the patient s need or if the patient sdemandsuddenlyincreases,exceedingtheventilatorsetting[10,11]. Ineffectivetriggering(orwastedeffort)(Fig.4.2)islikelyinpatientswithCOPDand is most often due to the additional inspiratory threshold load associated with intrinsic PEEP[10].ThepresenceofintrinsicPEEPcreatesagreaterpressuregradientbetween lungpressureandventilatorcircuitpressure.Ifthepatient seffortisnotsuf cienttoovercomethisgradient,itcannotbetransmittedtothesensortotriggertheventilator[11].As explained,thisasynchronycanbereducedbyapplyinganexternalPEEP. Ineffectivetriggeringcanbedetectedonairwaypressureor owcurvesasirregularities duringtheexpiratoryphase. Premature cycling (or short cycling) is mainly related to restrictive pulmonary mechanics.ItischaracterizedbyTilastinglessthanTiduringspontaneousbreathing(ventilatorcyclesoffbeforetheendoftheneuralactivityoftheexpiratorymuscles)[4,11]. Prolonged cycling (or delayed cycling) occurs when there is a difference between patientneuralTiandventilatorsetbreathtermination(ventilatorcyclesoffonlyafterthe activityoftheexpiratorymusclesisinitiated)[11].DuringPSV,leakshavebeenshownto bethemaincausesofdelayedcycling,whileincontrastobstructivemechanicsarelikely tobeacontributingfactorforintubatedpatients[10].
25
Fig. 4.2 Representative tracingofineffective triggering(IT)duringPSV (arrow).Upperpanel: patientunderPSV presentingIT;lowerpanel: thesamepatientafterPSV resetting.Pao=pressureat airwayopening,and Pes=esophagealpressure
Pao (cmH2O) 0 20
Pes (cmH2O) Pao (cmH2O)
0
Pes (cmH2O)
4
Pressure Support Ventilation
25
Table 4.1 MorefrequentproblemsobservedduringPSV(Modi edfrom[6]) Problems Mechanisminvolvedandpossiblesolution Ineffectivetriggering
Airleaks(controlcircuitandinterfaces) Insensitivetrigger(adjusttriggersensitivity) Highworkofbreathing(addPEEP,changetoflowtriggerif pressuretriggerisused)
Autotriggering
Toosensitivetrigger(reducesensitivity) Airleaks(controlcircuitandinterfaces) Waterinthecircuit(checkcircuit)
Inappropriate pressurization
Toolongrisetime(reducerisetime)
Delayedcycleto exhalation
Airleaks(checkinterfacesandchangetofacialmaskifnasalisused)
CO2rebreathing
Ventilatorwithsinglecircuit(changetoatwo-linescircuit)
Insuf cientpressuresupport(increasesupport) Highendinspiratory ow(increase ow-cyclingthresholdorset timelimitforinspiration) Notrueexhalationvalve(usenonrebreathervalve) AbsenceofPEEP(addPEEP) Largedeadspaceinthemask(reducedeadspaceorchangemask) Highrespiratoryrate(lookforcausesoftachypnoea)
Pressure-targeted ventilators can compensate for air leaks, but this capability differs markedlybetweendifferentventilators[6]. CO2rebreathingisanotherproblemobservedwithsomehomebilevelventilatorsthat haveasinglegasdeliverycircuitanddonotcontainatrueexhalationvalve.HighrespiratoryrateandlowexternalPEEPthatshortenexpiratorytimeandlowerCO2lavagefrom thecircuitincreasetheriskofCO2rebreathing[6]. Table4.1reportsthemorefrequentproblemsobservedduringPSV.
4.4 Conclusions PSVisabletoreducetheworkloadoftheinspiratorymusclesandimprovethebreathing pattern. PSVisawidelyusedmethodofNIV.
26
E. Bertella and M. Vitacca
Key Recommendations
› ›
ToavoidpatientsdiscomfortandineffectiveeffortsPSVshouldbeused appropriatelyandbyexpertpeople. MonitoringandreadjustmentofPSVsettingareneededtohavesuccess.
References 1. BritishThoracicSocietyStandardsofCareCommittee.BTSguideline(2002)Non-invasive ventilationinacuterespiratoryfailure.Thorax57:192 211 2. HillN(2006)Noninvasivepositivepressureventilation.In:TobinMJ(ed)Principlesandpracticeofmechanicalventilation,chap19,2ndedn.,McGraw-Hill,NewYork,pp433 471 3. InternationalConsensusConferencesinIntensiveCareMedicine(2001)Noninvasivepositive pressureventilationinacuterespiratoryfailure.AmJRespirCritCareMed163:283 291 4. BrochardL,LelloucheF(2006)Pressuresupportventilation.In:TobinMJ(ed)Principlesand practiceofmechanicalventilation.chap9,McGraw-Hill,NewYork,pp221 250 5. Hess DR (2005) Ventilator waveforms and the physiology of pressure support ventilation. RespirCare50(2):166 186 6. SchonhoferB,Sortor-LegerS(2002)Equipmentneedsfornoninvasivemechanicalventilation.EurRespJ20:1029 1036 7. VitaccaM,RubiniF,FoglioK,ScalviniS,NavaSetal(1993)Non-invasivemodalitiesof positivepressureventilationimprovetheoutcomeofacuteexacerbationinCOLDpatients. IntensiveCareMed19:450 455 8. GiraultC,RichardJC,ChevronV,TamionF,PasquisPetal(1997)Comparativephysiologic effects of noninvasive assist-control and pressure support ventilation in acute hypercapnic respiratoryfailure.Chest111:1639 1648 9. Kondili E, Prinianakis G, Georgopoulos D et al (2003) Patient ventilator interaction. Br J Anaesth91(1):106 119 10. VignauxL,VargasF,RoeselerJetal(2009)Patient ventilatorasynchronyduringnon-invasive ventilationforacuterespiratoryfailure:amulticenterstudy.IntensiveCareMed35:840 846 11. NilsestuenJO,HargettK(2005)Usingventilatorgraphicstoidentifypatient ventilatorasynchrony.RespirCare50(2):202 234
Ventilators for Noninvasive Mechanical Ventilation
5
RaffaeleScala
5.1 Introduction Theuseofnoninvasivepositivepressureventilation(NPPV)totreatbothacuterespiratory failure(ARF)andchronicrespiratoryfailure(CRF)hasbeentremendouslyexpandedin thelasttwodecadesintermsofspectrumofdiseasestobesuccessfullymanaged,settings ofapplication/adaptation,andachievablegoals[1 3]. ThechoiceofaventilatormaybecrucialfortheoutcomeofNPPVintheacuteand chronicsettingaspoortoleranceandexcessiveairleaksaresigni cantlycorrelatedwith thefailureofthisventilatorytechnique[4].Patient ventilatordyssynchronyanddiscomfortmayoccurwhentheclinicianfailstoadequatelysetNPPVinresponsetothepatient s ventilatorydemandsbothduringwakefulnessandduringsleep[5,6].Thisobjectivemay bemoreeasilyachievedifthetechnicalpeculiaritiesoftheappliedventilator(i.e.,ef ciency of trigger and cycling systems, speed of pressurization, air leak compensation, CO2 rebreathing, reliable inspiratory fraction of O2, monitoring accuracy) are fully understood. WiththegrowingimplementationofNPPV,awiderangeofventilatorshasbeenproducedtodeliveranoninvasivesupportbothinrandomizedcontrolledtrialsandin reallife scenarios. This chapter examines the key points concerning the technology of ventilatorsforNPPVandtheirmainimpactinclinicalpractice.Duetoconstraintsinspace, ventilators for negative pressure ventilation (i.e., iron lung, cuirass, poncho-wrap) arenotcovered.
R.Scala UnitàOperativadiPneumologiaeUnitàdiTerapiaSemi-IntensivaRespiratoria, AUSL8,OspedaleS.Donato,ViaNenni,20,52100,ArezzoItaly e-mail:
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_5,©Springer-VerlagBerlinHeidelberg2010
27
28
R. Scala
5.2 Classification of Ventilators EvenifanyventilatorcanbetheoreticallyusedtostartNPPVinbothARFandCRF,successismorelikelyiftheventilatorisableto(a)adequatelycompensateforleaks;(b)let thecliniciancontinuouslymonitorpatient ventilatorsynchronyandventilatoryparameters due to a display of pressure ow volume waveforms and a double-limb circuit; (c)adjustthefractionofinspiredoxygen(Fio2)withablendertoensurestableoxygenation;and(d)adjustinspiratorytriggersensitivityandexpiratorycyclingasanaidtomanagepatient ventilatorasynchronies[4]. Ventilators may be classi ed in four categories, whose features are summarized [4] inTable5.1. 1. Volume-controlled home ventilators were the rst machines used to deliver NPPV mostlyfordomiciliarycare;evenifwellequippedwithalarms,monitoringsystem,and innerbattery,theirusefulnessforapplyingNPPVislargelylimitedbytheirinabilityto compensateforairleaks.Consequently,theirapplicationistodayrestrictedtohomebasednoninvasivesupportofselectedcasesofneuromusculardisordersandtoinvasive supportofventilatory-dependenttracheostomizedpatients. 2. Bilevelventilatorsaretheevolutionofhome-basedcontinuouspositiveairwaypressure (CPAP) devices and derive their name from their capability to support spontaneous breathingwithtwodifferentpressures:aninspiratorypositiveairwaypressure(IPAP) andalowerexpiratorypositiveairwaypressure(EPAP)orpositiveend-expiratorypressure (PEEP). These machines were speci cally designed to deliver NPPV thanks to theiref ciencyincompensatingforairleaks.Duetotheireasyhandling,transportability,lackofalarmsandmonitoringsystem,andlowcosts,the rstgenerationofbilevel ventilators matched the needs for nocturnal NPPV in chronic patients with a large ventilatoryautonomy.However,traditionalbilevelventilatorsshowedimportanttechnicallimitations(riskofCO2rebreathingduetotheirsingle-limbcircuitinnonvented masks; inadequate monitoring; lack of alarms and O2 blending, limited generating pressures;poorperformancetofacetheincreaseinrespiratorysystemload;lackofbattery),whichhavebeenlargelyovercomebymoresophisticatedmachines.Thenewer generationsofbilevelventilatorshavegainedpopularityinclinicalpracticeforapplicationofacuteNPPVespeciallyinsettingswithhigherlevelsofcareaswellastoinvasivelysupportventilatory-dependentchronicpatientsathome. 3. Intensivecareunit(ICU)ventilatorswereinitiallydesignedtodeliverinvasiveventilation viaacuffedendotrachealtubeortrachealcannulaeithertosickpatientsintheICUorto the theatre room to allow surgery procedures. Despite good monitoring of ventilatory parametersandof ow pressure volumewavesaswellasa nesettingofFio2andof ventilation,performanceofconventionalICUventilatorstodeliverNPPVispoorasthey arenotabletocopewithleaks.So,anewgenerationofICUventilatorshasbeendevelopedtoef cientlyassistacutepatientswithNPPVthankstotheoptionofleakcompensation(i.e., NPPVmode ),whichallowspartialortotalcorrectionofpatient ventilator asynchronyinducedbyairleaks,evenifwithalargeintermachinevariability.
+/
++ ++
Yes
+++
Some
No
+
Yes +++ NewICU ventilators Absent;+/ low/absent;+low;++moderate;+++high
Conventional ICUventilators
Intermediate ventilators
+/ Secondgenerationbilevel ventilators
No
First-generation bilevelventilators
+++
No
Volume-target ventilators
+
Monitoring
Pressometric +++ andvolumetric
Pressometric +++ andvolumetric
Pressometric ++ andvolumetric
Pressometric ++ andvolumetric
Pressometric
Volumetric
Table 5.1 CharacteristicsofthefourcategoriesofventilatorsforNPPV CO2 Blender Adjustment Modality oftrigger ofNPPV rebreathing O2 andcycling
+++
++
+++
+++
+++
+++
+++
++
++
Airleak Alarms compensation
Yes
Yes
Yes
Yes
No
Yes
Battery
+/
+/
++
+++
+++
++
+++
+++
++
++
+
++
Transportability Costs
5 Ventilators for Noninvasive Mechanical Ventilation 29
30
R. Scala
4. Intermediate ventilators combine some features of bilevel, volume-cycled, and ICU ventilators(dual-limbcircuit;sophisticatedalarmandmonitoringsystems;innerbattery; both volumetric and pressometric modes; wide setting of inspiratory and expiratory parameters). These new machines are studied to meet the patient s needs both in the homeandinthehospitalcarecontextaswellastosafelytransportcriticallyillpatients.
5.3 Technologic Issues 5.3.1 Source of Gas and Oxygen Supply ICUventilatorsareequippedwithhigh-pressureairsourcesandwithablenderwhereO2 fromhigh-pressuresourcesandroomairarevariablymixed,makingtheFio2controlled and stable. Conversely, bilevel and several intermediate ventilators are provided with eitheracompressororanelectricallysuppliedturbinepumptopressurizetheroomair, whichmaynotensureaconstantlystablepressurization;moreover,thesemachinesdonot haveablender,soO2isdeliveredfromlow-pressuresources,andtheFio2duringNPPVis noteasilypredictablebecauseitisdependentonseveralvariables:siteofO2enrichment, typeofexhalationport,ventilatorsetting,O2 ow,breathingpattern,andamountofleaks [4].ItwascalculatedthatthehighestFio2isachievedwiththeleakportinthecircuitand O2addedintothemaskbyusinglowIPAPlevels[7](Table5.2).
5.3.2 Circuit RespironicsBiPAP,likemostofthe rst-generationbilevelventilators,isprovidedwitha single-limbcircuit,andtheexhalationoftheexpiredairoccursthroughthewhisperswivel, a xed-resistance,variable- ow,leakportsituatedinthecircuitproximallywithrespectto theinterface.ThisequipmentexposesthepatienttotheriskofCO2rebreathing,which maybedetrimentalwhentreatinghypercapnicpatients[8].Theoptionsthattheclinician hastopreventthisriskare(a)keeptheconventionalwhisperswivelandapplyhighEPAP levels, such as 8 cmH2O, which therefore may be poorly tolerated; (b) use the plateau exhalation valve which, thanks to its diaphragm, limits air leaks during inspiration and allowsunidirectionalair owduringexpiration;(c)applyanonrebreathingvalve( mushroom, diaphragm, balloon valve),whichworkslikea truevalve asduringtheinspirationthediaphragmoritsballoonisin atedwithafullocclusionoftheexpiratorycircuit limb,whileduringtheexpiration,asthevalveisde ated,theairisallowedtobeexhaled throughout. However, even with a large variability, these valves may interfere with the resistanceandtheexpiratoryworkandthereforemayincreaselunghyperin ation(i.e., intrinsicPEEP)[4]. TheCO2rebreathingisalsoin uencedbythesiteoftheexhalationport,beingsigni cantlylowerwhenusingafacialmaskwiththeexhalationportinsidecomparedtoafacial
5 Ventilators for Noninvasive Mechanical Ventilation
31
Table 5.2 KeypointsoftheperformanceofventilatorsforNPPV[4] Sourceofgases Compressedmedicalgases Compressororelectricallysuppliedturbinepump Oxygensupply High-pressuresourceswithablender Low-pressuresourceswithconnectionattheventilator,circuit,mask Circuit Single-limbcircuitwithnonrebreathingvalve,plateauexhalationvalve,orwhisper Double-limbcircuit Inspiratorytriggerwithsensitivitychangeableornot Flow,pressure,volume,mixed Expiratorycycle Flowdependent(withthresholdchangeableornot),timedependent,autofunction Inspiratory owchangeableornot Backuprespiratoryrate Airleakcompensation Humidi cation Heatedhumidi ers,heat moistureexchangers Battery Internal,additionalexternal Alarms Lackorminimal Sophisticated Monitoringsystems Onlysomeinspiratoryparameters Inspiratoryandexpiratoryparameters Flow,volume,pressurecurves Modeofventilation Onlyspontaneousmodeswithout(PSV,PAV)orwithaguaranteedVT(VAPS) Bothspontaneous(PSV,PAV)andmandatorymodes(VCV,PCV) Interface Nasalmask,full-facemask,total-facemask,helmet,mouthpiece PSVpressuresupportventilation,PAVproportionalassistventilation,VAPSvolume-assuredpressuresupportventilation,VCVvolume-controlledventilation,PCVpressure-controlledventilation
32
R. Scala
maskwiththeexhalationportinthecircuitandatotal-facemaskwiththeexhalationport inside[9]. With ventilators that have a dual-limb circuit in which a complete separation exists betweeninspiratoryandexpiratorylines(i.e.,ICU,last-generationbilevel,andintermediate ventilators),thereisnoriskofrebreathing.
5.3.3 Inspiratory Trigger and Expiratory Cycle Theoptimizationofpatient ventilatorinteractionduringNPPVisessentiallybasedonthe technological ef ciency of the machine in detecting the patient s minimum inspiratory effortasquicklyaspossible(i.e.,inspiratorytrigger)andinendingthedeliveryofmechanicalsupportascloseaspossibletothebeginningofthepatient sexpiration(i.e.,expiratory cycling)independentlyfromtherespiratorysystemimpedanceandfromtheairleaks[4]. Ideally,theinspiratorytriggershouldbesetatthehighersensitivitycapableofreducing thepatient seffortneededtoactivatethemechanicalsupport.Bilevelventilatorsequipped with owtriggersareassociatedwithlowerworkofbreathingandshortertriggeringdelay timewithrespecttothoseequippedwithpressuretriggers[10].However,atoosensitive trigger,especiallyif owbased,mayinduceauto-triggeringduringNPPVwithsubstantial airleaksand,consequently,patient ventilatordyssynchronywith wastedefforts. Inspiratory triggerfunctionmaysigni cantlydiffernotonlyamongthedifferentcategoriesofventilators but also within the same category due to the structural features of the circuit (i.e., single-limbcircuitwithhighresistivevalves; incompletedual-limbcircuit ;andaPEEP valveintheshortexpiratorylimb)andtheheterogeneityintheirperformance(pressure timeand ow timewaveforms,triggerdelay,leak-inducedautotriggeringduringNPPV with ow-triggeredventilators). Thecyclingtoexpirationoptimizesthesynchronybetweentheinspiratorytime(Ti)of thepatientandthatofthemachine.Duringpressuresupportventilation(PSV),cyclingto expirationis owdependentandoccursatathreshold,whichisthedecreasein oweither to a default or changeable percentage (usually 25%) of inspiratory peak ow or to an absolute ow[5].Patient ventilatordyssynchronywithexpiratorymuscleactivationand wasted efforts due to incomplete lung emptying may happen under NPPV in case of excessiveairleaks,whichdelayoravoidtheinspiratory owtoreachthethreshold(i.e., inspiratory hang-up ) [5]. Successful strategies in preventing the inspiratory hang-up maybeappliedwithsomeventilators:(a)setasuitablethresholdoramaximumTi;(b) usespecialalgorithms(i.e., autotracksystem );(c)switchtopressure-controlledventilation(PCV)mode,inwhichexpiratorycyclingistimedependent.Thechanceof nely settingthethresholdforexpiratorycyclingthankstothedisplayofmechanicswaveforms availableinsomenewerventilatorsmaybehelpfulclinicallytoimprovepatient ventilator synchrony during NPPV as well as comfort and the possibilities of success [4]. As observedwiththeinspiratorytrigger,thebehaviorofdifferentventilatorsvariesinterms ofcyclingtoexpiration,andamarkedheterogeneityisreportedforagivenventilatorin responsetovariousconditionsofrespiratorymechanicsandairleaks.Generally,mostof
5 Ventilators for Noninvasive Mechanical Ventilation
33
thebilevelventilatorsuseacutoffatahigherfractionofinspiratory owthanmostofthe ICU ventilators to avoid the mask leak-induced deleterious prolongation of Ti. As a matterofafact,newerbilevelventilatorstendtocycleprematurelytoexpirationunder normalrespiratorysystemmechanics,andthistendencyisexaggeratedinrestrictiveconditions. Conversely, under obstructive conditions, most of the bilevel ventilators show delayed cycling, and this behavior is greatly exaggerated by the presence of air leaks. Consequently, at their default setting, bilevel ventilators seem to be better adapted for supportingobstructedpatients[4].Oppositetobilevelventilators,intheabsenceofleaks andattheirdefaultsetting,newerICUventilatorspresentsomedegreeofdelayincycling toexpirationthatisworsenedbyobstructiveconditions,whilerestrictivemechanicslead toprematurecycling.Theadditionofleaksincreasesthedelayedcyclinginnormaland obstructiveconditionsandpartiallycorrectsprematurecyclinginrestrictivestatus.This dyssynchronyinexpiratorycyclingmaybepreventedbyusingNPPVmodesinnormal andobstructivemechanics[4].
5.3.4 Inspiratory Flow It is known that severely dyspneic patients with chronic obstructive pulmonary disease (COPD)copebetterwithhigherinspiratory owandpatientswithneuromuscularproblemsdobetterwithlowerinspiratory ow(i.e.,pressurerisetimeof0.05 0.1sand0.3 0.4s, respectively)[4].Inmostofthebilevelventilators,thisparameterisunchangeable;conversely,inmoreadvancedbilevelventilators,aswellasinmostoftheintermediateand ICUventilators,therisetimemaybesetwithapotentialprofoundeffectonunloadingof respiratorymuscles,tolerance,andleaks.Inaphysiologicstudy,thehighestpressurization ratewasassociatedwithincreasedairleakageandpoorerNPPVtoleranceeventhoughthe diaphragmaticeffortwasincreasinglyreducedcomparedtolowerspeedswithoutsigni cantdifferencesinbloodgasesorbreathingpattern.Asthepatient scomfortwasnotdifferentatthelowerpressurizationspeeds,theauthorssuggestedthattheindividualtitration shouldbetargetedtoachievegoodtoleranceandtominimizeairleaks,keepingarelatively highpressurizationrate[11].
5.3.5 Backup Respiratory Rate Somebilevelventilatorsdonothavetheoptionofsettingabackuprespiratoryratef,which thereforeraisesthecosts.Conversely,thegreatmajorityofnewerbilevelventilatorsand allintermediateandICUventilatorsareequippedwithabackupf.Thisoptionisparticularlyadvantageousinsickerpatientswithinstabilityoftheirrespiratorydriveasitprevents thephenomenaofapneaandofperiodicbreathing,suchasCheyne Stokesinchronicheart failure.Backupfmayalsobeusefulwhencautioussedationisadministeredtoimprove patientcompliancetoNPPV[4].
34
R. Scala
5.3.6 Air Leak Compensation Duetothekindofinterfaceused,airleaksarealmostaconstantfeatureofNPPVandmay interferewiththepatient scomfort,patient ventilatorsynchrony,and,eventually,thelikelihoodofsuccessinbothacuteandchronicpatients[1 6]. Unintendedleaks mayoccur throughthemouthduringnasalventilationorbetweentheinterfaceandtheskinwithboth nasal and oronasal masks. On the other hand, the attempt of tightly tting the straps of headgeartoreduceairleaksshouldbeavoidedbecausethismayreducethepatient stolerance and predispose to skin damage. Consequently, it is important to have a ventilator capable of well compensating air leaks during NPPV. Air leak compensation is greater whenusingbilevelratherthanvolume-targethomeventilators,withthefallintidalvolume VTmorethan50%withthelatter(Fig.5.1).Conversely,thefallinVTislessthan10%and inIPAPlessthan8%withbilevelventilatorsincaseofleaksthankstoanadequateincrease intheinspiratory owandintheTi.However,theeffectsofairleaksduringNPPVaremore complexthanthesimplefallinIPAPandVTduetotheroleplayedbyfurthervariables,such as Ti, expiratory cycling, and inspiratory trigger sensitivity. Mathematical models that
BiPAP (Respironics)
40
Nippy (Friday Medical) Monnal D (Taema)
Change in VT when leak opened %
20
Companin 2801 (Puritan Bennet)
0 −20 −40 −60 −80
−100 0
200
400
600
800
1,000
VT mL
Fig. 5.1 EffectofanadditionalleakonthetidalvolumeVTdeliveredbyfourhomeventilatorstested inalungmodel.TherelationshipbetweenthepercentagechangesinVTwithleakopenedandthe VTdeliveredintheabsenceofaleakshowedthatpressure-target(BiPAP,Nippy)andnotvolumetargethomeventilators(MonnalD,Companion2801)wellcompensatedfortheleak[4]
5 Ventilators for Noninvasive Mechanical Ventilation
35
a nalyzethecomplexinteractionbetweenairleaksandPSVintheobstructiveconditions andtheirpotentialclinicalimplicationhavebeenrecentlyimplemented.Eventhoughall bilevelventilatorsandmostintermediateandnewerICUventilatorsequippedwithNPPV modeswereabletocompensateforairleaks,theirperformancewasnotuniform[4].
5.3.7 Battery ForbothacuteandchronicpatientswithahighlevelofdependencyonNPPV,abattery powersourceismandatoryincaseofelectricitysupplyfailureathomeandincaseofneed totransportthepatientwithinthesamehospitalortoanotherhospital.However,theclinicianmustbeawarethatbatterydurationmaydiffergreatlyamongthedifferentportable ventilatorsandmaybeshorterthanthatreportedintheoperator smanual.Moreover,portableventilatorbatterydurationisaffectedbythesetting,thelungimpedancecharacteristics, andtheventilatorfeatures[4]. As an alternative or in addition to internal batteries for NPPV ventilators, it is also possibletouseexternalbatteriesthatguaranteeprolongedautonomyoftheventilatorin caseofelectricityblackout.Ithastobeconsideredthatexternalbatteriesmaymakethe ventilatortooheavyifitneedstobetransported.
5.3.8 Alarm and Monitoring System The need for sophisticated alarms and monitoring systems during NPPV is essentially basedonclinicalpracticeasuntilnowthereisnoscienti cevidencefortheirclinicalutility.Thisisespeciallytrueforpatientswithhomeventilation,socaremustbetakenwhen settingthealarmsontheventilatortoensurethattheywillonlyfunctionwhenagenuine needarisesasfrequent,oftenspurious,alarmscansigni cantlydisturbthesleepofthe patient.TheprototypeoftheRespironicsBiPAPhasneitheralarmnormonitoringfeatures, withanadvantageincostandtransportabilityforhomecare.Intheacutesetting,theavailabilityofnewerbilevel,intermediate,andICUventilatorswithmoresophisticatedalarms (i.e.,lowandhighpressure,VT,f,Fio2,leaks)andmonitoringgraph(i.e., ow,VT,and pressure curves) may be useful in terms of safety and in improving patient ventilator interaction[4,5].Conversely,tooelaboratealarmsmaybecounterproductiveinclinical practicesincetheyfrequentlyindicateveryminorairleaksduringNPPV. ThekeyparametertobemonitoredistheexpiratoryVTasexcessiveairleaksmaycause asigni cantdiscrepancybetweeninspiratoryandexpiratoryVT.Single-limbcircuitbilevel ventilatorsallowmonitoringonlytheinspiratoryVT,whichcorrespondstothesumofthe patient sVTandtheairleaks;astheinspiratoryVTincreasesforairleakcompensation,it doesnotre ectdirectlytheminuteventilationofthepatient.Moreover,theexpiratoryVT estimated by some bilevel ventilators has not been validated. Dual-limb circuit bilevel ventilators,aswellasmostoftheintermediateandalltheICUventilators,allowclose monitoringofexpiratoryVT,whosevalueismorereliablewithmachinesthatmakethe
36
R. Scala
measurement at the level of the expiratory branch of the Y-tube than with those that measureitattheinletoftheexpiratorytubeintotheventilator[4].
5.4 Controversial Issues
Moderate
Low
PS 5, 10 and 15 cmH2O
5
High
#
#
$
#
$
PB 7200*
Servo 900C*
2
Adult Star*
3
Bird 8400*
4
Bear 1000*
Inspiratory Area at 0.3 sec (cmH2O.sec)
Due to the huge gap between the commercially available increasing number of newer ventilators and their physiologic and clinical careful evaluation, unfortunately we still havenotpublisheddataaboutseveralsophisticatedventilatorsroutinelyusedinclinical practice.Becausetherearefewinvivoinvestigations,themajorityofdataabouttheperformanceofthedifferentavailableventilatorscomesfrominvitrostudiesconductedona lungmodel.Therefore,somedoubtsremainabouttherealclinicalsigni canceofthetechnical differences observed in the bench studies among the various types of ventilators. Consequently,everyextrapolationoftheseexperimentaldatatoclinicalpracticemustbe donecautiouslysincenolungmodelcansimulatetheventilatoryvariabilityobservedin patients.Thisisparticularlytruewhenthe ndingsofinvitrostudieshavetobeappliedto acutepatientsunderNPPVinthepresenceofleaks. Based on the published data, despite a wide heterogeneity found in each category of machines, several bilevel ventilators demonstrated better performance compared to some conventional ICU ventilators (Fig. 5.2) [4]. However, no study has shown greater NPPV clinicalsuccessforonetypeofventilatorthananotherinbothacuteandchronicsettings. Nevertheless,somepointsshouldbeclearwhentheclinicianhastochooseaventilator[4].
#
$
$
1 0 Helia**
Achieva**
Respicare**
O’Nyx**
Quantum**
St 30**
T Bird**
Vision**
Veolar*
PB 740**
Horus
Galileo
PB 840
Evita IV
Servo 300
Evita II dura
-2
Evita II
-1
Fig. 5.2 Pressurizationrateintheearlyinspiratoryphaseevaluatedinalungmodelastheinspiratoryareainthe rst0.3sofinspirationaccordingtothreelevelsofpressuresupport(PS5,10, 15cmH2O)andthreesimulatedlevelsofinspiratoryeffort(low,moderate,high)for22ventilators (fromlefttoright:sevennew-generationICUventilators,sixold-generationICUventilators,and ninepiston-orturbine-drivenhomeventilators).Allnew-generationICUventilators,butalsomost home devices, outperformed old-generation ICU ventilators. * Old-generation ICU ventilators; **Piston-orturbine-drivenhomeventilators;#p<0.05vsallnew-generationICUventilators; $p<0.05vsatleastoneofthenew-generationICUventilators[4]
5 Ventilators for Noninvasive Mechanical Ventilation
37
Key Recommendations
›
›
›
›
Asexcessiveairleaksarecorrelatedwithtreatmentfailure,theclinicianshould chooseventilatorsdesignedforNPPVwithleakcompensationcapability(i.e., bilevel,someintermediate,andnewICUventilators);moreover,thechanceof settingseveralparametersandlookingat ow volume pressurewaveformswith newerventilatorsmaybehelpfulinimprovingpatient ventilatorsynchrony, comfortand,itishoped,clinicaloutcome. Thechoiceofventilatorshouldbetailoredtothepathophysiologyandtheseverity ofARFandCFR.Intheacutesetting,forhypoxemicpatients,ventilatorswithan O2blenderarerecommended,whileinthosewithhypercapnia,ventilatorswitha dual-limbcircuithaveanadvantageinloweringPaco2.InpatientswithmildCOPD exacerbation,theuseofhomeventilatorsmaybeappropriate,particularlyifthe patientisalreadyonhomeNPPV;bycontrast,patientswithlife-threateningARFat riskofintubationshouldbetreatedwithmoresophisticatedmachines.Inthe chronicsetting,conditionsforwhichrespiratorydriveisgood(i.e.,COPD)could useasimpleventilatorthatworksinaspontaneousmode,whereasthoseforwhom respiratorydriveisabsentmusthaveamandatorybackuprate;conversely,inthe caseoffast-progressingneuromusculardiseases,moresophisticatedventilators withadequatemonitoringequipmentandaninnerbatteryarerecommended. Theselectionofaventilatorshouldalsotakeintoaccountcostsandstaff experience.Themoresophisticatedaventilatoris,thelongeristherequired trainingforclinicians.Duetothetremendousgrowthoftheventilatormarketin termsofcomplexity,someofthenewbilevelventilatorsarenotuserfriendly evenfortrainedICUclinicians.Thesmallerthevarietyofdevicesused,the greaterthelikelihoodthatallteammemberswillacquireenoughexperiencein NPPVsetupwithpositiverepercussionsincostsandworkload. Theclinicianshouldbeawareofthemultipleinterferencesoftheaccessoriesfor NPPV(interfaces,exhalationsystems,pressuresettings,andhumidi cation devices)withtheperformanceofthedifferentcategoriesofventilators.For example,concerninghumidi cationduringNPPV,heatedhumidi ersshowgreat clinicalandphysiologicaladvantagescomparedtoheat moistureexchangers, eventhoughtheformerismoretimeconsuming.
References 1. NavaS,HillN(2009July18)Non-invasiveventilationinacuterespiratoryfailure.Lancet 374(9685):250 259 2. OzsancakA,D AmbrosioC,HillNS(2008May)Nocturnalnoninvasiveventilation.Chest 133(5):1275 1286 3. AnnaneD,OrlikowskiD,ChevretSetal(2007Oct17)Nocturnalmechanicalventilationfor chronichypoventilationinpatientswithneuromuscularandchestwalldisorders.Cochrane DatabaseSystRev(4):CD001941
38
R. Scala
4. ScalaR,NaldiM(2008Aug)Ventilatorsfornoninvasiveventilationtotreatacuterespiratory failure.RespirCare53(8):1054 1080 5. VignauxL,VargasF,RoeselerJetal(2009May)Patient ventilatorasynchronyduringnoninvasiveventilationforacuterespiratoryfailure:amulticenterstudy.IntensiveCareMed35(5): 840 846 6. FanfullaF,TaurinoAE,LupoNDetal(2007Aug)Effectofsleeponpatient/ventilatorasynchronyinpatientsundergoingchronicnon-invasivemechanicalventilation.RespirMed101(8): 1702 1707 7. SchwartzAR,KacmarekRM,HessDR(2004)Factorsaffectingoxygendeliverywithbi-level positiveairwaypressure.RespirCare49(3):270 275 8. FergusonGT,GilmartinM(1995)CO2rebreathingduringBiPAPventilatoryassistance.Am JRespirCritCareMed151(4):1126 1135 9. SchettinoGP,ChatmongkolchartS,HessDRetal(2003)Positionofexhalationportandmask designaffectCO2rebreathingduringnoninvasivepositivepressureventilation.CritCareMed 31(8):2178 2182 10. NavaS,AmbrosinoN,BruschiCetal(1997)Physiologicaleffectsof owandpressuretriggeringduringnon-invasivemechanicalventilationinpatientswithchronicobstructivepulmonarydisease.Thorax52(3):249 254 11. PrinianakisG,DelmastroM,CarlucciAetal(2004)Effectofvaryingthepressurisationrate duringnoninvasivepressuresupportventilation.EurRespirJ23(2):314 320
Noninvasive Positive Pressure Ventilation Using Continuous Positive Airway Pressure
6
PedroCaruso
6.1 Introduction Continuouspositiveairwaypressure(CPAP)isatechniqueofrespiratorytherapy,ineither invasivemechanicallyornoninvasivemechanicallyventilatedpatients,inwhichairway pressure is maintained above atmospheric pressure at a constant value throughout the inspirationandexpirationbypressurizationoftheventilatorcircuit.Thischapterdiscusses theequipmentandtechnologyavailabletodeliverCPAPinnoninvasivepositivepressure ventilation(NPPV)inthehospitalscenarioanddoesnotdiscusstheequipmenttodeliver CPAP to patients with obstructive sleep apnea-hypopnea or at home care services. The interfacestodeliverCPAParenotdiscussed. CPAPef cacyhasbeencon rmedincommonclinicalconditionssuchascardiogenic pulmonary edema, chronic obstructive pulmonary disease, and chest wall trauma [1]. CPAPcanbeprovidedwithcontinuous owgenerators,intensivecareunit(ICU)ventilators (high-pressure-driven ventilators), ventilators designed to administer noninvasive positivepressureventilation(NPPVventilator)withorwithoutNPPVmodesandother medicaldevices,suchasthebubbleorBoussignacCPAP.
6.2 Equipments 6.2.1 Continuous Positive Pressure Flow Generators Continuous positive pressure ow generators are electricity-independent devices that utilizeanoxygen-drivenventuritoentrainatmosphericair,producinghighfreshgas ows. Theresultantoxygen airmixtureentersasingle-limbbreathingcircuitandexitsthrough P.Caruso UTI RespiratóriadoHospitaldasClínicasda FaculdadedeMedicinadaUniversidadedeSãoPaulo,SãoPaulo,Braziland UTI HospitalACCamargo,SãoPaulo,Brazil e-mail:
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_6,©Springer-VerlagBerlinHeidelberg2010
39
40
P. Caruso
a threshold resistor (the CPAP valve) in the mask or helmet (acting as a double-limb circuit).CPAPvalveshaveaspring-loadedvariableori cedesignthatopenatasetpressureandshouldmaintainconstantupstreampressureas owvaries( owindependence). Thegas owrateandO2inspiratoryfractiongeneratedbythecontinuous owgenerator areadjustableusinguncalibrateddials.Themanufacturersallegea owupto140l/min, buthigher owsaredescribed[2].Tomitigatethedecreaseofpressureduringinspiration, a continuous positive pressure ow generator uses an inspiratory reservoir (CF 800, Dräger,Lübeck,Germany). Thecontinuouspositivepressure owgeneratoradvantagesaresimpleuse,highportability,electricityindependence,andlowercosts.Thedisadvantagesarehighnoisetopatients andstaff,lackofmonitoringoralarms,and,mainly,lowperformance(decreaseofpressure duringinspirationorinabilitytoattainthepresetpressure).Twobenchstudies[2,3]demonstratedthatthemultiplepossibleadjustmentsinacontinuous owgenerator(fractionof O2,pipelinesupply,valveload,and owadjustment)maketheperformanceofacontinuous owpositivepressuregeneratorexcessivelyvariableandunpredictable.Besidesthat,the ubiquitousmask/circuitleak,aconditionnottestedinthosestudies,wouldmaketheperformanceofthe owgeneratorsevenmoreunpredictableandcertainlymoreunsuitable.
6.2.2 Intensive Care Unit Ventilators (High-Pressure-Driven Ventilators) The ICU ventilators offer CPAP mode, but they are designed to be used in intubated patients, so air leak, a ubiquitous condition in NPPV, is not contemplated. However, ICU ventilators can provide satisfactory CPAP since major air leaks are not present, and some adjustments are observed: adequate inspiratory ows, triggering sensitivity adjustedtopreventautocycling,andamechanismavailabletolimitinspiratorytimeand avoidinspiratory-to-expiratoryratioinversion[4].Dependingonthecriticalcareventilatorselected,CPAPmaybeadministeredusing demand, ow-by, or continuous ow techniques, with imposed work differing slightly between them in intubated patients[5]. TheICUventilatormanufacturershavebeenofferingICUventilatorsthattheyclaim areabletodeliverNPPVinthepresenceofleaks.However,theseventilatorswerenot testedintheCPAPmode.Astudythatevaluatedtheperformanceofthoseventilatorsin NPPVduringpressuresupportventilationconcludedthatleaksinterferedwithseveralkey functions,andtheNPPVmodecouldcorrectpartorallofthisinterferencebutwithwide variationsbetweenmachinesintermsofef ciency[6].
6.2.3 Ventilators Designed to Administer Noninvasive Positive Pressure Ventilation TheNPPVventilatorsaredesignedtobeusedinthepresenceofairleaks.Theyaremicroprocessedsystems,turbinedrivenandwithasingle-limbcircuitwithnonrebreathingvalve,
6
Noninvasive Positive Pressure Ventilation Using Continuous Positive Airway Pressure
41
plateauexhalationvalve,orwhisperswivel.Theyofferalarmsandamonitoringsystem.In theory,NPPVventilatorsshouldbebetterthantheotherdevicestoofferCPAPinNPPV. Two studies using lung simulators compared NPPV to continuous positive pressure owgeneratorsorICUventilators.The rststudycomparedanNPPVventilator(BiPAP, RespironicsInc.,Murrysville,PA)withtwocontinuouspositive owgenerators(Adjustable DownsFlowGenerator VitalSign,NewJersey;andWhisperFlow,Respironics-Philips, Murrysville, PA) to deliver CPAP. In that study, adjusted to their better oxygen supply pressure, owgeneratorshadasimilarorbettercapacitytomaintaintheCPAPlevel,but theNPPVventilatorwasmorereliableforattainingthepresetCPAP[2].Thesecondstudy comparedthesameNPPVventilator(BiPAP)tonineICUventilatorsintheNPPVmode. TheNPPVventilatorandoneventilator(ServoI,Maquet,Solna,Sweden)weretheonly ventilatorsthatrequirednoadjustmentsastheyadaptedtoincreasingleaks[7].Theclinicalsigni canceofthedifferencesbetweenNPPVventilatorsandICUventilatorswiththe NPPVmodeisunclear.
6.2.4 Boussignac CPAP TheBoussignacCPAPisasimplesystemforuseonafacemaskandisbasedonthegenerationofpositiveairwaypressurebyajet[8].Pressureisgeneratedbytheinjectionof gases, which pass through four microcapillaries (located all around the CPAP device), increasinginspeedandgeneratingturbulence,thereforecreatinga virtualvalve. The resulting CPAP level ranges from 2.5 to 10 cmH2O according to gas ow. The CPAP devicehastwoports:oneforinjectinggasesandanotherforcontrollingpressurethrough amanometerormonitoringCO2oraddingoxygen. Becauseofitssimplicity,lowweight,andsmallsize,theBoussignacCPAPisaportable device.Itsef cacyduringbronchoscopyinhypoxemicpatients[8]andinthetreatmentof acutecardiogenicpulmonaryedemahasbeenreported. AnimprovementintheBoussignacCPAPwasproposed(theSuper-Boussignac)[9]. InsertingaT-piecebetweentheBoussignacvalveandthefacemaskandconnectingthe T-piecetoareservoirballoonreceivingoxygenbyanindependentsourceallowedasmaller dropinairwaypressureduringinspirationandhighertidalvolumes.
6.2.5 Bubble CPAP The bubble CPAP can be set up with existing equipment (an ICU ventilator or oxygen blender)usingthecircuitofaventilator.Theinterfaceisamaskornasalprong.Pressure isgeneratedbyplacingtheexpiratorylimbunderwater.Thenumberofcentimetersunder waterthetubingisplacedequalstheCPAPlevel.Inthecircuit,aconnectiontoapressuremonitoringdeviceoroxygenanalyzercanbeincorporated.Itsuseisadvocatedinneonates becausethecolumnofwatercausesaslightoscillationinthepressurewaveformthatis thoughttodecreasetheincidenceofbronchopulmonarydysplasia[10].
42
P. Caruso
6.3 Discussion TherearedifferenttypesofequipmenttodeliverCPAPinNPPV.Theyrangefromvery simpleequipmenttosophisticatedmicroprocessedventilators.Unfortunately,thereareno studiesthatsimultaneouslycomparedtheperformanceofallthesetypesofequipment.The fewstudiesofthisissuecomparedonetypeofequipmenttodeliverCPAPtoanother,and most were bench studies using lung simulators. Clinical trials comparing the different equipmentthatdeliverCPAPinNPPVarerequired. Intheory,theNPPVventilatorsandtheICUventilatorswithNPPVmodeareabetter choicetodeliverCPAPinNPPVbecausetheyarepreparedtodealwithairleaks,butfew studiesweredonetoverifythis.Anobviousadvantageoftheseventilatorsisthepresence ofalarmsandmonitoring.
Key Recommendations
› › ›
Thereareatleast vetypesofequipmenttodeliverCPAPinnoninvasive ventilation.Thechoiceisbasedonavailabilityofequipmentandthestaff s expertise. ICUventilatorswithNPPVmodesandventilatorsdesignedtoadministerNPPV arepreferredbecausetheyarepreparedtodealwithairleaksandhavebetter monitoringandalarms. Ifcontinuouspositivepressure owgenerators,BoussignacorbubbleCPAPsare used,itisrecommendedtoprovideclosemonitoringofthepatientbythestaff andmonitoringofCPAPpressureandoxygenfractionbyaggregateddevices.
References 1. Nava S, Hill N (2009) Non-invasive ventilation in acute respiratory failure. Lancet 374: 250 259 2. FuC,CarusoP,LucattoJJetal(2005)Comparisonoftwo owgeneratorswithanoninvasive ventilatortodelivercontinuouspositiveairwaypressure:atestlungstudy.IntensiveCareMed 31:1587 1592 3. Glover GW, Fletcher SJ (2009) Assessing the performance of the whisper ow continuous positiveairwaypressuregenerator:abenchstudy.BrJAnaesth102:875 881 4. Mehta S, McCool FD, Hill NS (2001) Leak compensation in positive pressure ventilators: alungmodelstudy.EurRespirJ17:259 267 5. SassoonCS,LodiaR,RheemanCHetal(1992)Inspiratorymuscleworkofbreathingduring ow-by,demand- ow,andcontinuous- owsystemsinpatientswithchronicobstructivepulmonarydisease.AmRevRespirDis145:1219 1222 6. VignauxL,TassauxD,JollietP(2007)PerformanceofnoninvasiveventilationmodesonICU ventilatorsduringpressuresupport:abenchmodelstudy.IntensiveCareMed33:1444 1451
6
Noninvasive Positive Pressure Ventilation Using Continuous Positive Airway Pressure
43
7. FerreiraJC,ChipmanDW,HillNSetal(2009)BilevelvsICUventilatorsprovidingnoninvasiveventilation:effectofsystemleaks:aCOPDlungmodelcomparison.Chest136:448 456 8. Maitre B, Jaber S, Maggiore SM et al (2000) Continuous positive airway pressure during beropticbronchoscopyinhypoxemicpatients.Arandomizeddouble-blindstudyusinganew device.AmJRespirCritCareMed162:1063 1067 9. BellaniG,FotiG,SpagnolliEetal(2009)AnimprovedBoussignacdeviceforthedeliveryof non-invasiveCPAP:theSUPER-Boussignac.IntensiveCareMed35:1094 1099 10. AveryME,TooleyWH,KellerJBetal(1987)Ischroniclungdiseaseinlowbirthweight infantspreventable?Asurveyofeightcenters.Pediatrics79:26 30
Home Mechanical Ventilators
7
FrédéricLofaso,BrigitteFauroux,andHélènePrigent
7.1 Introduction Awidevarietyofpatientsrequiresmechanicalventilation;therefore,itisnotsurprising thatnumerousventilators,ventilationmodes,andequipmentarenecessarytoselectthe mostappropriatenoninvasiveventilationtechnologyforeachpatient.Wevoluntarilylimitedthischaptertopositivepressureventilationmodesconsideringthatnegativepressure ventilationandabdominalpressureventilationareusedmuchlessoftennow,andthatno technologicalbreakthroughhasemergedinpastyearstoimproveorincreasetheuseof thesemethods.Wealsodonotpresentcontinuouspositiveairwaypressure(CPAP)consideringthatthismodedoesnotactivelyproduceorassistinspiration.However,CPAPventilationsharessimilarequipmentwithothermethodsofpositivepressureventilation.
7.2 Technology and Equipment 7.2.1 Ventilators Homecareventilatorshaveimprovedoverthepast20years,andnowtheircharacteristics andperformanceareclosetocriticalcareventilators.Theyofferavarietyofmodesand featuresdesirablefornoninvasiveventilation.Theyhaverealexhalationvalvesthatlimit CO2rebreathing.Moreover,theexhalationvalvecanbelocatedinsidetheventilator,which
F.Lofaso()andH.Prigent AP-HP,RaymondPoincaréTeachingHospital,UniversitéVersailles-StQuentinenYvelines, Physiology FunctionalTesting,E.A.4497andCIC-IT,92380,Garches,France e-mail:
[email protected];
[email protected] B.Fauroux PediatricPulmonaryDepartment,AP-HP,HôpitalArmandTrousseau,Paris,France A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_7,©Springer-VerlagBerlinHeidelberg2010
45
46
F. Lofaso et al.
allows improvement of monitoring, alarms, and loop regulation. Some ventilators are smallandlightweight,thusportable,andcanoperatefromabattery.Therefore,theycan beeasilytransported(e.g.,onwheelchairs).Theseventilatorsaregenerallyproposedwhen patientsrequirefullventilatorysupport. Besidesthesesophisticateddevices,someverysimpleventilators,bilevelpositiveairwaypressuredevices,areavailablespeci callyfornoninvasiveventilationduringsleep. Theyareblowerdevicesthatmaydelivervariableinspiratoryandexpiratorypressuresin response to the patient s inspiratory effort. Therefore, they provide a pressure-targeted modewithoutavolume-targetedmode.Theseventilatorsuseasinglehosethatdoesnot haveatrueexhalationvalve.Expiredgasespassthroughaholepreferablypositionedatthe maskleveltoreduceasmuchaspossibleCO2rebreathing[1].Leaksthroughthishole depend on the level of airway pressure; to avoid the risk of rebreathing, manufacturers imposeaminimalend-expiratorypressureofabout4cmH2O.
7.2.2 Mechanical Ventilation Modes Positivepressureventilationdependsonthreeimportantvariables:thesignalallowingthe initiationofpositivepressure,thealgorithmthatcontrolshowthegasisdeliveredbythe ventilatorduringinspiration,andthesignalterminatingthegasdeliverybytheventilator.
7.2.2.1 Initiation of Positive Pressure Whenthepatientisabletoproduceaninspiratoryeffort,assistedmodesarepreferredtocontrolledmodes,withthelimitthatassistedmodeshavebeenshowntoinducesleepfragmentation [2]. A controlled mode can be proposed for safety reasons; however, maintaining an assistedmodeandusingabackupratecanbeanalternative.Controlledmodesarealsoproposedwhentheventilatorisnotabletodetecttheinspiratoryeffortorwheninspiratoryeffort detectionissystematicallyassociatedwithautotriggering.Infact,thetriggervariableusedto detectthepatient sinspiratoryeffortcanbepressure, ow,volume,and owwaveform.With apressuretrigger,thepatienttriggerstheventilatorwhenthepatientdecreasesthepressurein theventilatorcircuittoacertainpresetvalue,whereaswith owandvolumetriggerspatients havetoproduceacertaininspiratory oworvolume.Withthe owwaveformmethod,the ventilatordetectstheexpiratory owwaveformdistortioncausedbythepatient sinspiratory effort.Finally,sometriggerscombineboth owandpressure.However,sincethevariations oftheseparametersaremuchsmallerinpediatricpatients,triggersensitivityisfrequently insuf cientforthepediatricpopulation[3].Itcanalsobechallengedinsomesituations,such asairleaking,whichalters owandpressureintotheventilatorcircuitryandfacilitatesautotriggering; or inability to detect the patient s effort [3]; or dynamic hyperin ation, which producesintrinsicpositiveexpiratorypressureandineffectiveefforts.Onealternativesolutioncouldbetodetecttheactivityofthediaphragmusingeitherelectromyography[4]or transdiaphragmaticpressure[5],butthesetoolsarenotyetavailableforhomedevices.
7
Home Mechanical Ventilators
47
7.2.2.2 Gas Delivery by the Ventilator During Inspiration Itisusualtoseparatethevolume-targetedventilatorsfrompressure-targetedventilators. Historically,the rstventilatorsusedavolume-targetedmodewithaconstant ow.These devicesusedapistonorabellow.Duringthe1990s,pressure-targetedmodesdeliveringa constantpressure(withadecelerating owoncethesetpressureisreached)byusingturbines,andnowmicroturbines,weredeveloped.Withthismodeofmechanicalventilation, itispossibletoadjustthepressurizationrate(theamountoftimerequiredtoreachthe targetedpressure),andtheclinicianhasto ndacompromisebetweenafasterpressurizationratethatbetterunloadsinspiratoryeffortandalowerpressurizationrate,whichmay decreaseairleaksandimprovetolerance. The advantages of the pressure-targeted modes compared to the volume-targeted modesarethat,forthesameinspiratorytime,thepressure-targetedmodeusuallydelivers morevolumethanthevolume-targetedmodeand,forthesametidalvolume,thepressuretargetedmodeusuallyrequiresalowerpeakinspiratorypressurethanthevolume-targeted mode.Therefore,toleranceisoftenbetterwithpressure-targetedmodes.Moreover,the pressure-targetedmodesareabletocompensateleaks,whereasthevolume-targetedare not.Last,butnotleast,withapressure-targetedmodethetidalvolumedependsonboth theventilatorsettingsandthepatient sinspiratoryeffort(tidalvolumecanincreasewith the patient s inspiratory demand), while with the volume-targeted mode obviously the patientcannotincreasehisorhertidalvolume.Theadvantagesofthevolume-targeted modesarethatpistons,orbellows,canprovidehigherventilatingpressure,whichmaybe requiredinpatientswithhighrespiratorysystemimpedance;thatairstackingispossible with the volume-targeted modes [6]; and that volume-targeted ventilators can operate considerablylongeronbatterypowerthanpressure-targetedventilators,whichgenerally useaturbine. Now,severalventilatorshavetheabilitytocombinetheadvantagesofbothmodesof noninvasive ventilation. Some volumetric ventilators are able to deliver a volume- controlledbreathwithadescending-ramp owwaveformthatapproximatestheshapeof the owwaveformduringpressure-targetedmode,andsomeventilatorsthatuseapressure-targetedmodearealsoabletoensureaminimaltidalvolumedeliveredtothepatients (whichmaydecreasewheninspiratoryactivitydecreases,respiratorysystemimpedance decreases,oraleakoccurs)byincreasingeitherthetargetedpressure[7]ortheinspiratory time[8].Inaddition,thebatteryautonomyhasimprovedovertheyears,anditisnowpossibletoaddasecondbatteryonsomedevices. Proportionalassistventilation(PAV)isanalternativemodeofnoninvasivemechanical ventilation[9].Itdeliversapressureproportionaltoinstantaneous owandvolumewith factorsthattakeintoaccountboththerespiratorysystemcomplianceandresistance.This may approximate the patient s demand except when leaks occur. In this situation, the patient s demand is overestimated, and a runaway may occur. Finally, leaks frequently observedduringnoninvasiveventilationareanimportantlimitofPAVuse.Analternative couldbepressurizationproportionaltotheactivityofthediaphragmusingeitherelectromyography[4]ortransdiaphragmaticpressure[5],butthesetoolsarenotyetavailablefor homedevices.
48
F. Lofaso et al.
7.2.2.3 Cycling Off Variable Thecriterionforcyclingofftheventilatorandthereforeallowingexhalationdependson themodeofsupportandmaybetime,volume,airwaypressure,or ow.Ideally,theendof insuf ationshouldcoincidewiththeendofinspiratoryeffort.However,thisrarelyhappens, demonstratingthatthealgorithmusedtocycleofftheventilatorhastobeimproved.
7.2.3 Interfaces for the Delivery of Noninvasive Ventilation Thechoiceofinterfacehasamajorimpactonthesuccessofnoninvasiveventilationand thereforeshouldbeoptimal.Differenttypesofinterfacesareavailable.
7.2.3.1 Nasal Interfaces Nasal interfaces include nasal masks, which can be commercially produced or custom made, and nasal pillows. Nasal masks can induce facial side effects (skin injury, facial deformityongrowingfacialstructures)[10].Whenskininjuryoccurswithacommercial nasalmask,theuseofacustom-mademaskmayreduceskininjuryrisks[10].AnalternativecouldbetheuseofnasalpillowsconsideringthataCochranereview[11]suggested thatnasalpillowsinducedfewersideeffectsthannasalmasks.Moreover,itisalsopossible towearglasseswithsomenasalpillows.Leakthroughthemouthiscommonwiththese interfaces.Achinstrapcanreduceairleaks[12];however,whenitisinsuf cient,oronasal interfacesmightbeneeded.
7.2.3.2 Oronasal Interfaces Oronasalmasksandfull-facemaskscanbeproposedwhenleaksoccur.Full-facemasks arealsoanalternativetothenasalmaskwhennasalskinbreakdownoccurs.Thosewithan antiasphyxiavalveandquick-releasefeaturesshouldbepreferred.Helmetsarenotappropriateforhomemechanicalventilationbecauseoftheriskofasphyxiaincaseofpower failure.
7.2.3.3 Mouth Interfaces Fewindividualsusemouthpieces.Thisisthepredominantmethodofdaytimeventilation when noninvasive ventilation must be permanent [13]. The mouthpiece has to be positionedclosetothemouthsothatthepatientcanconnectanddisconnectasheorshewants.
7
Home Mechanical Ventilators
49
In this situation, volume-targeted ventilation is preferred, and the ventilator circuit can remain open without alarm because the resistance of the mouthpiece allows a residual inspiratorypeakpressureinsidetheventilator.Thepatientcanreceiveinsuf ationswhen thepatientdecidesbymakingasipeffort.
7.2.4 Humidification Upperairwaydrynesscommonlyoccursduringnoninvasivemechanicalventilation,especiallywhenleakoccurs.Inthepresenceofleaks,aheat-and-moistureexchangerisinef cient.Aheatedhumidi ercanbeproposed(exceptduringtransportation).
7.2.5 Safety Theroleofalarmsandmonitoringfornoninvasiveventilationiscontroversial.Itdepends onpatientrespiratoryautonomy.Nonetheless,disconnectionandpowerfailurealarmsare recommended.Batterybackupisdesirableforpatientswhorequirefullventilatorysupport.Moreover,familyshouldbetrainedintheuseofamanualballoonresuscitator.
7.3 Conclusion Theuseofnoninvasivemechanicalventilationisincreasingwiththeincreasingevidence ofimprovementoflifeexpectancyinsomepopulations.Theselectionofequipmentand thesettingsarebasedonthepatient sneeds,whichmayvarywidelyfromonepatientto another.Thekeystothesuccessofthistherapyarethebedsidecaregiver sunderstanding oftheequipment,theventilationmode sfunctioning,andthetimethecaregivercanto devotetothepatientandthepatient sfamily.
References 1. SaatciE,MillerDM,StellIMetal(2004)Dynamicdeadspaceinfacemasksusedwithnoninvasiveventilators:alungmodelstudy.EurRespirJ23:129 135 2. ParthasarathyS,TobinMJ(2002)Effectofventilatormodeonsleepqualityincriticallyill patients.AmJRespirCritCareMed166:1423 1429 3. FaurouxB,LerouxK,DesmaraisG(2008)Performanceofventilatorsfornoninvasivepositivepressureventilationinchildren.EurRespirJ31:1300 1307 4. SinderbyC,NavalesiP,BeckJetal(1999)Neuralcontrolofmechanicalventilationinrespiratoryfailure.NatMed5:1433 1436
50
F. Lofaso et al.
5. SharsharT,DesmaraisG,LouisBetal(2003)Transdiaphragmaticpressurecontrolofairway pressuresupportinhealthysubjects.AmJRespirCritCareMed168:760 769 6. BachJ(2004)Airstackingforcoughassistance.MuscleNerve30:680 681,authorreply681 7. JanssensJP,MetzgerM,SforzaE(2009)Impactofvolumetargetingonef cacyofbi-level non-invasiveventilationandsleepinobesity-hypoventilation.RespirMed103:165 172 8. OrlikowskiD,MroueG,PrigentHetal(2009)Automaticair-leakcompensationinneuromuscularpatients:afeasibilitystudy.RespirMed103:173 179 9. HartN,HuntA,PolkeyMIet al(2002)Comparisonofproportionalassistventilationand pressuresupportventilationinchronicrespiratoryfailureduetoneuromuscularandchestwall deformity.Thorax57:979 981 10. FaurouxB,LavisJF,NicotFetal(2005)Facialsideeffectsduringnoninvasivepositivepressureventilationinchildren.IntensiveCareMed31:965 969 11. ChaiCL,PathinathanA,SmithB(2006)Continuouspositiveairwaypressuredeliveryinterfacesforobstructivesleepapnoea.CochraneDatabaseSystRev18(4):CD005308 12. GonzalezJ,SharsharT,HartNetal(2003)Airleaksduringmechanicalventilationasacause ofpersistenthypercapniainneuromusculardisorders.IntensiveCareMed29:596 602 13. BachJR,AlbaAS,SaporitoLR(1993)Intermittentpositivepressureventilationviathemouth asanalternativetotracheostomyfor257ventilatorusers.Chest103:174 182
Maintenance Protocol for Home Ventilation Circuits
8
MichelToussaintandGregoryReychler
8.1 Introduction Homemechanicalventilationhasbecomeastandardofcaretoeffectivelytreatchronicrespiratoryfailureeitherinpatientswithrestrictivediseasessuchasneuromuscularandthoraxcage disordersorinpatientswithobstructivediseasessuchasselectedcasesoflungandairwaydisorders.Dependingonthegroupofpatients,homeventilationmayimprovesurvivalandquality oflifeinthelongtermandmaydecreasetherateoflowerrespiratorytractinfections[1].
8.2 Equipment for Home Mechanical Ventilation Homemechanicalventilationrequiresequipmentconsistingofapressuregenerator (volume-orpressure-cycledventilator),acircuitwithtubing(withorwithoutexpiratory valve),andaninterfacetodeliverairtothepatient.Inthemajorityofpatients,anasalmask isthemostappropriateinterfacefornocturnaluse.Full-facemasksmaybeusedintherare casesforwhichnasalmasksareuseless.Finally,mouthpiecesarepreferentiallyusedin wakingpatientsfordaytimenoninvasiveventilation.Invasiveventilationviatracheostomy mayberequiredwhenitisnotpossibletoconductfurthernoninvasiveventilation.
M.Toussaint() CentreforNeuromuscularDiseaseandCentreforHomeMechanicalVentilationUZ- VUB-Inkendaal,RehabilitationHospitalInkendaal,Inkendaalstraat,1,1602Vlezenbeek,Belgium e-mail:
[email protected] G.Reychler DepartmentofPhysicalMedicineandRehabilitationandwiththeCentreforCysticFibrosis, CliniquesUniversitairesSaint-Luc,UniversitéCatholiquedeLouvain,AvenueHippocrate10, 1200Brussels,Belgium e-mail:
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_8,©Springer-VerlagBerlinHeidelberg2010
51
52
M. Toussaint and G. Reychler
8.2.1 Dirtiness, Contamination, Colonization Contaminationofcircuitsinfersthetransientpresenceofbacteriainthecircuitsorinthe airways, while colonization infers the multiplication of the germs in the airways of patients,whichmayleadtochronicrespiratoryinfection.Bycontrastwiththehospital setting,transmissionofinfectionbycrosscontaminationisrareinthehomesettingsince patients receiving home mechanical ventilation use their own equipment and have no directorindirectcontactwithotherpatients.Inhomeuse,thequestionistowhatextent homeventilationcircuits(HVCs)mustbedisinfected.IsdirtinessofanHVCariskfactorforHVCcontaminationandapatient sself-colonization?Whatisthebestprotocol forcleaning?Isdisinfectionneeded,andhowoftenisitrecommended?Theaimofthis chapteristoanswerthesequestionsandtosuggestanadequateprotocolformaintenance ofHVCs.
8.2.2 Maintenance Is Empirically Driven Although home ventilation is widely used around the world, maintenance of HVC is empiricallydriven.Instructionsgivenbeforedischargingpatientshomearemostlytaken fromtherecommendedguidelinesfromotherareas,suchaslungfunctiontests,nebulizationtechniques,orrespiratorymonitoring.Theseinstructionsaregenerallybasedontradition rather than scienti c evidence and vary depending on the countries and centers. Instructions are often too elaborate and not speci cally adapted for patients receiving homeventilation.Currentinstructionsoftenincludetheuseofdisinfectantsolution,vinegarmixedwithwater,oraquaternaryammoniumcompoundbutgenerallyfailtoexplain howbasicmaintenancemaybeachievedbysimplecleaningwithsoapandhotwateror withthedishwasher.
8.2.3 A European Survey on Maintenance InaEuropeansurvey[2]includingmorethan20,000patientsreceivinghomeventilation(two-thirdsrestrictive,one-thirdobstructivepatients),only60%oftheparticipating centers provided written instructions on the cleaning and maintenance of the equipment. There was a significant positive correlation between the size of centers andtheproportionofwritteninstructions(p<0.001).Onaverage,only56%ofthe centershadprotocolsforcorrectcleaningandmaintenanceofcircuitsandinterfaces. These findings clearly demonstrate that a huge effort is needed to improve the communication to patients regarding adequate rules of maintenance before home discharge.
8
Maintenance Protocol for Home Ventilation Circuits
53
8.2.4 Patients Do Not Clean Their Equipment In a recent study, two-thirds of patients who were taught cleaning instructions prior to dischargedidnotadequatelycleantheirequipmentathome[3].Tubingandmaskswere most commonly found as unacceptably dirty. It was hypothesized that dirtiness of equipmentexposescircuitsandmaskstoahigherriskofcontamination.Indeed,thedirtiest circuits were found signi cantly more contaminated than the cleanest ones [3, 4]. Dirtinessandcontaminationshouldpotentiallyexposepatientstoahigherriskofairway colonization,whichinturnshouldcauserespiratoryinfections.However,thisrelationship hasnotyetbeendemonstratedwithevidence.
8.2.5 Sensitivity to Infections Clearly,regularcleaningappearstobethemostimportantinstructionthatneedstobefollowedbyallpatientsforthemaintenanceofHVCs.Aspreviouslyseen,however,there needstobeconsiderableefforttotargetandinstitutethisbasiceffectivecleaning.Bycontrastwithcleaningrules,theinstructionsforpostcleaningdisinfectionwilldependonthe relativesensitivityofpatientstorespiratorytractinfectionsandtherelatedrisksforbacterialcolonizationoftheairways.Twogroupsofpatientsneedtobeconsideredhere:those withrestrictiveandthosewithobstructivedisease.Clearly,bothgroupsarenotequally sensitivetoinfectionsand,asaconsequence,shouldnotrequireasimilarlyelaboratedisinfectionlevel.
8.3 Analysis and Discussion 8.3.1 Restrictive Disorders Bycontrastwithpatientsaffectedbyobstructiverespiratorydiseases,patientsaffectedby restrictive respiratory diseases or hypoventilation syndrome are a priori at low risk for bacterialcolonizationofairways. Inanuncontrolledstudywithstablepatientsreceivingwrittenandverbalinformation onmaintenanceofHVCs(recommendationwasfordailycleaningwithsoapandwater), aSpanishgroupquestionedpatientsregardingtheircleaninghabits[3].Theyconducted bothvisualinspectionofHVCsandsamplingofmasks(contamination)plusnostrils(colonization)ineachpatient.Asaresult,thefrequencyofcleaningwasfoundasfollows:
54
M. Toussaint and G. Reychler
47%cleanedtheirHVCsonceaweek,23%cleanedonceamonth,15%cleanedsporadically,and15%nevercleanedtheirequipment.Intotal,67%ofHVCsweredeemedas verydirty,andapositiverelationshipbetweencircuitcontaminationandnostrilcolonizationwashighlighted.Bacterialcolonizationwasmoreimportantinthosepatientswith dirtierHVCs.Theauthorscouldnotconcludewhethercolonizationprecededorfollowed contamination.However,theysuggestedthatadequatecleaningdecisivelydecreasedthe rateofcontamination.Theseauthorsdidnotprovideaprotocolforadequatemaintenance ofHVCs. Inanotherstudy[4],visualandbacterialinspectionsofHVCswereassessedbefore andaftercleaningina rstexperiment.Inasecondexperiment,theauthorsrandomly comparedeithercleaningwiththehouseholddishwasherorlow-leveldisinfectionwith anammonium chlorhexidinecomplex.Their ndingswereinagreementwiththe ndingsofRodriguezetal.[3].Priortocleaning,circuitswerefounddirtyin69%ofthe cases. HVCs were dirtier in invasive ventilation. There was a signi cant positive correlationbetweenthelevelofvisualdirtinessandbacteriologiccontaminationofHVCs (r=0.56;p<0.001).Bacteriologiccontaminationreached22%ofnoninvasiveHVCs withlittlepresenceoffungi.Nevertheless,bycontrastwithinvasiveHVCs,contaminationofnoninvasiveHVCsdidnotincludepotentiallypathogenicorganisms(PPOs)such as Serratia marcescens, methicillin-resistant Staphylococcus aureus (MRSA), or Pseudomonas aeruginosa. In invasive HVCs, contamination affected 81% of HVCs, includingtheimportantpresenceoffungi;19%ofHVCshadPPOs,includingS.marcescensintwocasesandMRSAinonecase,butnoP.aeruginosacontaminatedHVCsin thisgroup.Inthesecondexperimentofthisstudy,cleaninginthedishwasherwasshown tobesuperiortothechemicalcompoundsforbothcleaninganddisinfectingHVCs.In addition,gram-negativebacteriaandfungisurvivedinthechemicalcomplexbutnotin thedishwasher. Inaccordancewiththe ndingsofEbneretal.[5],wesuggestusingeitheradishwasher at65°CorbasicsoapandhotwaterasthebestmeansofcleaningHVCsusedbyrestrictive patients(Fig.8.1).Nevertheless,adisinfectiveagentmayberecommended(1)forthevery dirtyHVCs,(2)incircuitsfrominvasiveventilation,and(3)inHVCsfrompatientsknown fortheirhighsensitivitytorespiratoryinfections,suchasobstructivepatients.Effective cleaningmustalwaysprecedeanydisinfection.ItisimportanttobesurethatathermostableHVCisusedbeforecleaningordisinfectingattemperaturesabove60°C.Effective disinfectionisdescribedinthenextsection.
8.3.2 Obstructive Disorders The situation regarding hygiene of HVCs is slightly different in obstructive respiratory diseasessuchascystic brosis(CF)andchronicobstructivepulmonarydisease(COPD) comparedtorestrictiverespiratorydiseases.Themajorreasonforthisdifferenceconsists ofahighersensitivitytobacterialcolonizationoftheairwaysinthesepatientpopulations. Therateofairwaycolonizationoftencorrelateswiththeseverityorthespeedofobstructive
8
Maintenance Protocol for Home Ventilation Circuits
Fig. 8.1 Protocolofmaintenanceforhomemechanical ventilationcircuits
55
Dirty circuits of Home Mechanical Ventilation
CLEANING: - 65° dishwasher or - brush, detergent and hot water RINSING DRYING Restrictive patient
Diagnosis ?
Obstructive patient
Very dirty circuits or invasive ventilation?
no
yes
NO DISINFECTION -
SPORADIC CONTROL : - cleaning
DISINFECTION: hypochlorite solution (20 minutes of soaking in a concentration of 0.5%) high temperature disinfection (>75°c)
REGULAR CONTROL : -cleaning - bacteriologic sampling in case of doubt
diseaseprogression.Inaddition,thereisevidencethattheneedfornoninvasiveventilation becomesmorefrequentafterairwaycolonizationinthesepatients. Ventilator-associatedpneumoniaiswelldocumented.Inintensivecareunits,theuseof mechanical ventilation is an important risk factor for the development of nosocomial pneumonia.Moreover,currentriskisgreaterwiththeuseofinvasivemechanicalventilation comparedwithnoninvasiveventilation.Unfortunately, the relationship betweenthe use of noninvasive ventilation and an increased risk for nosocomial pneumonia is not demonstrated. Thegreaternumberofmanipulationsandthepresenceofanendotrachealtubeassociated with invasive ventilation contribute to HVC contamination. It can be hypothesized that manipulations related to noninvasive ventilation also represent a potential risk for
56
M. Toussaint and G. Reychler
c ontamination.Thisimpliesrigorousimplementationofclassicalnonspeci crulesofhygiene, including hand washing. Nevertheless, the ventilator, the circuit, and the interface do not representmajorriskfactorsforcontaminationandcolonization,butmonitoringpotentialbacterialcontaminationofdevicesandpayingattentiontothebasicrulesofhygieneprobably remainimportantchallenges. There is little published research to support the relationship between hygiene and noninvasiveventilationdevicesinobstructivediseases.Nevertheless,wecanextrapolate ndingsfromtherapiessuchasrespiratoryphysiotherapydevicestoobstructivepatients receivinglong-termnoninvasiveventilation.Indeed,thematerialinvolvedinnoninvasive ventilationispartofthesemicriticaldevicesthatareincontactwithmucousmembranes asde nedbytheCentersforDiseaseControlandPrevention.Fortunately,recommendationsonhygieneofthesedevicesareavailable. InpatientsaffectedbyCFandCOPD,nebulizersareconsideredpotentialvectorsof bacterialcolonizationofairways.Notably,studiesshowedthatnebulizersofCFpatients are frequently contaminated [6]. Similarly, it was suggested that nebulizers can lead to nosocomial disease in COPD patients [7]. The bacterial contamination of an HVC is relatedtothedurationofitsuseandtheairwaycolonizationofthepatient. Basedonthisevidence,severalrecommendationswereproposedandcouldbeappliedto thepiecesofthecircuitinvolvedinnoninvasiveventilationinobstructivediseases.Asshown inFig.8.1,regularcleaningofHVCsandmasksismandatory,atleastasabasichygiene procedureand,morespeci cally,toeliminatethebio lmdepositedonthesurfaces,which furtherdecreasestheef cacyofdisinfectants[8].Thenecessaryfrequencyofcleaningisstill beingdebated.Basedontheresultsofstudiesonnebulizers,adailycleaningcouldtheoreticallybetherecommendedtiming.However,less-regularcleaning(i.e.,onceaweek)could beacceptableinpractice.Thepossibilityofusingtapwaterforcleaningmustbetakeninto accountifHVCsarecontaminatedbyS.marcescensandStenotrophomonasmaltophila. Whenconsideringdisinfection,differentmethodsmaybeproposed.Thechoiceofthe optimalmethodlargelydependsonthematerialchosentodisinfect.Thermaldisinfection (i.e., sterilizer, boiling water) may be not suitable for some nonthermostable pieces of HVCseventhoughitsef cacyisevidentwithallgerms.Thereareanumberofchemical methods,andeachhasitsowncharacteristics.Thedurationofsoakingandtheconcentrationofthechemicalwilldependontheparticularsubstanceused,andtheguidelinesfor eachmustbefollowedcarefully.Aceticacidisnotrecommendedduetoitsinef cacyon gram-positiveandgram-negativebacteria[9,10].Bycontrastwithacidacetic,hypochloritesolution(20minofsoakingina0.5%concentration)maybethebestalternativeof thosereadilyavailablechemicalsolutions. Afterdisinfection,rinsinganddryingisthelastpartofthecleaninganddisinfection sequence.Dryingseemsimportantasahighercontaminationratewasrelatedtonondried nebulizersinCFpatients.Becausethereisapaucityofspeci cdatarelatedtononinvasive ventilation, precise recommendations cannot be made. However, it could justify more studiesonthistopic.Finally,itappearscriticallyimportanttoinvestigatetherelativeeffectivenessofthedifferentestablishedprotocolsforcleaninganddisinfectingofHVCsto maintaintheirintegrity.
8
Maintenance Protocol for Home Ventilation Circuits
57
Key Recommendations
› › › ›
›
Cleaningtheventilator,circuits,andinterfacesisrequiredtwotofourtimes permonthinallpatientsreceivingmechanicalventilationathome. Writteninstructionsonhowtocleantheequipmentforhomeventilation isuseful.Regularassessmentofwhethercircuitsandinterfacesarecorrectly cleanedandmaintainedismandatory. Inrestrictivepatients,cleaninginthedishwasheriseffectiveandsuf cient forthermostablecircuitsandinterfaces.Cleaningwithsoapandhotwatermay besuf cientforallpieces.Disinfectionisnotmandatory. Inobstructivepatients,cleaningmustbemorefrequentthanforrestrictive patients.Cleaningalwaysprecedesdisinfection.Aftercleaning,rinsingand dryingareimportant.Aneffectiveweeklydisinfectionmaybeachievedbyusing anhypochloritesolution(20minofsoakingina0.5%concentration). Theexpiratoryvalve must be washed speci cally, with care so that the balloon isnotplacedunderwater.
References 1. Dohna-SchwakeC,PodiewskiP,VoitTetal(2008)Non-invasiveventilationreducesrespiratorytractinfectionsinchildrenwithneuromusculardisorders.PediatrPulmonol43:67 71 2. Farre R, Loyd-Owen SJ, Ambrosino N et al (2005) Quality control of equipment in home mechanicalventilation:aEuropeansurvey.EurRespirJ26:86 94 3. Rodriguez Gonzalez-Moro JM, Andrade Vivero G, Miguel Diez J et al (2004) Bacterial colonizationandhomemechanicalventilation:prevalenceandriskfactors.EurRespirJ40: 392 396 4. ToussaintM,SteensM,VanZeebroeckAetal(2006)Isdisinfectionofmechanicalventilation neededathome?IntJHygEnvironHealth209:183 190 5. EbnerW,EitelA,ScherrerMetal(2000)Canhouseholddishwashersbeusedtodisinfect medicalequipment?JHospInfect45:155 159 6. VassalS,TaammaR,MartyNetal(2000)Microbiologiccontaminationstudyofnebulizers afteraerosoltherapyinpatientswithcystic brosis.AmJInfectControl28:347 351 7. MastroTD,FieldsBS,BreimanRFetal(1991)NosocomialLegionnaires diseaseanduseof medicationnebulizers.JInfectDis163:667 671 8. MerrittK,HitchinsVM,BrownSAetal(2000)Safetyandcleaningofmedicalmaterialsand devices.JBiomedMaterRes53:131 136 9. KarapinarM,GonulSA(1992)Effectsofsodiumbicarbonate,vinegar,aceticandcitricacids ongrowthandsurvivalofYersiniaenterocolitica.IntJFoodMicrobiol16:343 347 10. ReychlerG,AarabK,VanOsselCetal(2005)Invitroevaluationofef cacyof5methodsof disinfectiononmouthpiecesandfacemaskscontaminatedbystrainsofcystic brosispatients. JCystFibros4:183 187
Nocturnal Noninvasive Mechanical Ventilation
9
DavidOrlikowski,HassanSka ,andDjillaliAnnane
9.1 Introduction Long-term mechanical ventilation in patients with neuromuscular problems was rst introducedbetween1950and1960inFranceandSwedenasaconsequenceofthepoliomyelitisepidemics.Duringthefollowingdecades,theconceptofhomemechanicalventilation expanded rapidly. Long-term mechanical ventilation was implemented in many othercountriesandformanyotherconditions,includingneuromuscularorchestwalldisorders,spinalcordinjury,andchronicobstructivepulmonarydisease.Atthebeginningof the1990s,therewere26,000peopleinFranceand11,419intheUnitedStatesreceiving long-termrespiratoryassistance.About10%presentedwithneuromuscularorchestwall disorders.AEuropeansurveyconductedbetweenJuly2001andJune2002reportedthe useofhomemechanicalventilationin483centersin16countries.Thatstudyidenti ed 27,118participantswithlong-termmechanicalventilationforlungorneuromusculardiseases related to chronic respiratory failure. Then, the estimated prevalence was 6.6 per 100,000people. Chronic alveolar hypoventilation is a state characterized by reduced arterial oxygen tension(Pao2)andincreasedcarbondioxidetension(Paco2),whichthepatientmaycorrect atleastpartiallybyvoluntaryhyperventilation.Inmostcases,chronicalveolarhypoventilationleadstodaytimefatigue,hypersomnia,andchangesinpsychologicalfunction.The mechanismsunderlyinghypercapniainpeoplewithneuromuscularorchestwalldisorders aremultipleandnotyetfullyunderstood.Theymayinvolveimpairmentoflungmechanicsorairwayfunctionandcough,ventilation perfusionmismatch,bluntedcentralventilatorydrive,orrespiratorymusclefatigue.Abnormalitiesmayoccurwhileawakeorduring sleep.Numerousobservationalanduncontrolledstudiessuggestedthatnocturnalmechanicalventilationatleastpartiallyimproveslungmechanics,respiratorymusclestrength,or
D.Annane(),D.Orlikowski,andH.Ska ServicedeRéanimation,HôpitalRaymondPoincaré(AP-HP), UniversitédeVersaillesSQY,104boulevardRaymondPoincaré,92380Garches,France e-mail:
[email protected]
A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_9,©Springer-VerlagBerlinHeidelberg2010
59
60
D. Orlikowski et al.
respiratorydriveorreducesventilation perfusionmismatch,bydayaswellasnight.A multicenterrandomizedtrialofpreventivenocturnalnoninvasivepositivepressureventilatoryassistancein70participantswithmoderatepulmonaryinsuf ciencyduetoDuchenne musculardystrophyshowedthatsurvivalwassigni cantlyworseinparticipantsreceiving preventivenocturnalventilatoryassistance,althoughdaytimebloodgaseswereimproved. Several other randomized trials, performed on parallel groups or based on a crossover designandsmallsamples,suggestedthatnocturnalventilationhadbene cialeffectson arterial blood gases or sleep parameters. The Consensus Conference of the American CollegeofChestPhysiciansrecommendedtheimplementationoflong-termventilationin patientswithchronichypercapniaduringthedayandinthosewithsymptomaticnocturnal hypercapnia,particularlywhensecondarytoneuromuscularorskeletaldisorders.
9.2 Effect of Nocturnal Mechanical Ventilation A systematic review from the Cochrane collaboration examined the effects of nocturnal mechanicalventilation in patients with chronic alveolar hypoventilation [1]. The primary objectiveofthisreviewwastoexaminetheeffectsofnocturnalmechanicalventilationin peoplewithneuromuscularorchestwalldisordersontheimprovementofchronichypoventilation.Subsidiaryendpointsweretoexaminetheeffectsofrespiratoryassistanceonsleep quality,hospitaladmissions,qualityoflife,andmortalityrelatedtochronichypoventilation. Participantswithstablechronichypoventilation,de nedbyanarterialCO2tensionabove6 kPaduringtheday,orsymptomsofnocturnalhypercapnia(i.e.,anyofthefollowing:diurnal hypersomnia, headaches, nightmares, enuresis), including children and adults with all degreesofseverity,whetherlivingininstitutionsorinthecommunity.Chronichypoventilationduetooneofthefollowingmedicalconditionswasconsideredaccordingtotheclassi cationoftheConsensusConferenceoftheAmericanCollegeofChestPhysicians:Central nervoussystemdisorders,includingArnold Chiarimalformation,centralnervoussystem trauma,cerebrovasculardisorders,disordersofcongenitalandacquiredcentralcontrolof breathing, myelomeningocele, spinal cord traumatic injuries; neuromuscular disorders, includingamyotrophiclateralsclerosis,spinalmuscularatrophy,polioandpostpoliosyndrome,congenitalchildhoodhypotonia,Guillain Barrésyndrome,infantilebotulism,musculardystrophy,myotonicdystrophy,phrenicnerveparalysis,myastheniagravis;andskeletal disorders,includingkyphoscoliosis,thoracicwalldeformities,andthoracoplasty. Typesofinterventionswereanalyzedasfollows[1]: 1. Treatment with nocturnal mechanical ventilation (for at least 3 h per night) versus noventilation. 2. Typeofventilation.Invasivetechniques(i.e.,tracheostomy[intermittentpositivepressure])versusnoninvasivetechniquesusingnegativepressureorpositivepressure.For negative pressure, the four available types of body enclosures were considered: (a) bodytanks(ironlungs),(b)chestshells(rigiddomesthat toverthechestandabdomen),(c)bodywraps(nylonorplasticjacketsthatsurroundthechestandabdomen), and (d) abdominal pneumobelts (in atable rubber bladders held rmly against the
9
Nocturnal Noninvasive Mechanical Ventilation
61
abdomenbynyloncorsets).Fornoninvasivepositivepressureventilation,nasal,mouthpiece,andoronasalinterfaceswereallconsidered. 3. Modeofventilation.Volume-cycled,pressure-cycledmechanicalventilationorbilevel positiveairwaypressure. Typesofoutcomemeasureswereasfollows:Primaryoutcomewasreversalofdaytime hypoventilation-related clinical symptoms (i.e., diurnal hypersomnia, headaches, nightmares,enuresis).Secondaryoutcomesincludedadmissiontohospital(otherthanroutine visits);mortality;reversalofdaytimehypercapnia(i.e.,arterialCO2tension[onroomair] below6kPa);andlungfunctionmeasurements(i.e.,forcedvitalcapacity,respiratorymusclestrength,ventilation perfusionmismatch,sleepstudies[i.e.,apnea hypopneaindexor meanoxygensaturation],orthetimespentwithanarterialoxygensaturationbelow90%). Theprimaryandthesecondaryoutcomeswererecordedseparatelyforthe rst24h(shorttermeffects)andfor12months(long-termeffects)followingimplementationofmechanicalventilation[1]. The authors concluded that the current evidence about the therapeutic bene t of mechanicalventilationwasweakbutdirectionallyconsistent,suggestingalleviationofthe symptomsofchronichypoventilationintheshortterm.Inthreesmallstudies,survivalwas prolonged, particularly in participants with motor neuron disease. They also concluded thatlargerandomizedtrialsareneededtocon rmpossiblelong-termbene cialeffectsof nocturnal mechanical ventilation on hypoventilation-related symptoms, quality of life, unplannedhospitaladmissionrate,andmortalityandtoevaluateitscost-effectivenessin peoplewithneuromusculardiseasesotherthanmotorneurondiseaseaswellasinpeople withchestwalldisorders.Futuretrialsshouldbestrati edaccordingtothetypeofdisease andtowhetherthecourseisrapidlyprogressiveornot.Thecomparisonsbetweeninvasive andnoninvasiveventilationandbetweenvolume-cycledandpressure-cycledventilation alsorequirewell-designedmulticenterrandomizedtrials[1].
9.3 Equipment Requirements for Nocturnal Ventilation Prolongedmechanicalventilationisalife-supportingtechnologythatcanbedeliveredat home. This therapy can be applied with a variety of interfaces, ventilator settings, and severalreviewshavefocusedonboththetypeofventilatorsandinterfaces[2,3]. Bodyventilatorsareusedrarely,andthegoldstandardisactuallynoninvasivepositive pressureventilation(NPPV)[4].
9.3.1 Type of Ventilator VentilatorsusedforhomeventilationcanprovideNPPVinavolumetric(volume-cycled) orbarometricway(pressurecycled).Inthe rstcase,a xedtidalorminutevolumeis
62
D. Orlikowski et al.
deliveredthatwillgenerateapressuresuf cienttoachieveventilation.Inthecaseof highin ationimpedance,ahighpressurewilloccurtoreachthetargetedvolumewitha riskofbarotrauma.Anothermajorproblemisthatanappropriatetidalvolumemaynot be delivered in case of leaks. The volume-cycled mode is useful because it permits breathstackingandcoughassistance.Theseventilatorshavealarms,operatefrombatterypower,andareequippedwithexhalationvalvestooffersecurehomeuseevenin verydependentpatients. Thepressure-cycledventilatorsdeliverapredeterminedpressure,andtheresultingtidal volumedependsontheimpedanceoftherespiratorysystem.Inthecaseofleaks, owis increasedtocompensate,butinthecaseofobstruction,thetidalvolumemaybereduced. Airstackingisusuallynotpossiblewiththistypeofventilators.Theseventilatorscanbe equipped with alarms, battery, and exhalation valves or can be simpler, such as bilevel positiveairwaypressure.TheseportablepressureventilatorsarewelldesignedforNPPV and require a leak and positive expiratory pressure to avoid CO2 rebreathing. They are usuallynotequippedwithabatteryandhavenoexhalationvalve.
9.3.2 Modes of Ventilation Mechanicalventilationcanbecontrolled(respiratoryfrequencyisdeterminedbytheventilator)orassisted(ventilatorcyclesaretriggeredbythepatient sspontaneousbreaths)or amixofbothmodes(assistcontrol[A/C]orspontaneous-timed[S/T]).ModesofventilationusedforNPPVarevolume-controlledventilation(VCV),pressuresupportventilation (PSV), or pressure-controlled ventilation (PCV). Pressure modes are actually the most commonlyused[5].Mixedmodesusingapressingsupporttechnologybutenslavedtoa volumetrictargethavebeendeveloped.Intheory,theyseeminterestingbymixingboth advantagesofpressureandvolumeventilation[6].Inpractice,studiesarestilllackingto recommendtheirbroaduse.
9.3.3 Type of Interface Choiceoftheinterfaceisacrucialissuewhenstartinghomeventilation. Commercialorcustomizedinterfacesmaybeusedandabroadvarietyofmasks(nasal, oronasal,oreventotalfaceorhelmet),mouthpieces,orpillowsareavailable.Theselection oftheinterfaceshouldtakeintoaccountthetypeofdisease;theseverityoftherespiratory weakness;thedurationofventilationper24h(nightonlyoralsouseofdaytimeventilation);thelevelofhandicappingabilityofthepatientforplacingorremovingtheinterface; thepresenceofswallowingimpairment;andpatientmorphology.Intentionalleaksmaybe presentonthemaskifnoexhalationvalveisused.Thetypeofinterfacemaybemodi ed secondarilybytheoccurrenceofnonintentionalleaks(needforachinstraporchangeto anoronasalorfacialinterface)orpresenceofskinsores.
9
Nocturnal Noninvasive Mechanical Ventilation
63
9.4 Conclusion Nocturnalhomenoninvasiveventilationisacommontreatmentinneuromusculardisease orchestwalldisorders.Actually,positivepressureventilationthatcanbedeliveredviaa broadrangeofinterfacesisthegoldstandardforlong-termventilation.Differentmodes maybeusedandlikelyhavesimilaref cacy.Homeventilatorsoffermorechoicesinterms ofsettingsandmodeofventilation.Theyalsoofferanincreasedpossibilityformonitoring andalarms,providingmoresecureuseeveninthemostdisabledanddependentpatients. Qualitycontroloftheequipmentusedinhomemechanicalventilationisthereforenecessary toensuresafeandaccurateventilatorysupport.
Key Recommendations
› › › ›
Noninvasivenocturnalventilationisthetreatmentofchoiceforneuromuscular diseaseandchestwalldeformities. Thereisnosuperiorityofonemodeofventilationcomparingtoothers. Aregularfollowupisneededbyspecializedteaminordertoindicateandto verifyef cacyofhomeventilation. Adedicatednetworkofcareincludinghomehealthcarepractitionersisparticularly importantforthispopulation.
References 1. AnnaneD,OrlikowskiD,ChevretS,ChevroletJC,RaphaelJC(2007)Nocturnalmechanical ventilationforchronichypoventilationinpatientswithneuromuscularandchestwalldisorders. CochraneDatabaseSystRev17(4):CD001941 2. HessDR(2006)Noninvasiveventilationinneuromusculardisease:equipmentandapplication. RespirCare51(8):896 912 3. SchonhoferB,Sortor-LegerS(2002)Equipmentneedsfornoninvasivemechanicalventilation. EurRespirJ20(4):1029 1036 4. Lloyd-OwenSJ,DonaldsonGC,AmbrosinoN,EscarabillJ,FarreR,FaurouxBetal(2005) PatternsofhomemechanicalventilationuseinEurope:resultsfromtheEuroventsurvey.Eur RespirJ25(6):1025 1031 5. Janssens JP, Derivaz S, Breitenstein E, De Muralt B, Fitting JW, Chevrolet JC et al (2003) Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the GenevaLakearea.Chest123(1):67 79 6. OrlikowskiD,MroueG,PrigentH,MoulinC,BohicM,RuquetMetal(2009)Automaticairleakcompensationinneuromuscularpatients:afeasibilitystudy.RespirMed103(2):173 179
Section III Patient–Ventilator Interactions
Patient–Ventilator Interaction During Noninvasive Pressure-Supported Spontaneous Respiration in Patients with Hypercapnic Chronic Obstructive Pulmonary Disease
10
WulfPankow,AchimLies,andHeinrichBecker
10.1 Introduction Noninvasivepressuresupportventilation(NPSV)hasbecomeastandardofcareinpatientswith acuteexacerbationsofchronicobstructivepulmonarydisease(COPD).InstableCOPD,hypercapniaiscorrelatedwithlessrespiratorymusclestrengthandgreatermuscleload.Inselected patients,mechanicalventilationwithNPSVmaybeindicatedinadditiontooxygentherapyto preventworseningofhypercapniaandtoimprovesleepqualityandqualityoflife.Epidemiologic studiesonNPSVhaveshownthatpatienttoleranceisakeyfactorpredictingsuccessorfailure. TheobjectiveofNPSVistoimprovebloodgasesandtounloadtherespiratorymuscles. SuccessofNPSVisrelatedtomanyfactors.Oneofthemostimportantistheinteraction ofthepatientandtheventilator.Importantdeterminantsareintrinsicpositiveend-expiratory pressure(PEEPi),pressuregeneratedbytheinspiratorymuscles,triggeringoftheventilator,andpatient ventilatorsynchrony.
10.2 Patient Response to the Ventilator WithNPSV,patient-initiatedbreathsarefollowedbyapresetlevelofpressureassist.Intheory,therespiratorysystemcanrespondtoassistedventilationintwoways.First,ventilator
W.Pankow()andA.Lies VivantesKlinikumNeukölln,Berlin,Germany e-mail:
[email protected];
[email protected] H.Becker AsklepiosKlinikBarmbeck,Hamburg,Germany e-mail:
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_10,©Springer-VerlagBerlinHeidelberg2010
67
68
W. Pankow et al.
workisusedtoincreaseventilation,whilerespiratorymuscleactivityisunchanged.Second, ventilatorworkisusedtounloadtherespiratorymusclesataconstantlevelofventilation. SeveralstudiesinpatientswithexacerbatedCOPDandwithseverestableCOPDhave shownthat,inclinicalpractice,botheffectsarecombined.Bloodgasesareimprovedas ventilation increases, while respiratory muscle activity is reduced. Downregulation of respiratorymuscleactivityisattributedtofeedbackmechanisms,whichareactivatedby unloading the muscles (nonchemical feedback) and by reducing Pco2 (chemical feedback). WeinvestigatedthephysiologiceffectsofNPSVinsevenpatientswithstablehypercapnicCOPD[1].Inspiratorypositiveairwaypressure(IPAP)wasappliedwith12 14cmH2O andexpiratorypositiveairwaypressure(EPAP)with3cmH2O.Comparedtospontaneous breathing,ventilationwithNPSVwasincreased,asindicatedbyadropofPaco2from58to 50mmHg.Respiratorymuscleactivity,measuredwiththetransdiaphragmaticpressure timeproduct(PTPdi),wasreducedby33%.Othershavedemonstratedevenstrongereffects whenNPSVwasappliedtopatientswithstableorexacerbatedCOPD[2].Differencesmay dependonalternativeventilatorsettingsandpatientcharacteristics. Behavioralfeedbackmayalsoaffectpatient ventilatorinteraction.InCOPDexacerbation, dyspnea and anxiety cause rapid, shallow breathing. These mechanisms promote dynamichyperin ationandPEEPi,affectingtriggersensitivityandpatientcomfort.Asa result,thepatientmay ghtwiththeventilatorratherthenacceptitssupport.Judicious sedationcanhelptoinitiateNPSV. Duringsleep,breathingdriveisreduced,andthedependenceoftherespiratorycontroller onPco2isincreased.ThepotentialeffectofNPSVtoincreasetidalvolumeandtodecrease Pco2mayinduceapneaandperiodicbreathingwithconsequencesonthepatient ventilator interaction.Indeed,astudyshowedthatineffectiveeffortsarecommonduringnocturnal NPSV, while no patient ventilator asynchrony occurred during daytime [3]. Ventilator settings adjusted during wakefulness may therefore not be appropriate for nocturnal mechanicalventilation.
10.3 Ventilator Response to the Patient Thewayinwhichtheventilatorrespondstoinspiratoryandexpiratoryeffortsisin uenced by the patient s respiratory system mechanics and by machine properties (triggering, cycling,andpressurization). RespiratorymechanicsinsevereCOPDisimpairedbystaticanddynamichyperin ation andPEEPi.PEEPiisthemostcommoncauseofineffectivetriggeringinCOPD.Totrigger theventilator,thepatientmust rstperformacertainamountofinspiratorymuscleactivity tocounterbalancePEEPiandthusinducesubatmosphericalveolarpressure.Thisdelays inspiratorypressureassist,andpatient ventilatorsynchronymaybeseverelydisturbed. Also,extra(ineffective)respiratorymuscleactivityisnecessarytotriggertheventilator. Attimes,apatient seffortmightnotevenbestrongenoughtolowerthepressureatthe airwayopeningbelowPEEPiandtotriggertheventilator(Fig.10.1).
10
Patient–Ventilator Interaction During Noninvasive Pressure-Supported Spontaneous Respiration
69
· V 50 (L/min)
Pmask [cm H2O] 10
Pes [cm H2O] 10
Pdi [cm H2O] 10
5 sec
Fig. 10.1 Recordingsof ow(V¢),maskpressure(Pmask),esophagealpressure(Pes),andtransdiaphragmaticpressure(Pdi)inapatientwithstableCOPDreceivingNPSV.Arrowindicatesineffectivetriggering:Positivede ectionoftransdiaphragmaticpressureisnotfollowedbypositivemask pressure,and owremainsatlowlevel(ReproducedfromPankowetal.[1].Withpermission. ©GeorgThiemeVerlagKG)
PEEPi in stable COPD normally ranges from 1 to 6 cmH2O during spontaneous b reathing. In overweight patients with hypercapnic COPD [1] and in acute respiratory failure,highervaluesupto13cmH2Ohavebeenmeasured.Theapplicationofexternal pressure at the airway opening (PEEPe or EPAP) can effectively reduce the work of breathingandimprovetriggering.EPAPcanbeappliedasmaskCPAP(continuouspositive airway pressure), but tolerance and respiratory muscle unloading are more effective in combination with IPAP. The combination of IPAP and EPAP also increases alveolar ventilation.Inclinicalpractice,PEEPicannotbemeasured,andtheoptimallevelofEPAP isappliedinapragmaticway.Anappropriatewayistostartwith0 2cmH2Oandincrease EPAP slowly until ineffective efforts disappear. In addition, effective bronchodilator therapymayoptimizepatient ventilatorinteractionbyreducingexpiratory owlimitation, dynamichyperin ation,andPEEPi. Therespiratorymuscleactivityrequiredtotriggertheventilatoralsodependsonthe triggersystem.Withpressuretriggering,thepatient seffortdecreasesthepressureinthe ventilatorsystemtoopenthedemandvalve.With owtriggering,apresetinspiratory ow isgeneratedtoactivateinspiratorypressureassist.InpatientswithCOPD, owtriggering reduces inspiratory effort compared to pressure triggering [4]. However, the clinical signi canceofthisdifferenceisunclearandmightbeofminorrelevance.
70
W. Pankow et al.
Airleakingthroughthemouthoraroundthemasksealmayinterferewithventilator triggering.Inastudyonpatient ventilatorinteraction,severeasynchronywithNPSVwas observedin43%of60patients[5].Thestudypopulationwasheterogeneous:40%sufferedfromCOPD,and55%werehypercapnic.Airleakswereidenti edasamajorcontributingfactortoineffectivebreathsandlatecycling[5].Anintensivecareunit(ICU) ventilatorwasused;therefore,theseresultsmaynotbeapplicabletomodernbilevelventilators. They have the potential to compensate for leaks and thus improve triggering. However, with NPSV generated by a modern bilevel device, ineffective triggering has beenidenti edasthedominantcauseofpatient ventilatordyssynchronyinfouroften patients. In the same study, ineffective triggering was observed in three of ten patients using conventional ventilation [6]. To reduce air leaking, chin straps, tightening of the mask,orreplacementofthenasalmaskbyanoronasalmaskmaybetried. Delayed or premature cycling is another source of patient ventilator asynchrony. Ideally,pressuresupportshouldbetightlycoupledtotheinspiratorydriveofthepatient. The ventilator detects the transition from inspiration to expiration by a predetermined decrease of inspiratory ow. In COPD, delayed cycling is a common problem. Airway obstructionisaccompaniedbya atteningofthe owcurve.The owdeterminedtocycle offisreachedlateinthebreathingcycle.Thisinturnshortensexpiratorytime,decreases lung emptying, and contributes to dynamic hyperin ation and PEEPi. Also, air leaking may prolong the reduction of inspiratory ow to the cycling threshold. Cycling can be improvedwhenthedefault owthresholdischangedtoapresettime.Inacuterespiratory failure,inspiratorytimeshouldbelimitedtobelow1.0s. AnimportantadvantageofNPSV,comparedtoinvasiveventilation,isthatthepatient canbeaskedhowcomfortableheorsheinteractswiththemachine.Doesthepatientget enoughair:pressurization?Isiteasyorexhaustingtoobtainventilatorsupport(trigger threshold)? Does the machine interfere with breathing (cycling, leaks, PEEPi)? Visual evaluation of the patient s breathing effort and breathing rhythm is another important meanstooptimizepatient ventilatorsynchrony.
Key Recommendations
›
› ›
InseverehypercapnicCOPD,NPSVwithexpiratoryPEEP(PEEPeorEPAP) caneffectivelyreduceapatient srespiratorymuscleeffortandincreasealveolar ventilation.Patient ventilatorsynchronyisaprerequisiteforachievingthis effect. PEEPiisthemostcommoncauseofineffectivetriggering.Tocounterbalance PEEPi,EPAPmaybestartedwith0 2cmH2Oandincreasedslowlyuntil ineffectiveeffortsdisappear. Airleaksalsointerferewithventilatortriggeringandcycling.Toreduceleaking, tighteningofthemask,replacementofthenasalmaskbyanoronasalmask,or chinstrapsmaybeappropriate.
10
Patient–Ventilator Interaction During Noninvasive Pressure-Supported Spontaneous Respiration
71
References 1. PankowW,BeckerH,KöhlerU,SchneiderH,PenzelT,PeterJH(2001)Patient ventilator interactionwithnoninvasivepressuresupportventilationinpatientswithhypercapnicCOPD. Pneumologie55:7 12 2. VitaccaM,NavaS,ConfalonieriMetal(2000)Theappropriatesettingofnoninvasivepressure supportventilationinstableCOPDpatients.Chest118:1286 1293 3. FanfullaF,TaurinoAE,LupoND,TrentinR,D AmbrosinoC,NavaS(2007)Effectofsleep onpatient/ventilatorasynchronyinpatientsundergoingchronicnon-invasivemechanicalventilation.RespirMed101:1702 1707 4. NavaS,AmbrosinoN,BruschiC,ConfalonieriM,RampullaC(1997)Physiologicaleffectsof ow and pressure triggering during non-invasive mechanical ventilation in patients with chronicobstructivepulmonarydisease.Thorax52:249 254 5. VignauxL,VargasF,RoeselerJetal(2009)Patient ventilatorasynchronyduringnon-invasive ventilationforacuterespiratoryfailure:amulticenterstudy.IntensiveCareMed35:840 846 6. Mulqueeny Q, Ceriana P, Carlucci A, Fanfulla F, Delmastro M, Nava S (2007) Automatic detection of ineffective triggering and double triggering during mechanical ventilation. IntensiveCareMed33:2014 2018
Asynchrony and Cyclic Variability in Pressure Support Ventilation
11
AntoineCuvelierandJean-FrançoisMuir
Adaptationbetweenthepatientandtheventilatorhasalwaysbeenthe rstgoalofthephysicianfacingwithapatienttreatedbymechanicalventilation.Sedationiscommonlyused underinvasiveventilationtofacilitateit,especiallyindif cult-to-ventilatepatientswith acuterespiratorydistresssyndrome(ARDS).Adaptationtononinvasiveventilation(NIV) isoftendif culttoobtainintheacutephaseasthismodeofventilationisa leaky ventilation,andspontaneousventilationhastoberespected,withcontraindicationofsigni cant sedation.Thus,speci cattentionhasbeenbroughttothisphenomenoncalledsynchrony, which may be de ned as the agreement between the patient respiratory efforts and the inspiratoryandexpiratorytimeoftheventilator.So,asynchronymaybeexplainedbythe inspiratorydriveandtheairwayspressurization,whichissecondarytothemechanicaland technicalcharacteristicsofthemachineandtheinterface,theventilatorysettings,andthe pathophysiologicalabnormalitieslinkedtotheetiologyoftherespiratoryfailure[1].This dyssynchronyisthemismatchbetweenpatientandventilatorinspiratorytimeandsecondarywastedorineffectiveefforts. Withasynchronyasthesourceofdiscomfortforthepatientwithincreasedsensationof dyspneaandimpairmentofthequalityofventilatorysupport,itisimportanttoprovideits precisesemiologytoevaluateitsclinicalrelevanceanditspathophysiologytocorrectit, mainly by an improvement of the settings of the respirator and special attention to the inspiratoryandexpiratorytriggers.Ontheotherhand,dyssynchrony,stilltodaydetected andanalyzedduringdaytime,maysigni cantlyoccurduringnight,generatingsleepfragmentationandthusdaytimefatigueandsomnolence.Itwasnecessarytohavetheopportunitytorecordmoreeasilyandforalongtimesucheventstocorrectthemthroughappropriate respirator setting modi cations. Signi cant improvements in recording and detection of patient ventilatorasynchronyhavebeendevelopedinourlaboratorythatmaybederived fromthepressureand owtracesonthescreenoftherespiratorandthususedintheclinical setting.Thethreemajordeterminantsofthepatient-ventilatorsynchronyaretheventilator triggering,theairwaypressurizationandtheventilatorcycling(passagetoexpiration)[2].
A.Cuvelier()andJ.-F.Muir PulmonaryDepartmentandRespiratoryIntensiveCareUnit, RouenUniversityHospital,Rouen,Franceand UPRESEA3830HopitaldeBois-Guillaume 76130Rouen,Cedex,France e-mail:
[email protected];
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_11,©Springer-VerlagBerlinHeidelberg2010
73
74
A. Cuvelier and J.-F. Muir
Poorpatient ventilatorinteractions,especiallyineffectiveinspiratorytriggeringefforts (ITEs)mayoccurduringnoninvasivepressuresupportventilation(PSV)inpatientswith cystic brosis(CF)[3,4],inpatientswithchronicobstructivelungdisease(COPD)with lungin ationandintrinsicpositiveend-expiratorypressure(PEEPi)[5,6],andinpatients with various other pulmonary diseases [7]. ITEs under PSV are more frequent during sleep[8,9]andwhenincreasingthelevelofventilatoryassistance[10,11].ITEsduringNIV areassociatedwithpoorergasexchangeduringsleep[12]andsleepfragmentation[13]. Moreover, ITEs may be a cause of PSV intolerance and failure in critically ill patients ghting againsttheirventilator.Otherwise,theincidenceofITEanditsimpactonPSV ef cacyandcomfortremainunknown.AsimplenoninvasivemethodtodetectITEduring PSVisthereforehighlydesirable.Esophagealpressure(Pes)monitoringiscommonlyused asthestandardfordetectingtheonsetofinspiratoryefforts,althoughdiaphragmaticelectromyographyhasbeenusedbysomeauthors[14].Thislasttechniquerequiresesophageal orsurfaceelectrodesandcannotbeperformedonaroutinebasisduringsleeporfordomiciliaryassessments.Consequently,moststudiesonITEhaveassessedPesortransdiaphragmaticpressure(Pdi)variationstoidentifytherelationshipbetweenindividualinspiratory effortsandventilatortriggering.However,esophagealrecordingsarenotpracticalasaroutinemeasureinmostcentersandareinadequateforprolongedorlong-termassessmentsin patientstreatedbyhomeventilation,whichrequirearealinvestigationofthefrequencyand duration of such events and which cannot be correctly identi ed, scored, and quanti ed fromshortrecordings.Ontheotherhand,manualscoringofITEistimeconsuming.For thisreason,anewresearchaxisiscurrentlybeingexploredthroughalgorithmsthatintegrate airway pressure and ow variations to automatically detect ITE in real time. This automaticnoninvasivemethodhasbeenvalidatedbycomparingitwiththemanualdetectionofITEusingconventionalPesrecordings[15 17].Thisdetectionmethodology,based onsimplephysiologicaldata,isverysensitiveandspeci ccomparedtothestandardmethod (i.e., measurements of Pes variations). Also, the structure of the phase portraits reconstructedfromthe owtimeseriesappearstobeverysensitivetothedynamicsofunderlying patient ventilatorinteractions[16].Phaseportraitsprovideglobalsignaturesofthequality oftheventilationfromamechanicalpointofview.Dependingonloopdispersionandshape, patients with regular ventilatory patterns could be easily distinguished from patients not adaptedtotheirventilators.Itshouldbenotedthatairleakswereeasilydetectedbythis approachsincetheyinducedloopswithabnormalshapesandusuallywithlargeamplitudes. AparallelapproachwasdevelopedbyMulqueneeyetal.[18].Theybuiltanalgorithmthat wasabletodetectineffectivetriggeringeffortsbasedonsigni cantalterationsoftheexpiratory ow signal. However, their technology was connected to a speci c ventilator and required an electronic signal delivered by this machine to detect the expiratory phase. Conversely,thealgorithmofAchouretal.[15]runswithanynoninvasiveventilatorandhas theabilitytocombinetheanalysisof ow/pressuretimeseriesandtheirmathematicaltransformation according to the nonlinear dynamic system theory. It quanti es the breathing patternandalsoidenti essigni cantinspiratoryeffortvariations.Chenetal.[19]havealso nalizedanalgorithmthatworksbyanalyzingminimalandmaximal owvaluesduringthe expiratoryphaseoftheITE.Bycomparison,thealgorithmofAchouretal.uses owderivativesovereachwholeventilatorycycleandnotonlyduringitssoleinspiratoryorexpiratoryphaseandrepresentsanef cienttooltoidentifyrepeatedITE.
11
Asynchrony and Cyclic Variability in Pressure Support Ventilation
75
The standard criteria commonly used to de ne ITE are based on a Pes decrease of morethan1cmH2Owithasimultaneousdropinairwaypressureorchangein ow[8]. Giannoulietal.werethe rsttosuggestthatITEcouldbedetectedexclusivelyfromPaw and owtimeseries[9].Thisapproachisaccurateinintubatedpatients,andanacceptable ITEunderestimationmaybeencounteredincaseofseverepatient ventilatorasynchronies.Thepreviouslycitedarticlesshowedthatasimilarapproachcanbeautomatedand canalsobeappliedtopatientsreceivingnoninvasivePSV.Suchalgorithmscouldbeof potentialclinicalinteresttoidentifyITEduringprolongedrecordingsduringsleeporwhen assessing domiciliary ventilation. This new approach for assessing patient ventilator interactions avoids the inherent dif culties and discomfort associated with esophageal pressureassessments.
References 1. NavaS,CarlucciA,CerianaP(2009)Patient ventilatorinteractionduringnoninvasiveventilation:practicalassessmentandtheoreticalbasis.Breathe5:323 333 2. TobinMJ,JubranA,LaghiF(2001)Patient ventilatorinteraction.AmJRespirCritCareMed 163:1059 1063 3. FaurouxB,LeRouxE,RavillySetal(2008)Long-termnoninvasiveventilationinpatients withcystic brosis.Respiration76:168 174 4. FaurouxB,NicotF,EssouriSetal(2004)Settingofnoninvasivepressuresupportinyoung patientswithcystic brosis.EurRespirJ24:624 630 5. KriegerBP(2009)Hyperin ationandintrinsicpositiveend-expiratorypressure:lessroomto breathe.Respiration77:344 350 6. NavaS,BruschiC,RubiniFetal(1995)Respiratoryresponseandinspiratoryeffortduring pressuresupportventilationinCOPDpatients.IntensiveCareMed21:871 879 7. NavaS,BruschiC,FracchiaCetal(1997)Patient ventilatorinteractionandinspiratoryeffort during pressure support ventilation in patients with different pathologies. Eur Respir J 10:177 183 8. ParthasarathyS(2005)Effectsofsleeponpatient ventilatorinteraction.RespirCareClinN Am11:295 305 9. FanfullaF,DelmastroM,BerardinelliAetal(2005)Effectsofdifferentventilatorsettingson sleepandinspiratoryeffortinpatientswithneuromusculardisease.AmJRespirCritCare Med172:619 624 10. LeungP,JubranA,TobinMJ(1997)Comparisonofassistedventilatormodesontriggering, patienteffort,anddyspnea.AmJRespirCritCareMed155:1940 1948 11. GiannouliE,WebsterK,RobertsDetal(1999)Responseofventilator-dependentpatientsto different levels of pressure support and proportional assist. Am J Respir Crit Care Med 159:1716 1725 12. FanfullaF,TaurinoAE,LupoNDetal(2007)Effectofsleeponpatient/ventilatorasynchrony in patients undergoing chronic non-invasive mechanical ventilation. Respir Med 101: 1702 1707 13. GuoYF(2004)Contributionofpolygraphyandpolysomnographytonocturnalmonitoringof patientswithobesity-hypoventilationsyndrome(OHS)andnon-invasiveventilation(NIV). DepartmentofMedicine.Medicalthesis,UniversityofGeneva,Geneva
76
A. Cuvelier and J.-F. Muir
14. Parthasarathy S, Jubran A, Tobin MJ (2000) Assessment of neural inspiratory time in ventilator-supportedpatients.AmJRespirCritCareMed162:546 552 15. AchourL,LetellierC,CuvelierAetal(2007)Asynchronyandcyclicvariabilityinpressure supportnon-invasiveventilation.ComputBiolMed37:1308 1320 16. Rabarimanantsoa H (2008) Qualité des interactions patient ventilateur en ventilation non invasive nocturne. PhD Thesis, University of Rouen. http://www.coria.fr/spip.php? article551.AccessMay3,2010 17. CuvelierA,AchourL,RabarimanantsoaH,LetellierC,MuirJ-F,FaurouxB(2009)Anoninvasivemethodtoidentifyineffectivetriggeringinpatientswithnoninvasivepressuresupport ventilation.Respiration.Dec2(Epubaheadofprint) 18. MulqueenyQ,CerianaP,CarlucciAetal(2007)Automaticdetectionofineffectivetriggering anddoubletriggeringduringmechanicalventilation.IntensiveCareMed33:2014 2018 19. ChenCW,LinWC,HsuCHetal(2008)Detectingineffectivetriggeringintheexpiratory phaseinmechanicallyventilatedpatientsbasedonairway owandpressurede ection:feasibilityofusingacomputeralgorithm.CritCareMed36:455 461
Carbon Dioxide Rebreathing During Noninvasive Mechanical Ventilation
12
FrancescoMojoliandAntonioBraschi
12.1 Introduction Partial reinhalation of previously exhaled carbon dioxide (CO2) may impair the ef cacy of noninvasive mechanical ventilation (NIMV) in improving CO2 removal and unloadingventilatorymuscles[1].Atconstantalveolarventilation,anyCO2concentrationabovezeroininhaledgasescausesanincreaseofarterialCO2tensionbyanequal amount.Accordingly,signi cantCO2rebreathingincreasesalveolarventilationrequirementstomaintaindesiredarterialCO2tension.Thiscanlimitthebene cialeffectsof inspiratoryassistanceprovidedby NIMV.Inthischapter, we review general mechanismsofCO2rebreathingandtheeffectofdifferentinterfaces,respiratorycircuits,and ventilatorsettings.
12.2 General Mechanisms of Carbon Dioxide Rebreathing During NIMV, inspiratory and expiratory ows share the distal part of the respiratory circuitandtheinnervolumeofthepatient ventilatorconnectinginterface,beitamaskor ahelmet.ExpiredCO2 llsthis common spaceandispushedbytheventilatoragaininto thepatient sairwaysduringthefollowinginspiratoryphase.Anyway,thisspaceisnot
F.Mojoli()andA.Braschi FondazioneIRCCSPoliclinicoSanMatteo,ServiziodiAnestesiaeRianimazioneI, UniversitàdegliStudidiPavia,CattedradiAnestesiaeRianimazione, PiazzaleGolgi2,Pavia,Italy e-mail:
[email protected];
[email protected]
A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_12,©Springer-VerlagBerlinHeidelberg2010
77
78
F. Mojoli and A. Braschi
reallyequivalenttothedeadspacewedealwithduringinvasivemechanicalventilation. Suchclassic,orstatic,deadspaceis lledbythe nalpartofexpiratorytidalvolume,havingaCO2concentrationequaltomeanalveolarvalue(i.e.,theend-tidalCO2).Apartfrom aminorclearingeffectofbias owwhen ow-basedtriggeringisselected,CO2doesnot leave this static dead space. Thus, reinhalation of this volume does not signi cantly decreasealveolarCO2, nallyresultingineffectiveinremovingcarbondioxide. Thisisnotthecasefornoninvasiveventilation.Duringmaskventilation,highexpiratory owsthroughtheexhalationportandsigni cantairleaksattheinterfacewiththe patient sfacecansubstantiallydecreasetheCO2concentrationbelowthealveolarvalue [2];reinhalationofthispartiallycleared(i.e.,dynamic)deadspaceisthereforenotcompletelyineffectiveinremovingCO2.Duringhelmetventilation,CO2rebreathingisnotdue todeadspaceventilationatall.Expiredgasesfromthepatientareindeeddilutedinaspace thatismuchlargerthantidalvolume,withCO2concentrationinsidethehelmetmostly reducedbythe owoffreshgasesfromtheventilator.Therefore,helmetNIMVcanbe assimilatedtobreathinginasemiclosedenvironment[3,4].Fromwhathasbeenjustmentioned, factors underlying rebreathing during mask and helmet NIMV are substantially different;therefore,theywillbediscussedseparately.
12.3 CO2 Rebreathing During Mask Ventilation The amount of CO2 rebreathed from the mask and respiratory circuit depends on dead spacevolumeanditsCO2content. The volume of dead space may be modi ed by mask and respiratory circuit design, ventilatorsettings,andthepatient srespiratorypattern.Maskswithmajorinnervolume (once xed to the patient s face), like total-face masks, may improve comfort during NIMVbutenhanceCO2rebreathing[2].Regardingcircuitdesign,whenatwo-limbrespiratory circuit is used, dead space volume is limited to the mask inner volume plus the volumeoftherespiratorycircuitdistaltotheY-piece(Fig.12.1a). Anyway,NIMVisoftenputinplaceusingasingle-limbrespiratorycircuit.Inthis case, gases exhaled by the patient are discharged in the environment by one or more exhalationports,thepositionanddesignofwhichcansigni cantlyaffectrebreathing[2]. As owthroughexhalationportsislimited,inthe rstpartofpatient sexpiration(when owreachesitspeak),someexhaledgasescangouptherespiratorycircuit,muchbeyond theexhalationport(Fig.12.1b)[5].Actualdeadspacecanthusbecomelargerthanwhat theoreticallyattended(i.e.,thevolumebetweenthepatient smouthandtheexhalation port).Therefore,largetidalvolumesofthepatientandexhalationportswithhighresistancemayenlargedeadspace[1].Inthesecondpartofexpiration,deadspacemayinstead bereducedbythe owoffreshgasesproducedbytheventilatortomaintainpositiveendexpiratorypressure(PEEP);thisisduetointentionalleaksthroughtheexpirationport andunintentionalleaksbetweenthemaskandthepatient sface.AhigherPEEPleveland alongerexpiratorytimeincrease,respectively,thequantityanddurationofleak ows,
12
Carbon Dioxide Rebreathing During Noninvasive Mechanical Ventilation
79
a Two-limb circuit
b Exhaust port on circuit
c Unidirectional expiratory valve
d Exhaust port within the mask
Fig. 12.1 (a) In a two-limb circuit, theoretical dead space is limited to the volume distal to the Y-piece.Duetounintentionalleaksfromthemask patientinterface,theCO2concentrationinthis volumecanbesubstantiallylowerthanthealveolarmeanvalue(i.e.,end-tidalCO2),makingita dynamic dead space.(b)Inthisparticularvarietyofsingle-limbcircuit,theoreticaldeadspace isthevolumedistaltotheexhaustport.Actualvolumeofdeadspaceisincreasedbylargetidal volumesofthepatientandhighresistanceoftheexhalationport(dashedarrows),anddecreased by PEEP and prolonged expiratory time. The balance between these factors determines actual volume of dead space. (c) The existence of a unidirectional valve on a single-limb circuit can decreaseCO2deadspacevolume.Amajordrawbackisincreasedcircuitresistance.(d)Exhaustion portswithinthemaskdecreasedeadspacevolumeanditsCO2content
thuslimitingdeadspace(Fig.12.1b)[1].Exhalationportscanbeprovidedwithaunidirectional(nonrebreathing)valve;thiscansigni cantlydecreasedeadvolume(Fig.12.1c) [5]butmayincreaseinspiratoryandexpiratorycircuitresistance,leadingtobothlower inspiratorypressurizationandhigherexternalPEEP[1].Exhalationportswithinthemask insteaddecreasedeadspacevolumecomparedwiththoselocatedinthecircuit(Fig.12.1d), withoutadverseeffects[2]. DuringmaskNIMV,theCO2contentofdeadspaceisdirectlyrelatedtothepatient sendtidalCO2.Anyway,CO2concentrationinthemask sdeadspacecanbesubstantiallylowered belowthisvaluebymeansofa washing effectoffreshgasesdeliveredbytheventilator.
80
F. Mojoli and A. Braschi
HigherPEEPlevels,leaksbetweenthemaskandthepatient sface,andforsingle-limbcircuits,exhalationportslocatedwithinthemask(especiallyoverthenasalbridge)increasethe owoffreshgasesthroughthedeadspaceandthusdecreaseitsCO2content[1,2]. Therefore,tolimitCO2rebreathingduringmasknoninvasiveventilationthebestoption isprobablytheuseofPEEPand,forsingle-limbcircuits,facemasksprovidedwithexhalationportsoverthenasalbridge.Inthesesettings,rebreathingisnegligible,andmonitoring ofinhaledCO2isnottobeconsideredimperative.
12.4 CO2 Rebreathing During Helmet Ventilation Useofheadhelmetsfornoninvasiveventilationcouldbeadvantageous,comparedtofacemasks, intermsofapatient scomfortandtolerance,withimprovedfeasibility,continuity,andduration ofnoninvasiveventilatoryassistance[6].Ontheotherhand,theseadvantagescanbehindered byCO2rebreathingsigni cantlyhigherthanwhatisobservedduringmasknoninvasiveventilation[6,7].Ateverybreath,expiredcarbondioxidedoesnotcompletelyleavethehelmetbut partlydilutesitselfwithintheinternalvolumeofthedeviceandissubsequentlyinhaledagain.In thissetting,itcanbedemonstratedthattheamountofCO2reinhaledbythepatientdependson justtwofactors:thepatient scarbondioxideproduction(V¢CO )andthetotalgas owpassing 2 throughthehelmet(Ftot)[3,4].Infact,whenasteadystateisreachedandCO2isstableinsidethe helmet,theamountofCO2enteringthehelmetperminute(i.e.,thepatient sV¢CO ),mustbeequal 2 totheamountofCO2leavingthedeviceinthesametime.Becausethelastisafunctionofthe meanCO2concentrationinsidethehelmet(hCO2)andthesumofall owsdirectedfrominside thehelmettooutside(Ftot),theequationofCO2steadystateinsidethehelmetis V'CO2=hCO2× Ftot or,oncerearranged, hCO2=V'CO2 / Ftot Totalgas owpassingthroughthehelmetisequivalenttothevolumedeliveredbytheventilator every minute. This ow can be divided into three components: one reaches the patient srespiratorysystem;anotherintermittentlydistendsthehelmet;thelastcorresponds toleaksattheinterfacebetweenthesoftcollarofthehelmetandthepatient sskinsurface. Thepresenceofa helmetventilation, duetotherelativelyhighcomplianceofthisdevice, isauniquefeatureofthistechnique.ThetheoreticallyderivedequationofhelmetCO2content was fully con rmed by experimental data obtained during both continuous positive airway pressure [3] and pressure support ventilation [4] delivered by helmet. In a bench study,alltestedmanipulationsofthesystemaffectedCO2rebreathinginsofarastheywere abletochangeFtotorV¢CO [4].Therefore,signi cantrebreathingcanbeexpectedwhenthe 2 patient s metabolic requirements are high or the ventilator volume delivery is low. Remarkably,thevolumeofthehelmetandthepatient send-tidalCO2,incontrastwithmask ventilation,donotaffectCO2reinhalation.ToincreaseFtotandlowerCO2insidethehelmet, we can increase pressure support, add an intentional leak device, or implement a helmet
12
Carbon Dioxide Rebreathing During Noninvasive Mechanical Ventilation
81
ow-by.UseofleakdevicesdecreasesCO2rebreathingbuthindershelmetpressurization andthepatient sinspiratoryassistance,whicharecounterproductiveforCO2removal[4,8]. Whenpressureassistancetothepatient sspontaneousactivityisalreadyoptimalbutCO2 rebreathingisnot,theadditionofa ow-bycaninsteadbeconsidered[4].Aninteresting optionistheuseofbias owfromtheventilatorasa ow-by;oncea ow-basedinspiratory triggerisselected,theventilatormustbeconnectedtothehelmetbytwoindependentports, forinspirationandexpiration,toforcethebias owtopassthroughthehelmet.Thistrick effectively decreases rebreathing by increasing the ow inside the helmet, thus clearing awayCO2withoutadverseeffects. DuringhelmetNIMV,CO2rebreathingmustbemonitored.Inmechanicallyventilated patients, rebreathing is usually evaluated by end-inspiratory CO2 value. Unfortunately, inhaledCO2insidethehelmetcanbegrosslyunderestimatedbythisvalueduetotheslow decrease of CO2 concentration during the inspiratory phase of helmet ventilation (Fig.12.2)[4].TheCO2valuemeasuredina quietpoint (notaffectedby owstoand
airway opening, Y-piece and helmet CO2(%)
5
etCO2
4 yCO2 hCO2
hCO2 3
2
1 eiCO2
eiCO2 0
time (s)
Fig. 12.2 ContinuousCO2concentrationrecordingsattheairwayopening(blackline),attheY-piece oftheventilatorcircuit(dottedline),andinsidethehelmet(grayline)duringhelmetventilation with16.5L/minoftotalminuteventilationand350mL/minofCO2production.Atairwayopening,theminimumvalueisend-inspiratoryCO2(eiCO2),andthemaximumvalueisend-expiratory CO2(etCO2).TheCO2concentrationmeasuredattheY-piecerangesfromzeroduringinspiration (duetofreshgas owfromtheventilator)andtheend-expiratoryvalue(yCO2),whichislower thanetCO2becausegasesexpiredbythepatientaredilutedinthehelmetinternalvolume.CO2 concentrationmeasuredata quiet pointinsidethehelmet(hCO2)isconstantduringtheentire respiratorycycleandcorrespondstothemeanCO2concentrationininhaledgases
82
F. Mojoli and A. Braschi
from the patient) inside the helmet is instead stable and corresponds exactly to mean inhaledCO2[4].Whenastablevalueinsidethehelmetcannotbeobtained,theend-tidal CO2valuemeasuredattheY-pieceorattheexpiratoryportrepresentsafairestimateof CO2rebreathing[4].
Key Recommendations
› › ›
Duringmaskventilation,implementPEEPanduseexhalationportswithinthe masktoreduceCO2rebreathing. Whileventilatingwithahelmet,atotalgas owbelow40L/minisathighrisk ofsigni cantCO2rebreathing.Increasetotalgas owthroughthehelmetby raisingpressuresupportand/orbyaddinga ow-by. CO2rebreathinginthehelmetmustbemonitored,atleastperiodically.
References 1. LofasoF,BrochardL,TouchardDetal(1995)Evaluationofcarbondioxiderebreathingduring pressure support ventilation with airway management system (BiPAP) devices. Chest 108: 772 778 2. SchettinoGPP,ChatmongkolchartS,HessDetal(2003)Positionofexhalationportandmask designaffectCO2rebreathingduringnoninvasivepositivepressureventilation.CritCareMed 31:2178 2182 3. TacconeP,HessD,CaironiPetal(2004)Continuouspositiveairwaypressuredeliveredwith a helmet :effectsoncarbondioxiderebreathing.CritCareMed32:2090 2096 4. MojoliF,IottiGA,GerlettiMetal(2008)Carbondioxide rebreathing during non-invasive ventilationdeliveredbyhelmet:abenchstudy.IntensiveCareMed34:1454 1460 5. FergusonGT,GilmartinM(1995)CO2rebreathingduringBiPAPventilatoryassistance.AmJ RespirCritCareMed151:1126 1135 6. AntonelliM,PennisiMA,PelosiPetal(2004)Noninvasivepositivepressureventilationusing ahelmetinpatientswithexacerbationofchronicobstructivepulmonarydisease:afeasibility study.Anesthesiology100:16 24 7. Navalesi P, Costa R, Ceriana P et al (2007) Non-invasive ventilation in chronic obstructive pulmonarydiseasepatients:helmetversusfacialmask.IntensiveCareMed33:74 81 8. RaccaF,AppendiniL,GregorettiCetal(2008)Helmetventilationandcarbondioxiderebreathing:effectsofaddingaleakatthehelmetports.IntensiveCareMed34:1461 1468
Carbon Dioxide Rebreathing During Pressure Support Ventilation with Airway Management System (BiPAP) Devices
13
FrédéricLofasoandHélènePrigent
13.1 Introduction Inthe1980s,thedevelopmentofnoninvasiveventilationusingpressuresupportventilationwithorwithoutpositiveend-expiratorypressure(PEEP)constitutedamajorimprovementinthemanagementofbothacuteandchronicrespiratoryfailure.Meanwhile,the rst bilevelventilatorwasdesigned(BiPAP;Respironics;Murrysville,PA).Initiallyintended toimprovehometreatmentofsleepapneasyndrome,thisdevicelackedalarmsandmonitoringsystemsbutwaseasytohandleandlowpriced.Itwasanasalcontinuouspositive airwaypressuredeviceequippedwithasolenoidmagneticvalvesystemallowingseparationofPEEP(withaminimallevelbelow2cmH2O[1,2])andinspiratorypositiveairway pressure adjustments. Like other nasal continuous positive airway pressure devices designedforhome,itusedasingle-limbcircuitwithaleakport(i.e.,RespironicsWhisper Swivel).Therefore,therewasariskofCO2rebreathing,whichwasinitiallyconsideredan importantlimitationforextendingitsuseinthetreatmentofrespiratoryfailure,especially hypercapnicrespiratoryfailure,whichwasconsideredtohavethebestoutcomewithnoninvasiveventilation.
13.2 Rebreathing Mechanisms Toensurethatnoexhaledgasremainsinthetubingattheendofexpiration( readytobe inhaledagain ),themeanexpiratory ow,thatis,theratiobetweentidalvolumeandexpiratorytimeVT/TE,hastobelowerthantheintentionalleakobtainedthroughtheleakport
F.Lofaso()andH.Prigent AP-HP,RaymondPoincaréTeachingHospital,UniversitéVersailles-StQuentinenYvelines, Physiology FunctionalTesting,E.A.4497andCIC-IT,92380Garches,France e-mail:
[email protected];
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_13,©Springer-VerlagBerlinHeidelberg2010
83
84
F. Lofaso and H. Prigent
a Inspiration BiPAP device
patient Exhalation port
b Expiration < 200 ml/s patient
PEEP : 5 cmH2O
c
BiPAP device
Leak : 200 ml/s risk of rebreathing
> 200 ml/s patient PEEP : 5 cmH2O
BiPAP device
Leak : 200 ml/s
Fig. 13.1 BiPAPventilationwithanintentionalleak owoftheWhisperSwivelconnectorofabout 200ml/swhenPEEPissetat5cmH2O.(a)Inspirationperiod.(b)Expirationperiodwitha ow ratelowerthantheintentionalleakthroughtheleakport;noexhaledgasreturnsintothetubingat theendofexpiration.(c)Expirationperiodwitha owratehigherthantheintentionalleakthrough theleakport;someoftheexhaledgasremainsinthetubingattheendofexpirationandcanbe rebreathedduringthenextinspiration
duringexpiration.Therefore,rebreathingdepends rstonthepatternofbreathing:highVT andshortTEexposesahigherriskofrebreathingbyincreasingexpiratory ow.Second,it dependsonthesizeoftheportandthePEEPlevel:AsmallportandlowPEEPlevelconstituteriskfactorsforrebreathing.Forexample,Lofasoetal.[2]observedthattheintentionalleak owoftheWhisperSwivelconnectorwasabout200ml/swhenPEEPwasset at5cmH2O.Therefore,ifapatienthastoexpire500mlin2s,theexpiredvolumeremaininginthecircuitattheendofexpirationwouldbeapproximately100ml(Fig.13.1).
13.3 Bench and Clinical Studies TheinversecorrelationbetweenrebreathingandPEEPwiththeWhisperSwivelwasdemonstrated in a bench study [1] and a clinical study [3]. Moreover, it has been clinically demonstrated that CO2 rebreathing observed with the Whisper Swivel worsened the patients workofbreathing(WOB)[2].Theuseofaplateauexhalationvalveandanonrebreathing valve has been proposed to reduce or avoid CO2 rebreathing. Ferguson and Gilmartin[3]observedthat,withtheiruse,CO2rebreathingbecameminimalinpatients. Theplateauexhalationvalveconsistsofadiaphragmthatlimitsairleaksathighpressure (during inspiration) and works as a larger leak port at low pressure (during expiration),
13
Carbon Dioxide Rebreathing During Pressure Support Ventilation with Airway Management System (BiPAP) Devices
85
whilethenonrebreathingvalveisanantireturnvalvewithalateralintentionalleak.Lofaso etal.[1]con rmedthatthesubstantialrebreathingobservedwiththeWhisperSwiveldisappeared when using a nonrebreathing valve. However, the drawback is that the nonrebreathingvalveinducesadditionalexpiratoryresistance[2],whichmayhavesomeimpact onintrinsicPEEPandthereforeonWOB[4].Incontrast,inacrossoverstudywithseven patientsreceivinglong-termnocturnalnoninvasiveventilation,theplateauexhalationvalve didnotimprovedaytimeornocturnalgasexchangeorsymptomscomparedtotheWhisper Swivel,mostlikelybecauseofairleakageandCO2escapeoccurringviaotherroutes[5].
13.4 Exhalation Port Characteristics Toexplorethein uenceoftheexhalationportpositiononCO2rebreathing,Shettinoetal. [6]performedabenchstudythatobservedthattheCO2rebreathingwassigni cantlylower whentheexhalationportwasplacedwithinthemaskratherthanonthecircuit.Inaddition, thesmallestmaskvolumewasassociatedwithlowerCO2rebreathingthanthelargerone. However,thesedifferencesmayalsobeexplainedbydifferencesinexhalationportsizes.
13.5 Devices Evolution Now,thesedeviceshavebeenimproved;allbilevelventilatorshaveaminimalPEEPsettingof4cmH2Obydefault,andtheintentionalleakthroughtheleakportofmostavailable masksexceeds300ml/swhenPEEPissetat5cmH2O(higherthanwhatwasobserved withtheWhisperSwivelleak[2,7]).Thisgreatlyreducesandevenabolishestheriskof rebreathingduringnoninvasiveventilation,exceptwiththeuseofhelmets[8].Thisnovel interface,aimingtoimprovecomfortandtoreducelocalsideeffects,exposesthepatient toahigherriskofCO2rebreathing[8]andisnotcurrentlyadaptedforhomeventilation.
13.6 Conclusion Theriskofrebreathingduringnoninvasiveventilationisnowlowthankstonotonlythe improvementsachievedsincethe rstbilevelventilatorsandtheirinitialcircuitrybutalso secondarytononintentionalairleakageandCO2escapealmostconstantlyobservedduring noninvasiveventilationandsleep.ThesystematicuseofaminimalPEEPlevelof4cmH2O isusuallyef cientinreducingrebreathingbutcanbealimitationfortheuseofthisdevice forsomepatients.However,CO2rebreathingsystematicallyoccursduringtheuseofhelmetinterfaces.
86
F. Lofaso and H. Prigent
Key Recommendations
›
Finallytheclinicianshouldbeawareofriskofrebreathing,whichcanbeafactor ofmechanicalventilation,pooref ciencyandthisrebreathingisfacilitedbyhigh respiratoryfrequencyandlowpeeplevel.
References 1. LofasoF,BrochardL,HangTetal(1996)Homeversusintensivecarepressuresupportdevices. Experimentalandclinicalcomparison.AmJRespirCritCareMed153:1591 1599 2. LofasoF,BrochardL,TouchardDetal(1995)Evaluationofcarbondioxiderebreathingduring pressure support ventilation with airway management system (BiPAP) devices. Chest 108: 772 778 3. FergusonGT,GilmartinM(1995)CO2rebreathingduringBiPAPventilatoryassistance.AmJ RespirCritCareMed151:1126 1135 4. LofasoF,AslanianP,RichardJCetal(1998)Expiratoryvalvesusedforhomedevices:experimentalandclinicalcomparison.EurRespirJ11:1382 1388 5. HillNS,CarlisleC,KramerNR(2002)Effectofanonrebreathingexhalationvalveonlongtermnasalventilationusingabileveldevice.Chest122:84 91 6. SchettinoGP,ChatmongkolchartS,HessDRetal(2003)Positionofexhalationportandmask designaffectCO2rebreathingduringnoninvasivepositivepressureventilation.CritCareMed 31:2178 2182 7. LouisB,LerouxK,IsabeyDetal(2010)Effectofmanufacturer-insertedmaskleaksonventilatorperformance.EurRespirJ35:627 636 8. RaccaF,AppendiniL,GregorettiCetal(2008)Helmetventilationandcarbondioxiderebreathing:effectsofaddingaleakatthehelmetports.IntensiveCareMed34:1461 1468
Carbon Dioxide Rebreathing in Noninvasive Ventilation
14
DanielSamolskiandAntonioAntón
14.1 Introduction Severalfactorsinnoninvasivepositivepressureventilation(NIPPV)haveprovedtobe potentialcausesoffailurewhenthiskindofmechanicalrespiratoryassistanceisusedin patientswhosufferfromacute(ARF)orchronic(CRF)respiratoryfailure[1 3].Onesuch factoriscarbondioxide(CO2)rebreathing[1 4].Thisphenomenonconsistsofrebreathing partoftheCO2expiredbythepatientduringtheventilatorycycleasaresultofanaccumulationofthisgasinthemaskorthecircuit.Suchrebreathingtakesplacemainlyinsinglelimb circuits (inspiration and expiration into the same tube). Besides the use of such a circuit,therearetechnicalcircumstancesthatplayanactiveroleinthepresenceoreliminationofexpiredCO2:theventilatorymode[4,5],typeofmaskandexpiratoryport[6 12],aswellasthelevelofpositiveend-expiratorypressure(PEEP)used[4,10,11].Since 1995, when Ferguson and his collaborators rst described such a phenomenon, little research has been done on this issue. The development of technological innovations, mainlyininterfaces,hasrestrictedthepotentialclinicalimplicationsofthisdeleterious phenomenon.Likewise,researchworksconductedsofarhavenotcon rmedwhetherCO2 rebreathing does have a signi cant in uence on patients clinical evolution or is just a potentially,butrarely,harmfulphenomenon.
D.Samolski() RespiratoryMedicineDepartment,HospitaldelaSantaCreuiSantPau,Barcelona,Spainand Roosevelt49574°B,CP1431BuenosAires,Argentina e-mail:
[email protected] A.Antón RespiratoryMedicineDepartment,HospitaldelaSantaCreuiSantPau,Barcelona,Spain e-mail:
[email protected]
A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_14,©Springer-VerlagBerlinHeidelberg2010
87
88
D. Samolski and A. Antón
14.2 Main Topics Asoutlinedintheintroduction,thereareseveralelementsorcircumstancesthatin uence theCO2rebreathingscope.
Typeofcircuit Typeofmask:internalvolume,exhaustvent(EV),orcontrolledleakholes Devicesattachedtothecircuit(incaseofmaskswithoutanEV):conventionalorantirebreathingexpiratoryports,cylindricalspacers
Levelofexpiratorypressure(expiratorypositiveairwaypressure,EPAP) Patient sfeatures:ARForCRFinnormo-orhypercapnicpatientsandtheirventilatory pattern
14.2.1 Type of Circuit CO2rebreathingisaninherentcharacteristicofthesingle-limbcircuitsystem[1 3]andis lessfrequentintwo-limbcircuits(separateinspiratoryandexpiratorylimbs)orcircuitswith pneumaticexpiratoryvalves(domiciliaryvolumetricventilators).Logically,wecaninfer thatexpirationintothesametubeintowhichthepatientinspiresleadstorebreathingpreviouslyexpiredgasifsuchgasisnotappropriatelyeliminatedfromthetubingormask.
14.2.2 Type of Mask Maskswithhighlevelsofdeadspace[12,13]cangiverisetosigni cantlevelsofrebreathing incaseofinappropriatekineticsofexpiredgaselimination.Technologicaldevelopmenthas createdEVs(controlledleakholes)inmasks,whichallowadequateeliminationofgases beforethenextinspiration.Suchholesarelocatedinthemaskitselfaswellasintheelbowshapedtubejoiningthemaskwiththecircuit.Thekeyissueistocontroltheef ciencyof newmasksineliminatingCO2throughtheirholesasresearchstudiesconductedsofarhave testedonlyareducednumberoftrademodels[10,11]TheexistenceofaninherentphenomenoninNIPPV,suchasleaks,highlyfrequentinnasalmasks,willcertainlyplayakeyrole inpreventingCO2rebreathingbyreducingtheairvolumeexpiredintothecircuit.
14.2.3 Devices Attached to the Circuit Whenhermeticmasks(withoutEVs)andsingle-limbcircuitsareused,itisfundamentalto addexpiratoryports[4,11,12]thatwillallowairreleasebeforethefollowingventilatory
14
Carbon Dioxide Rebreathing in Noninvasive Ventilation
89
cycle.Somehow,thesemasksfellintodisuseafterthedevelopmentofEVmasks.However, theyarestillavailableinthemarketduetotheirlowcostanduseindomiciliaryventilators andinrespiratorycareunits.Consequently,weshouldbeawareofhowtousethemappropriately.Therearetraditionalexpiratorydevices,suchastheWhisperSwivel®,ordevices withananti-rebreathingsystem,suchasPlateauvalve®.Furthermore,sometubeshavea built-inleakport. Regardingtheuseofspacers(corrugatedcylindricaltubeswhosefunctionistokeep anykindofpotentiallyannoyingelementawayfromthepatientbecauseofitssizeorform) betweentheventilatorandthepatient,atleastintheorythesecouldincreasethedeadspace andthereforegiverisetorebreathing.Ourgroup[11]hasprovedthatasingle-limbcircuit withitsownpneumaticvalve,evenwithlargeattachedspacers,avoidedrebreathingwhile usingvolumetricventilation.
14.2.4 Level of EPAP Used Acertainlevelofexpiratorypressureimprovestheeliminationofexpiredgaseswithinthe maskandcircuit.AlthoughFerguson sworksuggestedaminimumlevelofEPAPbetween 6and8cmH2Owhenusingtraditionalexpiratoryvalves,theuseofantirebreathingdevices aswellasEVs(leakholes)inthemaskhashelpedreducesuchpressureto4cmH2Oor evenless[11].Inclinicalpractice,theEPAPaveragelevelreaches6 8cmH2O.
14.2.5 Patient Characteristics: Hypercapnia or Normocapnia Hypercapniahasprovedtoberelatedtorebreathinglevels[4].Onlyoneresearchstudy conductedinhypercapnicpatientshasshownazerorebreathinglevelwhenusingnasal maskswithEVsandantirebreathingdevicesduringNIPPV[14].Inaddition,thepatient s ownventilatorypattern(inspiratorytime/totaltimeTi/Ttot;respiratoryfrequency/tidalvolumef/Vt)mayin uenceboththedeadspaceandthedegreeofrebreathing,althoughthis facthasnotbeendemonstrated.
14.3 Discussion CO2rebreathingisapotentiallyharmfulphenomenonwithadirectin uenceonthefailure orsuccessofNIPPV[1 3].Thereareseveralfactorsinvolvedintheexistenceandscopeof thisphenomenon.Manyauthorshavedescribedtheimportanceofsuchfactors,givingrise toopposing ndingsinsomecases.Theactualin uenceofCO2rebreathinginusualclinical practicehasnotbeendulyevidencedbyanyresearch.Hilletal.[15]comparedgaseous
D. Samolski and A. Antón
60
7.5
40
5
20
2.5
0
10
20
30
Fi CO2 (%)
ET CO2 (mmHg)
90
40
Time (sec)
Fig. 14.1 ContinuousanalysisofCO2insidethemask.Horizontalarrow:ETCO2(end-tidalCO2, mmHg).Verticalarrow:FiCO2(inspiredCO2fraction,%)
interchangeandsymptomsinpatientsunderNIPPVwhousedbothaconventionalexpiratoryportandanantirebreathingone.Nodifferencewasfoundbetweenthetwogroups;even more,theantirebreathingvalvewasconsiderednoisierandbadlookingbypatients.Inaddition,Farréetal.[16]suggestedthatrebreathingcouldbetoodeleteriousincaseofcontinuouspositiveairwaypressure(CPAP)failure,aneventthatcouldbepreventedbyusingan antirebreathingvalve.AnothercontroversialissueisthemomentatwhichtheCO2should bemeasuredintheventilatorycycletoshowtheamountofgasrebreathingaswellasthe place on the patient ventilator unit where such value should be measured (Fig. 14.1). SeveralauthorsallegedthatCO2attheendofexpiration(ETCO2)[7,8,10,15]measurementhasproveduseful,whereasothersarguedthatthevalueofCO2inhaled(CO2inspired fraction, FiCO2) [8, 11] offers more accurate and bene cial information. Other research indicated a preference for measurement of CO2 partial pressure in an arterial blood gas sample(PaCO2)[4,5],transcutaneous[4]CO2,orsimplecontinuousCO2quanti cationin themask[4,6,16].Infact,allthesevaluescouldberegardedasinterdependentvalues. Accordingtoourpointofview,FiCO2isthemostrepresentativevalueinrebreathingasit showstheCO2amountinthepatients nostrilsattheprotoinspiratoryphase.However,this measurementmayundervaluerebreathingattheinitialstageofbreathinginitial. Atpresent,andaccordingtothestudiescarriedout,weshouldtakeintoconsideration severalkeyissueswhensettinguptherespiratory patientsysteminanattempttolimitthe in uenceofCO2rebreathing:
UseofmaskswithEVs,dulytestedthroughtechnicalstudiesthatprovetheirabilityto
eliminate the expired CO2 (only a small number of masks sold presently have been subjecttosuchtests) UseofantirebreathingexpiratoryportsincaseofusingmaskswithoutEVsandsinglelimbcircuits Useofcircuitswithpneumaticvalvesincaseofvolumetricventilators Useofspacerswiththecorrespondingvolumestatedinresearchworks OptimizationoftheexpiratorypressurelevelthatallowsadequateeliminationofCO2 fromthemask Optimizationofeachandeveryparameter,takingintoconsiderationpatients individual characteristics: CO2 level, ventilatory level, other factors for NIPPV success or failure(leaks,asynchrony)
14
Carbon Dioxide Rebreathing in Noninvasive Ventilation
91
Key Recommendations
› ›
CO2rebreathingisapotentialfactorforfailureinNIPPV. Whensingle-limbcircuitsareused,thefollowingelementsshouldbeusedto avoidhighlevelsofFiCO2:
Mask with minimum volume or dead space Duly tested masks with EVs – Antirebreathing expiratory ports in hermetic masks – Appropriate EPAP levels –
›
KnowledgeofthecurrentclinicalimportanceofCO2rebreathingisstillpending.
References 1. Hill NS (2001) Problems, remedies, and strategies to optimize the success of noninvasive ventilation.In:HillNS(ed)Noninvasivepositivepressureventilation.Futura,Armonk,NY, pp187 213 2. Kacmarek RM, Hill N (2001) Ventilators for NIPPV: technical aspects. Eur Resp Mon 16:76 105 3. Frades SH, Peces Barba G (2007) In: Lucas Ramos P, Jareño Esteban JJ (eds) Ventilacion mecanicanoinvasiva:ine caciaycomplicaciones.Monogra asdelaSociedadMadrileñade Neumologia y Cirugia toracica (NeumoMadrid), volumen IX: Ventilacion no invasiva. Madrid,pp45 61 4. FergusonGT,GilmartinM(1995)CO2rebreathingduringBiPAPventilatoryassistance.Am JRespirCritCareMed151:1126 1135 5. LofasoF,BrochardL,TouchardD,HangT,HarfA,IsabeyD(1995)Evaluationofcarbon dioxide rebreathing during pressure support ventilation with airway management system (BiPAP)devices.Chest108:772 778 6. ZhangX,ChenR,HeG(2000)Modi cationoffacialmaskonthedeadspaceeffectinnon invasivemaskventilation.ZhonghuaJieHeHeHuXiZaZhi23(12):734 736 7. SchettinoGP,ChatmongkolchartS,HessDR,KacmarekR(2003)Positionofexhalationport andmaskdesignaffectCO2rebreathingduringnon-invasivepositivepressureventilation.Crit CareMed31(8):2178 2182 8. TacconeP,HessD,CaironiP,BigatelloLM(2004)Continuouspositiveairwaypressuredeliveredwithahelmet.Effectsoncarbondioxiderebreathing.CritCareMed32(10):2090 2096 9. RaccaF,AppendiniL,GregorettiC(2005)Effectivenessofmaskandhelmetinterfacesto deliver noninvasive ventilation in human model of resistive breathing. J Appl Physiol 99: 1262 1271 10. MedianoO,GarciaRioF,VillasanteC(2006)Comparaciondelareinhalacióndeanhídrido carbónico originada por 3 mascarillas durante la aplicacion de CPAP. Arch Bronconeumol 42(4):189 193 11. SamolskiD,CalafN,GuellR,CasanP,AntonA(2008)Carbondioxiderebreathinginnoninvasive ventilation. Analysis of masks, expiratory ports and ventilatory modes. Monaldi ArchChestDis69(3):114 118 12. Racca F, Appendini L, Gregoretti C et al (2008) Helmet ventilation and carbon dioxide rebreathing:effectsofaddingaleakatthehelmetports.IntensiveCareMed34:1461 1468
92
D. Samolski and A. Antón
13. SaatciE,MillerDM,StellIM,LeeKC,MoxhamJ(2004)Dynamicdeadspaceinfacemasks usedwithnon-invasiveventilators:alungmodelstudy.EurRespirJ23:129 135 14. SamolskiD,GuellR,CalafNetal.(2006)AnalysisofCO2rebreathinginhypercapnicpatients whileusingdifferentexpiratorydevicesinnon-invasiveventilation.EurRespJ28(S50) 15. HillNS,CarlisleC,KramerN(2002)Effectofanonrebreathingexhalationvalveonlongterm nasalventilationusingabileveldevice.Chest122:84 91 16. FarreR,MontserratJM,BallesterE,NavajasD(2002)PotentialrebreathingafterCPAPfailureduringsleep.Chest121(1):196 200
New Adaptive Servo-Ventilation Device for Cheyne–Stokes Respiration
15
Ken-ichiMaenoandTakatoshiKasai
15.1 Introduction Severalstudieshaveshownthatpatientswithcongestiveheartfailure(CHF)oftensufferfrom thecomplicationofsleep-disorderedbreathing(SDB),includingCheyne Stokesrespiration withcentralsleepapnea(CSR-CSA)aswellasobstructivesleepapnea(OSA).Thesetwo typesofSDBoftencoexistinsuchcases.CSR-CSAischaracterizedbycyclicalrecurrenceof centralapneasandhyperpneaswithwaxingandwaningofthe owamplitude,whichresults frominstabilityoftherespiratorycontrolsystemcharacterizedbyatendencytohyperventilate duetotheheartfailurecondition.CentralapneaoccurswhenthePaco2fallsbelowtheapnea thresholdduringsleepduetoventilatoryovershoot.CSR-CSAismodi ablebyseveraltypes ofpositiveairwaypressure(PAP)therapy;however,intheclinicalsetting,CSR-CSApatients withCHFtendtohavepooradherencetotheconventionalPAPtherapies,especiallycontinuousPAP(CPAP),whicharewellestablishedastreatmentsforOSA.Furthermore,theyare wellknowntobe nonresponders toconventionalPAPasatherapyforCSR-CSA.Inthe CANPAP(CanadianContinuousPositiveAirwayPressureforPatientswithCentralSleep ApneaandHeartFailureTrial)study[1],CPAPonlydecreasedtheaverageapnea hypopnea index(AHI)byabout50%(from40to19/h).TheposthocanalysisoftheCANPAP.study[2] showedsubjectswitharesidualCSR-CSAofAHI³15usingCPAPremainedwithapoor prognosis.ThesedatasuggestthatothertreatmentoptionsthatcansuppresstheCSR-CSA moreeffectively(i.e.,AHI<15)andcanproducebettercomplianceareneeded. Adaptiveservo-ventilation(ASV),anovelPAPdevice,hasbeendevelopedasaneffectivetherapeuticalternativetootherconventionalPAPtechnologies.TheASVcansuppress notonlyOSAbutalsoCSR-CSA.WereviewtheASVtherapyforCSR-CSAmainlyin patientswithCHF.
T.Kasai()andK.Maeno SleepCenter,ToranomonHospital,Tokyo,Japanand DepartmentofCardiology,JuntendoUniversity,SchoolofMedicine, 2-2-2Toranomon,Minatoku,Tokyo,105-8470,Japan e-mail:
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_15,©Springer-VerlagBerlinHeidelberg2010
93
94
K. Maeno and T. Kasai
15.2 Methods WesearchedforEnglisharticlesusingMEDLINE(PubMedandOvid)fromJanuary1996 throughAugust2009usingtherelatedterminologyofASVandCSR(orSDB).Thesearch waslimitedtoclinicaltrial,humans,andalladultsolderthan19years. TheASVisanocturnalPAPtherapythroughamaskandbasicallyissimilartobilevel PAP therapy with a spontaneous/timed mode, which delivers two treatment pressures, inspiratorypositiveairwaypressure(IPAP)toprovide xedpressuresupportandexpiratorypositiveairwaypressure(EPAP)tokeeptheupperairwaypatentandpreventobstructiveapnea,hypopnea,snoring,and owlimitation;thereisatransitiontoatimedmode withbackuprespiratoryrateduringsustainedapnea.However,thecurrentASVhastwo noveltherapeuticalgorithmsforCSR-CSA(Fig.15.1a).Theprimaryalgorithmisanadaptivepressurecontrolsystemthatnormalizespatientventilationlevelsbyadjustingeach amount of pressure support (equal to the pressure difference between IPAP and EPAP) withalmostbreath-by-breathresponsetowardthechangesintidalvolumeofCSR.Brie y, the algorithm rapidly increases pressure support in responsse to hypoventilation and decreases it during hyperventilation by varying the level of IPAP (or pressure support) betweenthetwopresetIPAPs(orpressuresupports):minimumIPAP(pressuresupport) andmaximumIPAP(pressuresupport).Thesecondaryalgorithmisanautomaticbackup systemthatallowsthepatienttotakenaturalpausesininspirationwhilestillproviding pressuresupportassistanceduringtrueapneas.Theautomaticbackupsystemtracksthe patient sspontaneousbreathpattern.Basedonthesedata,abackupbreathwithadjusted rateandpressureisautomaticallydeliveredtothepatientduringacentralapneaevent.
15.3 Results ThereweretenarticlesaboutASVtherapyforCSR-CSAinpatientswithheartfailure;all includedaverysmallsample.The rstwasacrossoverstudybyTeschleretal.in2001, whichwastocomparetheeffectsofasinglenighteachofoxygen(2L/min),CPAP,bilevel PAP,andASVonCSR-CSAandsleepon veconsecutivenightsinrandomorderin14 patients with heart failure [3]. Patients preferred the ASV night to either the CPAP or bilevelPAPtitrationnights.ASVsuppressedCSR-CSAandimprovedsleepqualitybetter thanCPAPornasaloxygen.Thereweretwoothersimilararticles,inwhichheartfailure patientswithCSR-CSAunderwentthreenightsofpolysomnography:baseline,conventionalPAP(CPAPorbilevelPAP)titration,andASVtitration[4,5].Inboth,compared withconventionalPAPtherapy,ASVsigni cantlyreducedCSR-CSAandwaswelltolerated.Oldenburgetal.reportedthatuseofASVfor5.8±3.5monthssigni cantlyimproved left ventricular ejection fraction (LVEF), amino-terminal pro-brain natriuretic peptide (BNP)level,andexercisetolerancetothecardiopulmonaryexercisetestaswellasCSRCSAin29malepatientswithheartfailure[6].
15
New Adaptive Servo-Ventilation Device for Cheyne–Stokes Respiration
95
a EOG
30 sec
EMG
EEG
Air Flow Chest Movement Abdominal Movement Device Pressure ECG
SO2
b EOG
30 sec
EMG
EEG
Air Flow Chest Movement Abdominal Movement Device Pressure ECG SO2
Fig. 15.1 Polysomnographyduringadaptiveservo-ventilation(ASV)inapatientwithCheyne Stokes respirationwithcentralsleepapnea(CSR-CSA)andheartfailure.(a)InitiationofASVforCSRCSA;notethebackupventilationduringacentralapneawithmaximuminspiratorypositiveairway pressure(insidesolidlineoval)andthereductioninpressuresupportduringthehyperventilation phase(insidedottedlineoval).(b)GradualstabilizationofventilatorystateunderASVtherapy;note theabsenceofbackupventilationandtheadaptationoftheASVwiththeminimumnecessarypressuresupportsonspontaneousbreathing.ContinuingASVinturncorrectsthe uctuationofPaco2and bringsinthestabilizationofbreathing.EOGelectro-oculogram,EMGsubmentalelectromyogram, EEGelectroencephalogram,ECGelectrocardiogram,SO2oxyhemoglobinsaturation
96
K. Maeno and T. Kasai
ThereweretwoprospectiverandomizedcontrolledtrialsofASVforCSR-CSAwithheart failure.Inonestudy,30subjectswithheartfailureandCSR-CSAweretreatedwith4weeks oftherapeuticASV(n=15)orsubtherapeuticASV(n=15)[7].Comparedwithasubtherapeuticcontrol,thereweresigni cantfallsinplasmaBNPlevelandurinarymetadrenaline excretioninthetherapeuticASVgroup.Intheotherstudy,25patientswithheartfailureand CSR-CSA were randomly assigned to either CPAP or ASV [8]. Both CPAP and ASV decreasedAHI,butonlyASVcompletelysuppressedCSA-CSR,withAHIbelow10.At6 months,compliancewithCPAPwassigni cantlylessthanwithASV,theimprovementin qualityoflifewashigherwithASV,andonlyASVinducedasigni cantincreaseinLVEF. TherewereafewreportsofASVforCSR-CSAinpatientswithoutCHF.Somereports showedtheef cacyofASVforcomplexsleepapneasyndrome(i.e.,CPAP-emergedCSA) oridiopathicCSRthatwasunresponsivetoCPAPoroxygen.Ontheotherhand,theresults ofstudiesoftheASVforopioid-inducedSDBwerecontroversial.
15.4 Discussion ASVhasbeendesignedtomoreeffectivelyreducethenumberofCSR-CSAepisodes.In fact,somestudiesshowedthatASVdecreasedtheAHImoreeffectivelythanconventional PAPtherapyinpatientswithCSR-CSAandheartfailure[3 5,8].Moreover,itwasreported thatheartfailurepatientswithCSR-CSAweremorecompliantwithASVthanconventional PAP[3,5,8].TheseresultsseemtobeduetotheuniquealgorithmsofASV,whichcanlead toreducedalterationinthePaco2levelandmaintainingthePaco2abovethehypocapnic apneathreshold,whichcaninturnunspreadtheCSR,stabilizethebreathingpattern,and improvesleeparchitectureandquality(Fig.15.1b).Ontheotherhand,bilevelPAPwasalso effectiveforCSR-CSA,butitcouldbethatthis xedpressuresupportinCSR-CSApatients setupoverventilationduringphasesofnormalbreathingorhyperpnea,whichcausesarousalsanddiscomfortorleadstoafallinthePaco2level,whichmayinducecentralapnea.In practice,suchpatientstendtorequiretheIPAPleveltobesettolowervaluesbecauseofthe perceiveddif cultywithhigher-pressuresupport,andsuchreductioninIPAPoftenleadsto insuf cientmanagementoftheCSR-CSA.TheASVmightbeabletoresolvethisproblem ofbilevelPAPbecausetheIPAPlevelisautomaticallyandappropriatelyadapted. SomestudiesshowedthatASVimprovednotonlytheSDBbutalsocardiacfunctionin patientswithheartfailure[6 8].IncreasedintrathoracicpressurethroughPAPcanreduce preloadduetothedecreaseofthevenousreturnandafterloadduetothedecreaseofthe leftventriculartransmuralpressure.ItwasreportedthatPAPcausesdose-relatedincreases incardiacandstrokevolumeindicesamongpatientswithheartfailurewithelevatedleft ventricular llingpressure[9].Westudiedtheeffectof3-monthASVtherapyonresidual CSR-CSAwithAHI³15onCPAPandusedtenpatientswithheartfailurewhoalready hadundergoneCPAPtherapy[10].Inthestudy,thechangeofCPAPtoASVsigni cantly improvedAHIandsleepquality,increasedLVEF,anddecreasedthelevelsofplasmaBNP andurinenoradrenaline.Remarkably,thecompliancewithASVwassigni cantlybetter thanwithCPAP.Intheory,allkindsofPAPtherapiescanbringinthesebene cialeffects
15
New Adaptive Servo-Ventilation Device for Cheyne–Stokes Respiration
97
onhemodynamicsinpatientswithheartfailure.However,ASVislikelytomoreeffective thanconventionalPAPoncardiacfunctioninpatientswithheartfailurewithCSR-CSA, which may result from better-suited pressure delivery of ASV, better compliance with ASV,oramoresuppressanteffectontheincreasedsympatheticnerveactivity. Currently,twoASVdevicesareclinicallyavailableonaglobalscale.OneisAutoSet CS2/VPAPAdaptSV manufacturedbyResMed(Sydney,Australia),andtheotheris BiPAP®autoSV byRespironics(Murrysville,PA,USA).Inbothproducts,pressuresupportisdynamicallyadjustedbreathtobreathasnecessarytoensurethatthepatients actual ventilation matches the target value. However, there are some differences between the devices; these are brie y shown in Table 15.1. The main points of difference are the mechanicstoassesstheventilatorystatusanddecidethetargetandthecon gurableparametersandsettingranges.AutoSetCS2/VPAPAdaptSVprovidesvolume-targetedASV, whichsetsaminuteventilationtargetthatis90%oftherecentaverageminutevolumein a3-mincollectionperiodandtriestokeepventilationatthetarget.Tomakethesynchrony withthepatient sventilationbetter,thisdevicealsolearnsthepatient srecent owpattern in an 8-s period. On the other hand, the BiPAP autoSV provides ow-targeted ASV, whichmonitorsthepeakinspiratory owofthepatientoverarecentmoving4-minwindowbycalculatinganaveragepeak owateverypointwithinthiswindowtosetatarget peak ow,comparesittotheinternaltarget,andmaintainsatargetpeakinspiratory ow. Theclinicianhastosetthreetypesofpressurelevels.TheEPAPlevelissettomaintain upperairwaypatencyasamanagementofanyobstructiveSDB.Todeterminetherangeof pressuresupportlevels,minimumIPAPandmaximumIPAPneedtobeset.TheAutoSet CS2/VPAPAdaptSValwaysprovidesapressuresupportofatleast3cmH2O.TheBiPAP autoSVcanconformEPAPtominimumIPAPandapplythesamepressureduringinspirationandexpiration(whichisthesameasCPAP)instablebreathing.Whilebothdevices provideanautomaticbackuprateforsustainedapnea,theBiPAPautoSVcanalsomanuallysetthe xedbackuprate.TherearenostudiescomparingthesetwodifferentASV. Table 15.1 Comparisonbetweentwoadaptiveservo-ventilation(ASV)products Volume-targetedASV Flow-targetedASV Productname
AutoSetCS2orVPAPAdapt SV
BiPAPautoSV
Manufacturer
ResMed
Respironics
Targetparameter
90%ofminuteventilation
Peak ow
Calculationwindow
Recentaverageof3-min window
Recentaverageof4-min window
Backupventilation
Auto(15±a/min)
Automodeor xedmode(off or4 30/min)
EPAP
4 10cmH2O
4 25cmH2O
IPAPmin
3 6cmH2OplusEPAP
EPAPlevel 30cmH2O
IPAPmax 8 16cmH2OplusEPAP IPAPminlevel 30cmH2O EPAPexpiratorypositiveairwaypressure,IPAPmin,minimuminspiratorypositiveairwaypressure,IPAPmax,maximuminspiratorypositiveairwaypressure
98
K. Maeno and T. Kasai
Each manufacturer introduces the recommended methodologies to titrate each ASV device.WewouldemphasizethatthetitrationforASVapplicationunderattendedpolysomnography should be performed because these automatic algorithms do not always workappropriatelyforallpatientswithoutanytitrationstudies. There have been no data to evaluate the effect of ASV on long-term prognosis in patientswithCSR-CSA and heart failure until now. However, a large randomized controlledtrialisongoingmainlyinEurope;itspurposeistoinvestigatethelong-termeffects ofASVonthemorbidityandmortalityofpatientswithstableheartfailurewhohaveSDB predominantlywithCSR-CSA.Theresultsofthisstudyareimportantandmayyieldthe primary evidence and determine the rst-line therapy for CSR-CSA in patients with chronicheartfailure.
References 1. BradleyTD,LoganAG,KimoffRJetal(2005)Continuouspositiveairwaypressureforcentralsleepapneaandheartfailure.NEnglJMed353:2025 2033 2. ArztM,FlorasJS,LoganAGetal(2007)Suppressionofcentralsleepapneabycontinuous positiveairwaypressureandtransplant-freesurvivalinheartfailure:aposthocanalysisofthe Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and HeartFailureTrial(CANPAP).Circulation115:3173 3180 3. TeschlerH,DöhringJ,WangYMetal(2001)Adaptivepressuresupportservo-ventilation:a noveltreatmentforCheyne Stokesrespirationinheartfailure.AmJRespirCritCareMed 164:614 619 4. KasaiT,NaruiK,DohiTetal(2006)Firstexperienceofusingnewadaptiveservo-ventilation deviceforCheyne StokesrespirationwithcentralsleepapneaamongJapanesepatientswith congestiveheartfailure:reportof4clinicalcases.CircJ70:1148 1154 5. ArztM,WenselR,MontalvanSetal(2008)Effectsofdynamicbilevelpositiveairwaypressuresupportoncentralsleepapneainmenwithheartfailure.Chest134:61 66 6. OldenburgO,SchmidtA,LampBetal(2008)Adaptiveservoventilationimprovescardiac functioninpatientswithchronicheartfailureandCheyne Stokesrespiration.EurJHeartFail 10:581 586 7. PepperellJC,MaskellNA,JonesDRetal(2003)Arandomizedcontrolledtrialofadaptive ventilation for Cheyne Stokes breathing in heart failure. Am J Respir Crit Care Med 168:1109 1114 8. PhilippeC,Stoïca-HermanM,DrouotXetal(2006)Compliancewithandeffectivenessof adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne Stokesrespirationinheartfailureoverasixmonthperiod.Heart92:337 342 9. DeHoyosA,LiuPP,BenardDCetal(1995)Haemodynamiceffectsofcontinuouspositive airwaypressureinhumanswithnormalandimpairedleftventricularfunction.ClinSci(Lond) 88:173 178 10. KasaiT,DohiT,MaenoKetal(2009)Impactofadaptiveservoventilationinheartfailure patients with central sleep apnea which is not suf ciently treated with continuous positive airwaypressure[abstract].AmJRespirCritCareMed179:A5336
Section IV Monitoring and Complications
Nocturnal Monitoring in the Evaluation of Continuous Positive Airway Pressure1
16
OresteMarrone,AdrianaSalvaggio,AnnaLoBue,andGiuseppeInsalaco
16.1 Introduction Continuous positive airway pressure (CPAP) counterbalances forces leading to upper airway narrowing or collapse during sleep and is the most widely used treatment for obstructivesleepapnea(OSA).InpatientswithOSA,progressivelyhigherCPAPlevels appliedduringsleepturnobstructiveapneasintohypopneas,hypopneasintocontinuous inspiratory owlimitation,withorwithoutsnoring,and owlimitationintounobstructed breathing. When breathing becomes unobstructed, respiratory arousals (i.e., arousals that may follow increased inspiratory efforts associated with obstructed breathing) are eliminated,whilesleepbecomesmorestableandsleepcyclesmoreregular,contributing toimprovementsinsubjectivesleepquality,daytimesleepiness,andqualityoflifeusually observed after just a few nights of CPAP application [1]. Also, relief of upper airway obstruction is associated with resolution of intermittent hypoxemia and hemodynamic swingsthataccompanyobstructiveevents,withaconsequentreductioninlong-termcardiovascularmorbidityandmortality[2]. TheobjectivesofCPAPtreatmentareeliminationofsymptomsandofcardiovascular and,possibly,metabolicriskrelatedtoOSA.Today,thebestwaytoaccomplishtheseaims is usually considered to fully eliminate all degrees of upper airway obstruction during sleep.ThelowestCPAPthateliminatesupperairwayobstructioninallsleepstagesand bodyposturesinapatientisindicatedas optimal CPAP.
This work was supported by the Italian National Research Council, order number ME.P01.014.002.
1
O.Marrone(),A.Salvaggio,A.LoBue,andG.Insalaco ItalianNationalResearchCouncil,InstituteofBiomedicineand MolecularImmunology,Palermo,Italy e-mail:
[email protected];
[email protected];
[email protected];
[email protected]
A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_16,©Springer-VerlagBerlinHeidelberg2010
101
102
O. Marrone et al.
ThereismuchcontroversyaboutthemostconvenientprocedurestoadoptbeforeCPAP prescription.Atoneextreme,of cialguidelinesstillconsiderthecomplexmanualCPAPtitrationduringassistedpolysomnographythegoldstandardprocedurebeforeCPAPprescription [3].Attheoppositeextreme,ithasbeenclaimedthatneitherpressuretitrationnoranyinstrumentalmonitoringwithCPAPapplicationisessentialforprescription[4].Inthischapter,we reviewproceduresforinitiationofCPAPtreatmentanddiscusstheireffectiveness.
16.2 Analysis and Discussion TheCPAPtitrationprocedureconsistsoftheapplicationofvariousCPAPlevelstoassess their effects and to identify which level may be most appropriate for the correction of upperairwayobstruction(optimalpressure).ManualCPAPtitrationinthesleeplaboratory istheoldestmethodforthedeterminationofoptimalpressure.Itisperformedduringa polysomnographicrecordingwhileatechnicianmanuallymodi espressureadministered byaCPAPdevice.Thetitrationpolysomnographicstudyshouldful lsomeconditions:It shouldhaveanadequateduration(accordingtosomeindications,atleast3hinsubjects whose apnea hypopnea (AHI) index is more than 40 or longer in subjects with milder disease)[5],anditshouldincludetherecordingofsomerapid-eye-movement(REM)sleep and of some sleep time in the supine posture since REM sleep and, even more, supine posturemayrequiretheapplicationofhigherCPAPlevels.Then,thequalityofthetitrationisevaluatedwithanalysisofthecharacteristicsofsleepandrespiration,ineachbody posture,inrelationshiptothepressuresthathavebeenapplied[3].Therefore,allsignals generally recorded during polysomnography have an important role: electroencephalogram, electro-oculogram, and chin electromyogram for recognition of sleep stages and arousals;bodyposition;pressureatthemasktomonitortheCPAPlevelthatisadministered;signalsfordetectionofsnoring,air ow,respiratorymovements,andoxyhemoglobin saturation to observe modi cations in breathing characteristics as CPAP level is changedandtomakesurethatregularunobstructedbreathingisachieved.Inparticular, regardingair ow,monitoringbyapneumotachographisrecommendedasa attenedshape intheinspiratoryportionofthe owsignalrecordedbythismethodisindicativeof ow limitation. Morerecently,identi cationofoptimalpressurebyauto-CPAPdeviceshasbeenintroduced ( autotitration ). Auto-CPAP machines are designed to automatically deliver a variable CPAP level that should correspond to the lowest required pressure in each moment. They are able to record several types of information during their application, includingpressuresdelivered,airleaks,andrespiratoryeventsdetected,andcanusually calculateanAHI. Autotitrationcanbeperformedwiththeapplicationofanauto-CPAPdeviceduringa standard polysomnographic study. A technician may assist autotitration to control the polysomnographic recording and the patient. Analysis of the polysomnographic study allows us to verify the relationship between pressures that have been delivered and breathing characteristics, sleep stages, arousals, and body postures. In this way, it is
16
Nocturnal Monitoring in the Evaluation of Continuous Positive Airway Pressure
103
possibletoselecttheCPAPlevelthatprovesmostappropriateforcorrectionofupper airway obstruction. This method is now of cially recognized as a valid alternative to traditional manual titration [6], but differences in costs and time required for the two proceduresarelimited. As an alternative to the search for optimal CPAP with polysomnography, unassisted autotitration without any monitoring, except that provided by the auto-CPAP machine itself, has been introduced. With this method, an auto-CPAP is given to the patient for nocturnalself-application.Datacollectedandelaboratedbythemachinearedownloaded, andperiodswithexcessiveairleaksarediscardedfromanalysis.The90thor95thpercentilepressure(i.e.,thepressurethatisnotexceededfor90%or95%ofthetimeoftheautoCPAPapplication,respectively)isusuallyconsideredequivalenttotheoptimalpressure. Lackofexternalmonitoringduringauto-CPAPapplicationcouldleadtoerrorsintherecognitionofoptimalCPAPlevel.Auto-CPAPdeviceshavedifferentprinciplesofoperation;althoughmostofthemareeffectiveinthecorrectionofupperairwayobstructionand reliableinthevastmajorityofpatients,theiref cacyisvariable.Bothadministrationof excessively high pressures and undercorrection of obstruction are possible. Erroneous pressure administration may be easily recognized during polysomnography, while it is oftenundetectedifnomonitoringinadditiontotheoneperformedwiththeauto-CPAPis done.AHIvaluescalculatedbytheauto-CPAPmachinesmayhelptoidentifysomeunsatisfactoryautotitrations,butalthoughsomestudiesfoundthesevaluesreliableenoughwith somedevices,theymaysubstantiallydifferfromAHIvaluesobtainedwithexternalmonitoringandevaluatedmanually.Otherpossibleerrorsdonotdependonauto-CPAPdevices butonconditionspossiblyoccurringduringautotitration,likeinsuf cientsleeporlackof supinepostureduringtheauto-CPAPapplication.Again,thesecasesmaybeeasilyrecognizedwithappropriatemonitoring[7]. Thestrongestargumentagainstnocturnalmonitoringsforveryprecisedeterminations ofoptimalCPAPisthatpressuresneededbyeachpatientforthecorrectionofrespiratory disorderscanchangefromnighttonight.Reproducibilityofoptimalpressuredetermined with accurate manual titration during polysomnography is limited, with night-to-night changesupto3cmH2O[8].Therefore,theresultsofsingle-nighttitrations,eithermanual orautomatic,couldbequestionable,andcostsforsingle-nightassistedpolysomnographic titrationcouldbedisproportionate,whileanevaluationofoptimalCPAPonseveralnights couldbemorereliable. Aspolysomnographicmonitoringmaynotbeperformedformultiplenightsforpracticalreasons,ithasbeenproposedtoperformunassistedautotitrationwithoutexternalmonitoringforseveralnights.Theaverageofthe90thor95thpercentilepressuresonallnights ofauto-CPAPapplicationcouldrepresentanappropriatepressurefortreatment.Besides, progressiveadaptationofthepatientduringconsecutivenightstosleepwithCPAPcould preventerrorsassociatedwithpoorsleepqualityandminimizeerrorsduetothelackof externalmonitoring.Thenumberofnightsforthisautotitrationmethodisnotstandardized.Asmallnumberofnightscouldmakeitaneconomicalprocedureduetothelackof complexmonitoringsandanalyses,andoftechnicalassistance.Multiple-nightunassisted autotitrationhasbeenrecognizedasapossiblevalidalternativetopolysomnographictitration,butitisrecommendedtorelyonauto-CPAPdevicesthathavebeenbettervalidated andtostrictlykeepintouchwithpatientsafterinitiationofCPAPtreatment[6].Inour
104
O. Marrone et al.
experience,adisadvantageofunassistedautotitrationisthat,despiteprevioustraining,not allpatientsareabletostartsleepingwithCPAPiftheyhavenoassistanceduringthenight. Besides,somecasesofpoorperformanceoftheauto-CPAPmachinemayremainundetectedifnonocturnalinstrumentalmonitoringisperformedduringorafterautotitration;in our opinion, even simple cardiorespiratory monitorings may be helpful for identifying uncommonbutpossiblecasesofunsatisfactoryautotitrations. IthasbeenproposednottotitrateCPAPbuttoprescribeapressurecalculatedbymeans ofpredictiveequations,possiblymodifyingitthereafter,followingpatients complaintsor indications[9].DifferentpredictiveequationsfortherapeuticCPAPhavebeenelaborated. Calculatedpressurevaluesdiffertosomeextentaccordingtotheequation.Generally,in an OSA population, most calculated pressures are close to the pressure values that are obtainedmostoftenwhentitrationsareperformed;so,forstatisticalreasons,calculated andtitratedpressuresaresimilarinmostpatients.However,agreementbetweencalculatedandtitratedvaluesdropswhenvalueshighlydifferingfromtheaverageandmost common levels are calculated or are required for treatment [10]. Therefore, predictive equationscannotbeconsideredreliablesubstitutesfortitration.Aposteriorievaluationof clinicaleffectsoftheprescribedCPAPandofadherencetotreatmenthasbeenusedto assessef cacyofCPAPtreatmentbasedontheapplicationofpredictiveequations.Infact, clinicalevaluationisessentialtoevaluatetheadequacyofCPAPtreatment.Improvement insleepinessisoneoftheaimsofthetreatment;itisessentialthatpatientsareableto tolerateCPAPandhavegoodcompliancetotreatment;abettercontrolandareductionof bloodpressurearepossibleeffectsofaneffectiveOSAtreatment.However,thesecriteria arenotsuf cienttovalidateaprescribedpressure;improvementinsleepinessmaypartly dependonaplaceboeffect,compliancetotreatmentmaybegoodevenwithsubtherapeutic pressure, and OSA treatment does not always result in effects on blood pressure. IncompletetreatmentofOSAmayexposepatientstopersistenceofincreasedcardiovascularrisk.Changesinbodyweightorsleep-relatedcomplaintsmaysuggesttheneedto reevaluateCPAPtitration.
Key Recommendations
› › › › ›
Aninstrumentalnocturnalmonitoring,eithermanualorautomatic,shouldalways beperformedwhentitratingoptimalCPAP. Thehigherthenumberofsignalsrecordedduringthenocturnalmonitoring,the morereliablethedeterminedtherapeuticCPAPlevelwillbe. Subjectiveandclinical ndingsafterinitiationofCPAPtreatmentshouldbe evaluatedregardlessoftheprocedureadoptedforCPAPprescription. Lackofinstrumentalmonitoringandrelianceonlyonsubjectivereportscanlead toconsideracceptableCPAPlevelsthatinadequatelycorrectrespiratorydisorders. SubjectiveindicationsgivenbypatientsusingpreviouslytitratedCPAPmayhelp tosuspectapoorpreviousCPAPtitrationorachangeinpressurerequirements andcanbetakenintoconsiderationofmakingsmallchangesintheadministered CPAP.
16
Nocturnal Monitoring in the Evaluation of Continuous Positive Airway Pressure
105
References 1. GilesT,LassersonT,SmithB,WhiteJ,WrightJ,CatesCJ(2006)Continuouspositiveairways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 19(3): CD001106 2. MarinJM,CarrizoSJ,VicenteE,AgustìAGN(2005)Long-termcardiovascularoutcomesin men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positiveairwaypressure:anobservationalstudy.Lancet365:1046 1053 3. KushidaC,ChediakA,BerryRetal(2008)Clinicalguidelinesforthemanualtitrationof positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 4: 157 171 4. StradlingJR,HardingeM,SmithDM(2004)Anovel,simpli edapproachtostartingnasal CPAPtherapyinOSA.RespirMed98:155 158 5. AmericanSleepDisordersAssociationReport(1997)Practiceparametersfortheindications forpolysomnographyandrelatedprocedures.Sleep20:406 422 6. MorgenthalerTI,AuroraRN,BrownT,etal.(2008)Practiceparametersfortheuseofautotitratingcontinuouspositiveairwaypressuredevicesfortitratingpressuresandtreatingadult patientswithobstructivesleepapneasyndrome:anupdatefor2007.AnAmericanAcademy ofSleepMedicineReport.Sleep31:141 147 7. MarroneO,InsalacoG,SalvaggioA,BonsignoreG(2005)RoleofdifferentnocturnalmonitoringsintheevaluationofCPAPtitrationbyautoCPAPdevices.RespirMed99:313 320 8. WiestGH,FuchsFS,HarschIAetal(2001)Reproducibilityofastandardizedtitrationprocedurefortheinitiationofcontinuouspositiveairwaypressuretherapyinpatientswithobstructivesleepapnoea.Respiration68:145 150 9. FitzpatrickMF,AllowayCED,WakefordTMetal(2003)Canpatientswithobstructivesleep apnea titrate their own continuous positive airway pressure? Am J Respir Crit Care Med 167:716 722 10. MarroneO,SalvaggioA,RomanoS,InsalacoG(2008)Automatictitrationandcalculationby predictiveequationsforthedeterminationoftherapeuticcontinuouspositiveairwaypressure forobstructivesleepapnea.Chest133:670 676
Complications During Noninvasive Pressure Support Ventilation
17
MicheleCarron,UldericoFreo,andCarloOri
17.1 Introduction Thetermnoninvasivepressuresupportventilation(NPSV)referstoanyformofventilatorysupportappliedwithouttheuseofaninvasiveconduit[1].GoalsofNPSVincludethe improvementofdyspnoeaandofbloodgasabnormalitiesfromacuterespiratoryfailure (ARF),thereductionofworkofbreathingandtheavoidanceoftrachealintubation.LongtermadvantagesofNPSVarethedecreaseofneedfortrachealintubation,ofnosocomial pneumonia,ofstayintheintensivecareunit(ICU)andinthehospital,and,mostimportantly,oftheoverallmortalityrate[1,2].Thepatientinterfacesmostcommonlyemployed forNPSVareanasalorafacemask(maskNPSV)andahelmet(helmetNPSV).NPSV mayhavecomplications,someofwhicharefrequentandpredictableandsomerareand unpredictable.ThestaffresponsibleforNPSVshouldbeawareandbepreparedtoprevent, detectearly,andcurethesecomplications.NPSVissafeandwelltoleratedwhenapplied optimallyinappropriatelyselectedpatients[1].
17.2 Interface Related Complications Themostfrequentlyencounteredadverseeffectsandcomplicationsareminorandrelated totheNPSVinterface(seesummarizingTable17.1).
M.Carron(),U.Freo,andC.Ori DipartimentodiFarmacologiaedAnestesiologia,ClinicadiAnestesiaeMedicinaIntensiva, UniversitàdegliStudidiPadova,Padova,Italy e-mail:
[email protected]
A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_17,©Springer-VerlagBerlinHeidelberg2010
107
108
M. Carron et al.
Table 17.1 Adverseeventsandcomplicationsofnoninvasiveventilation(NIV)withdifferentinterfaces(IF)andpatientconditions Frequency(%)
IF/Patient condition
Remedy
References
Carbondioxide rebreathing Claustrophobia
50 100
H>FM>NM
2 4,7,8
5 10
FM>NM>H
Discomfort Facialskin erythema Nasalbridge ulceration Armedema andarmvein thrombosis Mechanical malfunction Noise
30 50 20 34
FM>NM>H FM>NM>H
Reducerespiratory rateandIFsize Reduceinspiratory pressure,sedation ChangeIF,sedation CheckIF t
7 100
FM>NM>H
ChangeIF
2,10
<5
H/malnutrition
CheckHarmpits
3
<1
FM=NM=H
Checkequipment
9
50 100
H>FM=NM
11
Patientventilator 50 100 dyssynchrony
H>FM=NM
ChangeIF,use heatandmoisture, earplugs,soundtraps Add/increasePEEP
CheckIF t,reduce pressure Addhumidi ers andemollients, reduceinspiratory pressure Reduceinspiratory pressure
2,4 7,13
FollowNPSV contraindications FollowNPSV contraindications
2
Interfacerelated
1,2 2 4,7,8 2
4,7
AirPressureandFlowRelated Airleaks
18 68
NM>FM>H
Nasalororal drynessand congestion
20 50
FM=NM>H
Gastric Distension
5 50
FM>NM>H
<5
AllIF/ileum
2,10,15
2,16
PatientRelated Aspiration pneumonia Barotrauma
2,17 AllIF/COPD, neuromuscolar disease,cystic brosis Hemodynamic <5 AllIF/highblood FollowNPSV 2,18 effects pressure contraindications COPDchronicobstructivepulmonarydisease;FMfacemask;IFinterface;NMnosemask;NPSV noninvasivepressuresupportventilation;PEEPpositiveend-expiratorypressure. <5
17
Complications During Noninvasive Pressure Support Ventilation
109
17.2.1 Arm Edema and Arm Vein Thrombosis ThecomplicationofarmedemaisobservedduringhelmetNPSV.Thehelmetissecured bytwoarmpitbracestoapairofhooksontheplasticringthatjoinsthehelmettoasoft collar.DuringhelmetNPSV,theprolongedcompressionfromthearmpitbracemayproducevenousandlymphaticstasiswithconsequentedema.Thisismorefrequentinpatients withseveremalnutritionandcachexiaandmaypromotedeepvenousthrombosisinthe axillaryveinandanticoagulanttherapy.Fixationofthebracesinseverelymalnourished patientsneedscloseattention[3].
17.2.2 Carbon Dioxide Rebreathing TherespiratorycircuitandtheinterfaceforNPSVrepresentanadditionaldeadspaceand increase chances of carbon dioxide (CO2) rebreathing in proportion to their volumes. Compared with the tidal volume, the dead space of the masks is smaller than that of thehelmet.TheamountofCO2rebreathedisconsequentlysmallerduringmaskNPSV than helmet NPSV. The helmet is less effective than masks in removing CO2 during NPSV[3,4].Further,singlerespiratorycircuitswithnoexhalationvalve,highrespiratory rates, no or low external positive end-expiratory pressure (PEEP), and a reduced expiratorytimemayallincreaseCO2rebreathing[5].TheissueofwhetherCO2rebreathing is clinically relevant remains an open question. According to some authors, CO2 rebreathingisbelow1.5%withbothmaskNPSVandhelmetNPSV,anditisclinically notrelevant[3].Accordingtoothers,however,CO2rebreathingmayimpairCO2elimination and ventilatory muscle unloading [6]. Decreasing the size of the helmet and increasingpressuresupportwillnotnecessarilypreventCO2rebreathingduringhelmet NPSV[4].However,ifarapidincreaseofalveolarventilationisrequiredinpatientswith severe ARF, helmet NPSV reduces hypercapnia less ef ciently than mask NPSV [3]. Usingatwo-linecircuitandanonrebreathervalve,loweringtherespiratoryrate,adding PEEP,andincreasingtheexpiratorytimehavebeenadvocatedasmeasurestoreduceCO2 rebreathing[5].
17.2.3 Claustrophobia Claustrophobiaisthefearofenclosedspaces.Fivepercentto10%ofthegeneralpopulationmaypresentfearofrestrictionandfearofsuffocation.ThedevelopmentofclaustrophobiainvolvestheimpossibilitytobeginortocontinuetheNPSV.Thechoiceofdevice is crucial regarding claustrophobia and discomfort as well. The masks are often poorly toleratedbydistressedpatientscomparedtothehelmet.InthecaseofmaskNPSV,the
110
M. Carron et al.
use of manual mask application at rst can minimize the sense of claustrophobia [1]. Theventilatorysupportshouldbeintroducedgradually,startingwithcontinuouspositive airwaypressureandaddinginspiratorypressuresupportasrequired[1].Ventilatorsettings shouldbeadjustedtoprovidethelowestinspiratorypressureneededtoimprovepatient comfort[1].Sedationmaypreventorbehelpfulforclaustrophobicpatients.
17.2.4 Discomfort Discomfortrepresentsanunpleasantsensationthatitisrelatedtothedeviceorpressure valuesadoptedduringNPSV.Inadirectcomparisonamongdifferentmodelsofmaskfor NPSV,thetolerancewaspoorestforthemouthpiecefollowedbythenasalandoronasal masks[7].Althoughallmaskswerereasonablycomfortablefortheeyes,allattachment systemswereconsidereduncomfortablefortheskin[7].Thehelmetwastoleratedbetter thanmasksbecauseoftheabsenceofthefeelingofuncomfortablepressureontheface[3]. It allowed the patients to communicate, drink, and read better than the facial mask; improvedthecollaborationbetweenthepatientandthemedicalstaffduringthetreatment period;andallowedmaintainingcontinuousNPSVforaperiodoftimelongerthaninthe maskgroup[3,8].Thepossibleadvantagesofthehelmetonpatienttolerabilityandcomfortmustbebalancedwithitsinterferencewithventilation,greaterdeadspace,andcompliance compared to the face mask [4]. When pressure support ventilation is adopted, thecomfortlevelsfollowaU-shapedtrendwhenlevelofassistanceismodi ed,andthe extremelevelsofpressuresupport(bothlowestandhighest)arenotassociatedwiththe bestcomfort.Thenasalsalineoremollientsorheatedhumidi cationduringnasalNPSV attenuatestheadverseeffectsofmouthleakoneffectivetidalvolumeandnasalresistance andimprovesoverallcomfort.Sedationmayrepresentacrucialissueforpoorlytolerant patients.
17.2.5 Mechanical Malfunction Avarietyofmechanicalcomplicationscanoccurduringmechanicalventilation,suchas accidentaldisconnection,leakswithintheventilatorcircuit,lossofelectricalpower,and lossofgaspressure.Forthesereason,themechanicalventilatorsystemshouldbechecked frequentlytopreventmechanicalmalfunctions.DuringhelmetNPSV,anaccidentalinterruptionofgas owcauses vemaineffects:theCO2increasesinsidethehelmet;theFiO2 diminishesduetotheinspirationofambientairandtheinspiredpartialpressureofCO2 increases;thePEEPislostinafewseconds;dyspneaofincreasingintensityandasenseof impending suffocation ensue; and a progressive increase in minute ventilation occurs. Somefeaturesofthehelmetdesign,suchasahighvolume,alow-resistanceinletport,and theadjunctofasafetysystemcaneffectivelylimitanddelaytheclinicalconsequencesof fresh gas supply interruption. There is a clear need to include a monitoring and alarm system,andclinicalcontrolisimportant[9].InNPSVathome,thecaregiversmustbe
17
Complications During Noninvasive Pressure Support Ventilation
111
preparedtoprovidebag-and-maskventilationtopatientsintheeventofanemergency. Iftheequipmentisavailable,thissimpletechniquemaybelifesavinginthepresenceof mechanicalmalfunctions.
17.2.6 Nasal Bridge Ulceration Nasalpain,eithermucosaloronthebridgeofthenose,andnasalbridgeerythemaorulceration from mask pressure account for a large portion of reported complications of maskNPSV[2].Theincidenceofskinnecrosisorabrasiondependsonthedurationof maskusageandvariesbetween7%and100%after48hofNPSV[10].Themeanpressurerecordedonthebridgeofthenosewasmuchhigherthanthatonthecheek(65vs. 15mmHg,nosevs.cheek),andthispressurecanbeclosetothelowervaluesofnormal diastolicbloodpressure[10].Progressivetighteningoftheharnessandincreasingofthe volumeofairintheoronasalmaskcushionsincreasedthepressureonthebridgeofthe nose,andtheeffectofthesetwofactorswasadditive[10].Thedevelopmentofpressure necrosisisonefactorthatcanlimitthetoleranceanddurationofmaskNPSV.Strategies usedtodecreasetheincidenceofpressurenecrosisduringNPSVincludeminimizingstrap tension,usingforeheadspacers,routinelyapplyingarti cialskintothebridgeofthenose intheacutesetting,applyingaGranu exdressingtotheareasofthefacethatareexposed topressure,usingwaterinsteadofairto llthecushionofafacemask,orswitchingto alternativeinterfacessuchasnasalpillows,newprototypefacemasks,cephalicmasks, andhelmets[2,10].
17.2.7 Noise Noise exposure during NPSV may be underestimated among the factors that in uence patientwell-beingduringtheICUstay.ThenoiseexceedstheusualICUbackgroundnoise, potentiallyincreasingpatientdiscomfort,causingsleepdisruption,andaffectingearfunction.TheintensityofnoiseinsidethehelmetduringNPSVisabout105dBandismostly caused by the turbulent gas ow through the respiratory circuit. By contrast, the noise perceived during mask NPSV is probably mostly caused by the ventilator and is about 65dB,notdifferentfromthebackgroundnoisethatismeasuredatpatients bedsidesinthe ICU[11].Theexcessnoiseinsidethehelmetmayhavesomedetrimentaleffectsonpatient wellness.Noisemayimpairapatient scontactwiththeenvironmentbymaskingsounds andhinderingconversation,andthisinconveniencemayaddtothephysicalbarrierthatthe helmetconstitutes.Suchnoiseintensityhasbeenregardedinthepastasamajorcauseof sleeparousalsincriticallyillpatients.MorerecentstudieshavereportedthatsleepdisruptionintheICUismultifactorial,andthatnoiseisresponsibleforonlyalimitedproportion ofarousalsandawakenings[11].Loudnoisemaydamagetheear.Damagemayresultin permanenthearinglossbutmorefrequentlycausesatemporaryauditorythresholdshift, whichmayrequiredaystorecoverifcausedbyprolongednoiseexposure(days)at100dB.
112
M. Carron et al.
Tinnitus,usuallytransitory,mayalsooccurafternoiseexposure,particularlyinpatients with preexisting hearing loss. Noise exposure during helmet NPSV may be attenuated by some devices. Heat and moisture exchanger lters did not affect noise intensity measuredbythesoundlevelmeterbutdecreasethenoiseperceivedbythesubjects[11]. Otherdevicesincludeearplugsandsoundtraps.Earplugsmaybeeffectiveagainstsleep disruption but may also make contact with the environment more dif cult. Conversely, addingsoundtrapstotheinspiratorybranchoftherespiratorycircuitmaypotentiallylimit noiseinsidethehelmetwithoutmajorinconvenience[11].
17.2.8 Patient–Ventilator Dyssynchrony Consideringthatthealgorithmsregulatingthebeginningandtheendofpressuresupport ventilationarepressureand owbased,thecharacteristics(i.e.,deadspace,compliance)of devices for NPSV have in uence on the patient ventilator interaction. Signi cant asynchronybetweenthebeginningandtheendofinspiratorysupportandthebeginningandthe end of patient inspiratory effort is commonly observed during NPSV [4]. Wasted efforts (i.e.,whenapatient sinspiratoryeffortisnotfollowedbyaventilatorcycle),autotriggering (i.e.,whenaventilatorcycleoccurswithoutbeingprecededbyapatient sinspiratoryeffort), andprolongedinspirations(i.e.,wheneachinsuf ationlastslongerthan1.5s)mayalsobe expectedduringNPSV[4,7].Thepatient ventilatordyssynchronyissigni cantlyhigher duringhelmetNPSVthanduringmaskNPSV[4],andamongthedifferentmasks,thedyssynchronyismoreevidentwithamouthpiecethanwithnasalororonasalmasks[7].With regardtoahelmet,thelowelastanceandhighinnervolumeofthedevicecausessigni cant overdampingofpressureassistanceandadeviationofventilator-delivered owfromthe patienttoexpandthecomplianthelmet(inparticularthesoftcollar)duringNPSV[4].These impaired patient ventilator interactions represent underlying mechanisms responsible for thereducedef ciencyofhelmetNPSVinunloadingtherespiratorymusclesinconditionsof increasedrespiratorymuscleworkload[4].AminimumPEEPof6cmH2Omightbehelpful intheclinicalsetting,whiletheuseofhigher owsandhigherpressuresmayreducethe complianceofthehelmetandmayoptimizetheef ciencyofhelmetNPSV[4].Ontheother hand,itmaynotbewelltoleratedbynormalsubjectsandmaybeassociatedtoworseningof patient ventilatorsynchronyanddyspneasensationinpatientwithARF[4].Aproportional assistventilationmayimprovepatient ventilatorinteractionandpatientcomfort[12].
17.3 Air Pressure and Flow Related Complications Airpressureand owarerequiredforNPSVbutarealsopotentialcausesofef ciencyloss andseriouscomplicationsduringNPSV.Theyshouldbemonitoredcloselyinanypatient undergoingNPSV(seesummarizingTable17.1).
17
Complications During Noninvasive Pressure Support Ventilation
113
17.3.1 Air Leaks InterfacesforNPSVdonotprovideaperfectsealoftheairway.Someairleakingthrough themouth(withnasalmasks)oraroundtheoronasalmaskorthecollarofthehelmetis virtuallyuniversalwithNPSV.Leaksaresigni cantlylargerwiththemouthpiece,butno differenceisobservedbetweentheothermasks.Theyrangefrom18%(integralfacemask) to68%(mouthpiece).Theleaksoflargeoronasalmaskandsmalloronasalmaskaresimilar(31%versus34%)[3].LeakscannotbequantitatedexactlyduringhelmetNPSVbut theyareestimatedtobeatleastcomparableifnotsmallerthanthoseobtainedwiththe mask[4].Besidesthe ttingofinterface,highvaluesofpeakandplateaupressurescan contribute air leaks during NPSV [2]. Air leaks are important because they can render NPSVineffectiveandbecausetheymayaffecttriggering[13]and,inpatientswithneuromusculardisease,cancausepersistenthypercapnia[6].Forthesereasons,leaksshouldbe monitoredcloselyandtakenintoaccountforthechoiceoftheinterfacebytheNPSVstaff. Forpatientswithnasalmaskmeasurestoreduceairleakingincludeinstructionstokeep themouthclosed,applicationofchinstraps,biteblocksorswitchingtooronasalmaskor helmet.Atighter ttingofthemaskorhelmetandareductionofpressuresmaybenecessarytoprovideadequateventilationinsomepatients[2,4,7].Involume-targetedventilators, small and moderate air leaks can be compensated for by increasing tidal volume whereaslargeleaksaredif culttocompensate.Airleakscanbecompensatedmuchbetter bypressure-targetedventilatorsthankstospeci ccompensatingfeaturesthatarepresent insomemodels[5,14]
17.3.2 Nasal or Oral Dryness and Nasal Congestion Nasalororaldrynessiscausedbyhighair ow,anditisusuallyindicativeofairleaking throughthemouth.Measurestominimizeleaksmaybeuseful,butnasalsalineoremollientsandheatedhumidi ersareoftennecessarytorelievethesecomplaints[2].Generally, gasesdeliveredfrommechanicalventilatorsaretypicallydry.Thephysiologiceffectsof inadequatehumiditycanbeduetoheatlossormoistureloss.Inparticular,moistureloss fromtherespiratorytractandsubsequentdehydrationoftherespiratorytractresultinepithelial damage, particularly of the trachea and upper bronchi, drying of secretions and atelectasis.Itwouldbedesirabletohaveanadequatehumidifyingsystemtoavoidexcessivedehydrationofairwaymucusand,atthesametime,toavoidthecontaminationoflung parenchymabyinfectiousagentsasmuchaspossible.Twohumidifyingdevicesarecommonlyusedwithintensivecareventilators:heatedhumidi ersandheat moistureexchangers.Thelatterarefrequentlyusedbecauseoftheirsimplicityandlowercost.However, duringNPSVtheincreaseddeadspaceofaheat moistureexchangercannegativelyaffect ventilatoryfunctionandgasexchangeinpatientswithARF[15].Nasalcongestionand dischargearealsofrequentcomplaintsandmaybetreatedwithtopicaldecongestantsor steroidsandoralantihistamine/decongestantcombinations.
114
M. Carron et al.
17.3.3 Gastric Distension Gastricinsuf ationisreportedinupto50%ofpatientsreceivingNPSVbutisrarelyintolerable.Theloweresophagealsphincterpressureisthepressureattheesophageal-gastricjunction(approximately20 25cmH2O)thatpreventsregurgitationofstomachcontentsintothe pharynxandinsuf ationofairintothegastrointestinaltractduringventilation.Thefrequency ofgastricinsuf ationincreaseswhenhighin ationpressuresareusedandmaybeworsened whenthecomplianceoftheabdomenisgreaterthanthatofthechest.Thisconditioncould occuriftheNPSVventilationsysteminjectsairwhilethepatient sownrespiratorycycleis intheexpiratoryphasesothatthecomplianceofthechestincreaseswhilethatoftheabdomenisrelativelyfreefromtherespiratorycycle[16].Gastricinsuf ation,whichworsensthe patient squalityoflife,canbefatalinseverecases.Gastricdistensioncompressesthelungs, therebydecreasingtheircomplianceanddemandinghigherairwayventilationpressure.The lastisalsoassociatedwithincreasedriskofgastricdistension,thusgeneratingaviciouscycle. Seriouscomplicationsofgastricdistensionareregurgitationofgastriccontents,pulmonary aspiration,intra-abdominalhypertension,andabdominalcompartmentsyndrome.Aconditionclinicallyidenticaltoatensionpneumothoraxhasbeenreportedbutwasrelatedtomassiveintrathoracicdilationofthestomachinapatientwithahiatusherniawhowastreated withNPSV.Airwaypressureshigherthan20cmH2Oshouldbeavoided,andNPSVventilationshouldbeusedinthesittingpositionabouthalfanhourafterameal[2,16].
17.4 Patient Related Complications AcarefulpatientselectioniscrucialforNSPVsuccess.Indicationsandcontraindications, eitherrelativeorabsolute,havebeenproposedforNPSV[1,2]butarebeingreviewedon thebaseofnewstudies(seesummarizingTable17.1).Evenpatientshighlyselectedfor NPSV,however,canpresentunpredictableandseriousorevenlife-threateningcomplicationsbecauseoftheirclinicalconditions.
17.4.1 Aspiration Pneumonia Aspirationpneumoniahasbeenreportedinasmanyas5%ofpatients[2].Ratesofaspirationareminimizedbyexcludingthosewithcompromisedupperairwayfunctionorwith problemsinclearingsecretionsandbypermittingat-riskpatientsnothingbymouthuntil theyarestabilized.Anasogastrictubecanbeinsertedifthepatienthasexcessivegastric distension,anileum,nausea,orvomitingorisdeemedtobeathighriskforgastricaspiration.However,suchpatientsarenotidealcandidatesforNPSV,andnasogastricororogastrictubesshouldnotberoutinelyusedbecausetheyinterferewithmask tting,promoteair leaking,andaddtodiscomfort[2].
17
Complications During Noninvasive Pressure Support Ventilation
115
17.4.2 Barotrauma Barotraumaisawell-recognizedcomplicationofpositivepressureventilation.Itisapulmonaryinjuryresultingfromalveolaroverdistensionandcanleadtopulmonaryinterstitial emphysema, pneumomediastinum, subcutaneous emphysema, and pneumothorax. A pneumoperitoneum associated with pneumomediastinum and tension pneumothorax associated with extensive vascular air embolism has also been reported. Barotrauma is thoughttoarisefromahigh-pressuregradientbetweenthealveolusandadjacentvascular sheet,causingruptureoftheoverdistendedalveolus,forcinggasintotheinterstitialtissue and subsequent dissection along the pulmonary vessels. It is likely that the risk of barotraumainpatientsusingNPSVislessthaninthosereceivinginvasiveventilation. Untilnow,ithasbeendescribedinthepresenceofchronicobstructivepulmonarydisease, acutelunginjuryfrompneumonia,cystic brosis,andneuromusculardisorders.During NPSV,thereisusuallyadropinin ationpressureacrosstheupperairway,andthepresenceoftheairleaksactsasasortof securityvalve thatmay,tosomeextent,prevent airway damage from excessive positive pressure. However, the transitory rise of peak pressureintolocalizedalveolaroverdistensionmayberelatedtopatient ventilatordesynchronizationandleadtodisruptionofthealveolarcapillarymembrane.So,itisimportant notonlythatthepeakalveolarpressureiskeptaslowaspossible(i.e.,<30cmH2O)but also that the patient ventilator desynchronization is minimized as much as possible to reduceriskofbarotraumas[2,17].
17.4.3 Hemodynamic effects Ingeneral,NPSViswelltoleratedhemodynamically,presumablybecauseofthelowin ation pressures used compared with invasive ventilation [2]. A short-term use of NPSV reducesheartrate,systolicbloodpressure,andsystemicvascularresistance.Inpatients whoarereceivingoptimaltherapy,thereductionofsystolicbloodpressureisnotsigni cant and may be associated with increase of ejection fraction and cardiac output [18]. On the other hand, signi cant hypotension and reduced cardiac output may occur in patientswithatenuoushemodynamicstatus(i.e.,patientswhoarehypertensiveorhave low uidvolume)orwithanunderlyingcardiacdiseasewithoutadequatepharmacologic therapy.Abilevelventilationinpatientswithacutepulmonaryedemaincreasestherateof myocardialinfarctionassociatedwithagreaterearlydropinbloodpressurecomparedcontinuouspositiveairwaypressurealonethatcouldhaveresultedfromhigherinitialmean intrathoracicpressure,causingagreaterreductioninvenousreturnThus,inthesepatients, clinicians are encouraged to begin with continuous positive airway pressure alone or NPSVusingrelativelylowin ationpressures(i.e.,11 12cmH2Oinspiratory,4 5cmH2O expiratory pressures) while monitoring the clinical response. Also, NPSV should be avoided in patients with uncontrolled ischemia or arrhythmias until these problems are stabilized[2].
116
M. Carron et al.
Key Recommendations
›
› › › › ›
DuringNPSV,airleaks,patient ventilatordyssynchrony,andpatientdiscomfort areallcommonproblemsthatdependonpatient ventilatorinteraction.They shouldbelookedforandimprovedwiththeappropriatechoiceand ttingofthe interfaceand,whenpossible,slightreductionofpressure. SkinnecrosisorabrasiondependonandlimitthedurationofmaskNPSV. Alternativeinterfacessuchcephalicmaskorhelmetmaybeconsidered. ThenoiseduringNPSVexceedstheusualICUbackgroundnoiseandcanbe anothercauseofdiscomfort,sleepdisruption,andeardamage.Itshouldbe diminishedwithearplugsandsoundtraps. Gastricinsuf ationfromNPSVincreaseswithventilationpressures,theupper safelimitbeing20cmH2O. BarotraumaisararebutapossibleeventduringNPSVresultingfrompatient ventilatorasynchronywhichshouldbecloselymonitored. Hypotension during NPSV is possible in hemodynamically instable patients. InpatientswithischemiaorarrhythmiasNPSVshouldbeavoidedordelayeduntil theseproblemsarestabilized.
References 1. InternationalConsensusConferencesinIntensiveCareMedicine:noninvasivepositivepressure ventilation in acute Respiratory failure (2001) Organized jointly by the American ThoracicSociety,theEuropeanRespiratorySociety,theEuropeanSocietyofIntensiveCare Medicine,andtheSociétédeRéanimationdeLangueFrançaise,andapprovedbyATSBoard ofDirectors,December2000.AmJRespirCritCareMed163:283 291 2. MehtaS,HillNS(2001)Noninvasiveventilation.AmJRespirCritCareMed163:540 577 3. Antonelli M, Pennisi MA, Pelosi P, Gregoretti C, Squadrone V, Rocco M, Cecchini L, ChiumelloD,SevergniniP,ProiettiR,NavalesiP,ContiG(2004)Noninvasivepositivepressure ventilation using a helmet in patients with acute exacerbation of chronic obstructive pulmonarydisease:afeasibilitystudy.Anesthesiology100:16 24 4. Racca F, Appendini L, Gregoretti C, Stra E, Patessio A, Donner CF, Ranieri VM (2005) Effectiveness of mask and helmet interfaces to deliver noninvasive ventilation in a human modelofresistivebreathing.JApplPhysiol99:1262 1271 5. SchönhoferB,Sortor-LegerS(2002)Equipmentneedsfornoninvasivemechanicalventilation.EurRespirJ20:1029 1036 6. GonzalezJ,SharsharT,HartN,ChaddaK,RaphaëlJC,LofasoF(2003)Airleaksduring mechanical ventilation as a cause of persistent hypercapnia in neuromuscular disorders. IntensiveCareMed29:596 602 7. Fraticelli AT, Lellouche F, L her E, Taillé S, Mancebo J, Brochard L (2009) Physiological effectsofdifferentinterfacesduringnoninvasiveventilationforacuterespiratoryfailure.Crit CareMed37:939 945 8. AntonelliM,ContiG,PelosiP,GregorettiC,PennisiMA,CostaR,SevergniniP,ChiarandaM, ProiettiR(2002)Newtreatmentofacutehypoxemicrespiratoryfailure:noninvasivepressure supportventilationdeliveredbyhelmet apilotcontrolledtrial.CritCareMed30:602 608
17
Complications During Noninvasive Pressure Support Ventilation
117
9. Patroniti N, Saini M, Zanella A, Isgrò S, Pesenti A (2007) Danger of helmet continuous positiveairwaypressureduringfailureoffreshgassourcesupply.IntensiveCareMed33: 153 157 10. MuncktonK,HoKM,DobbGJ,Das-GuptaM,WebbSA(2007)Thepressureeffectsoffacemasksduringnoninvasiveventilation:avolunteerstudy.Anaesthesia62:1126 1131 11. CavaliereF,ContiG,CostaR,ProiettiR,SciutoA,MasieriS(2004)Noiseexposureduring noninvasiveventilationwithahelmet,anasalmask,andafacialmask.IntensiveCareMed 30:1755 1760 12. Fernández-Vivas M, Caturla-Such J, González de la Rosa J, Acosta-Escribano J, AlvarezSánchezB,Cánovas-RoblesJ(2003)Noninvasivepressuresupportversusproportionalassist ventilationinacuterespiratoryfailure.IntensiveCareMed29:1126 1133 13. Miyoshi E, Fujino Y, Uchiyama A, Mashimo T, Nishimura M (2005) Effects of gas leak on triggering function, humidi cation, and inspiratory oxygen fraction during noninvasive positiveairwaypressureventilation.Chest128:3691 3698 14. Scala R, Naldi M (2008) Ventilators for noninvasive ventilation to treat acute respiratory failure.RespirCare53:1054 1080 15. JaberS,ChanquesG,MateckiS,RamonatxoM,SoucheB,PerrigaultPF,EledjamJJ(2002) Comparisonoftheeffectsofheatandmoistureexchangersandheatedhumidi ersonventilationandgasexchangeduringnon-invasiveventilation.IntensiveCareMed28:1590 1594 16. YamadaS,NishimiyaJ,KurokawaK,YuasaT,MasakaA(2001)Bilevelnasalpositiveairwaypressureandballooningofthestomach.Chest119:1965 1966 17. CarronM,GagliardiG,MichielanF,FreoU,OriC(2007)Occurrenceofpneumothoraxduringnoninvasivepositivepressureventilationthroughahelmet.JClinAnesth19:632 635 18. AcostaB,DiBenedettoR,RahimiA,AcostaMF,CuadraO,VanNguyenA,MorrowL(2000) Hemodynamiceffectsofnoninvasivebilevelpositiveairwaypressureonpatientswithchronic congestiveheartfailurewithsystolicdysfunction.Chest118:1004 1009
Section V Chronic Applications of Noninvasive Mechanical Ventilation and Related Issues
Efficacy of Continuous Positive Airway Pressure in Cardiovascular Complications of Obstructive Sleep Apnea
18
AhmedS.BaHammamandMohammedK.A.Chaudhry
18.1 Introduction Obstructive sleep apnea (OSA) is a form of sleep-disordered breathing (SDB) that is characterizedbyintermittentcompleteorpartialcollapseoftheupperairway.Thispattern of breathing has been considered a cause for several cardiovascular diseases, such as systemichypertension,heartfailure,arrhythmias,myocardialinfarction,andpulmonary hypertension.TheprevalenceofOSAinthemiddle-agedpopulationwas rstestimatedin 1993bytheongoingpopulation-basedWisconsinSleepCohortStudy[1]inasampleof 625employedadults.Theinvestigatorsfoundthat9%ofwomenand24%ofmenhadat least veormoreapneasorhypopneasperhourofsleep[1].Whenthepresenceofextreme daytimesleepinesswasincludedasacriterion,theprevalencewasestimatedtobe2%in womenand4%inmen[1].TheincidenceofSDBisindependentlyin uencedbyage,sex, waist hipratio,andbodymassindex(BMI).ThecorrelationbetweenOSAandcardiovasculardiseaseshasbeenwellstudied,andalinearrelationshipbetweenseverityofOSAand thecomorbiditieshasbeenreported[2,3].ThefamousSleepHeartHealthStudyrevealed thattherelativeoddsofheartfailure,stroke,andcoronaryarterydisease(CAD)(uppervs. lowerapnea hypopneaindex[AHI]quartile)were2.38,1.58,and1.27,respectively[3]. Inthischapter,wereviewthebest-availableevidencesupportingtheuseofcontinuous positiveairwaypressure(CPAP)inOSApatientswithhypertension,CAD,heartfailure, pulmonaryhypertension,andstroke.
18.2 Pathophysiology Thereareanumberofpathophysiologicmechanismsunderlyingcardiovascularcomplications in OSA patients (Fig. 18.1). The most notable immediate mechanisms are (1)
A.S.BaHammam()andM.K.Chaudhry UniversitySleepDisordersCenter,DepartmentofMedicine,CollegeofMedicine, KingSaudUniversity,P.O.Box225503,Riyadh11324,SaudiArabia e-mail:
[email protected];
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_18,©Springer-VerlagBerlinHeidelberg2010
121
122
A.S. BaHammam and M.K.A. Chaudhry
intermittent swings in blood gas chemistry that range from hypoxia reoxygenation to hypercapnia hypocapnia,(2)arousals,and(3)intrathoracicpressurechanges[4].PathophysiologicalfeaturesthathavebeenassociatedwithOSArangefromfragmentedsleep, todaytimesleepiness,torecurrentepisodesofapnea-relateddesaturationalongwithretention of CO2. All of these factors disrupt the normal structured hemodynamic and autonomic responses to sleep. There is a substantial amount of evidence supporting the conceptionthatintermittenthypoxia reoxygenationisthekeyfeatureofthecardiovascularpathophysiologyofthedisorder[5].Apneasandhypopneascauseintermittenthypoxia andconsecutiveintrathoracicpressureswings.Thistriggerstheautonomicnervoussystem,leadingtosympatheticoveractivation[6].Thishyperactivitypersistsduringthestate ofwakefulness.Thesepatientsthereforehavefasterheartratesduringrestingwakefulness.Thecycleofhypoxia reoxygenationreleasesincreasedquantitiesofreactiveoxygen radicals,triggersoxidativestressmechanisms,andreleasesin ammatorymarkers[7].The endotheliummaintainsharmonybetweenvasodilationandvasoconstrictionandregulates vasoactivemediators.Endothelialdysfunctionleadstoarterialwalldamage.Manystudies haveimplicatedarelationshipbetweenOSAandendothelialdysfunction[8].Figure18.1 showsanalgorithmfortheproposedpathophysiologicmechanisms.
Primary Events Sleep onset
Intermediary Mechanisms
Cardiovascular associations
Hypoxemia / Hypercapnia
Hypertension
Sympathetic activation
Heart Failure
Oxidative stress
Myocardial lschemia
Inflammation
Arrhythmias
Hypercoagulation
Pulmonary HTN
Intrathoracic pressure swings
Stroke
Metabolic dysregulation
Sudden cardiac death
Apneas Hypopneas
Arousals
Reoxygenation
Resumption of airflow
Fig. 18.1 Analgorithmoftheproposedpathophysiologicmechanisms.HTNhypertension
18
Efficacy of Continuous Positive Airway Pressure in Cardiovascular Complications of Obstructive Sleep Apnea
123
18.3 Cardiovascular Complications in Patients with OSA Table18.1summarizesthemainstudiesthatexaminedtheeffectsoftreatmentforOSA onoutcomescontributingtocardiovasculardiseases.
18.3.1 Systemic Hypertension ThereiscompellingevidenceshowingthatOSAisanindependentandimportantriskfactorforhypertension[9].ReporteddatafromtheWisconsinSleepCohortStudydocumented acause effectrelationshipbetweenOSAandhypertensionaftercontrollingfordifferent confounders[10].TheyreportedadirectrelationshipbetweentheprevalenceofhypertensionandtheseverityofOSAexpressedastheAHI[11].Afteradjustingforconfounders, theriskofhypertensionwastwofoldforthosewithanAHIof5 15/handthreefoldfor subjectswithanAHIabove15/h[11].
18.3.1.1 CPAP Therapy Effects ControlledtrialsthatstudiedtheeffectofCPAPonbloodpressurelevelinpatientswith OSAshowedcon ictingresults.AllstudiesthatdidnotshowaneffectofCPAPonblood pressurehadsigni cantlimitations.Limitationsincludedunderpower,asmostofstudied subjectswerenormotensive;theshortdurationoftherapy;orinadequatecompliance.A criticalreviewoftheavailableliteratureshowedthatCPAPtherapydropsbloodpressure byaround10mmHgonaverageinpatientswithmoderate-to-severesleepapnea[12,13]. Nevertheless, this effect was less obvious in patients with mild OSA and patients with OSAwhowerenormotensive.
18.3.2 Coronary Artery Disease Ingeneral,theriskofdevelopingacutecoronarysyndrome(ACS)orsuddencardiacdeath increasesduringtheearlymorninghoursafterwakening.ThefactthatpatientswithOSA haveincreasedriskofACSandsuddencardiacdeathduringsleephours(midnightto6 a.m.),whichisthenadirofACSinsubjectswithoutOSA,raisesaconcernabouttherole ofOSAininducingCAD[14].Inaddition,anobservationalprospectivestudythatevaluatedthetimecourseofSDBinpatientswithACSrevealedpersistenceofOSAinthese patients6monthsaftertheacuteevent,suggestingthatOSAmighthaveprecededtheACS eventandhencewasapossiblecausaleffect[15].Studieshaveshownahighprevalence ofCAD(20 68%)inpatientswithOSAreferredtothesleepclinic[16,17].
33
Therapeuticvs.sham CPAP
PulmonaryHTN
Ariasetal.[31]
18weeks
10.1years
7.5years
5years
3months
1month
1month
Mean65days
CPAPtreatmentreducedtherisk offatalandnonfatalcardiovascular events
Deathsfromcardiovasculardisease morecommonintheuntreatedgroup thanintheCPAP-treatedgroup duringfollow-up
Long-termCPAPtreatmentin moderate-to-severeOSAand ischemicstrokeassociatedwitha reductioninexcessriskofmortality
CPAPtreatmentassociatedwith signi cantimprovementsinLVEF
9%increaseinLVEF;10mmHg decreaseinsystolicbloodpressure; decreaseinheartrateof4beats/min
TherapeuticCPAPreducedmean arterialambulatorybloodpressureby 2.5mmHg
10mmHgdecreaseinsystolicand diastolicbloodpressure
Reductionofpulmonarysystolic pressure(from28.9 to24.0mmHg) CPAPcontinuouspositiveairwaypressure,HTNhypertension,LVEFleftventricularejectionfraction,OSAobstructivesleepapnea
1651
TherapeuticCPAP vs.noCPAP
Marinetal.[20]
168
TherapeuticCPAP vs.noCPAP
28
CPAPinsevere OSAvs.noCPAP
Dohertyetal.[21]
55
TherapeuticCPAP vs.noCPAP
Mans eldetal.[26]
Coronaryartery disease
24
TherapeuticCPAP vs.noCPAP
Kanekoetal.[25]
Martinez-Garcia etal.[41]
118
Therapeutic vs.shamCPAP
Pepperelletal.[12]
60
Therapeutic vs.shamCPAP
Beckeretal.[13]
Stroke
Heartfailure
Hypertension
Table 18.1 Summaryofthemainstudiesthatexaminedtheeffectsoftreatmentforobstructivesleepapneaonoutcomescontributingtocardiovasculardiseases Cardiovascular Study Treatment Patient Treatment Treatmentoutcomes association population(n) period
124 A.S. BaHammam and M.K.A. Chaudhry
18
Efficacy of Continuous Positive Airway Pressure in Cardiovascular Complications of Obstructive Sleep Apnea
125
18.3.2.1 CPAP Therapy Effects EarlyrecognitionandtreatmentofOSAmaybebene cialintermsofCADprevention. Treatment with CPAP reduces angina and nocturnal myocardial ischemia [18]. Drager etal.,inasmallrandomizedcontrolledstudy,reportedimprovementsinpulsewavevelocity, carotid intima wall thickness, and carotid artery diameter after 4 months of CPAP therapy[19].Marinetal.comparedthefatalandnonfatalcardiovasculareventsinpatients withtreatedandnontreatedOSA[20].PatientswithsevereOSA(AHI>30)hadsigni cantlyhigherfatalandnonfatalcardiovascularevents.Amongthepatientswhohadtreated OSA, the incidence of both fatal and nonfatal cardiovascular events approached levels seeninsimplesnorers[20].Along-termfollow-upstudyof168patientswithOSAswho hadbegunreceivingCPAPtherapyatleast5yearspreviouslycomparedthecardiovascular outcomesofthosepatientswhowereintolerantofCPAP(untreatedgroup,61patients) withthosecontinuingCPAPtherapy(107patients)[21].DeathsfromcardiovasculardiseaseweremorecommonintheuntreatedgroupthanintheCPAP-treatedgroupduring follow-up[21].
18.3.3 Heart Failure AnumberofstudiesreportedahighprevalenceofOSAamongpatientswithheartfailure (11 38%),aprevalencehigherthanthatreportedinpatientswithoutOSA[22].Patients withheartfailureandOSAareusuallyoverweightandsnorehabitually,whichisdifferent from the phenotype of patients with heart failure who have central sleep apnea and Cheyne Stokesrespiration.EvenpatientswithmildheartfailurehaveincreasedprevalenceofOSA.Vaziretal.describeda15%incidenceofOSAinpatientswithmildsystolicleftventriculardysfunction[23].HeartfailureinOSApatientscanbebothsystolic anddiastolic.
18.3.3.1 CPAP Therapy Effects CPAP therapy improves both systolic and diastolic functions. In a controlled crossover designstudy,Ariasetal.reportedsigni cantimprovementindiastolicdysfunctionwith CPAPtherapy[24].TworandomizedcontrolledtrialsassessedtheimpactofCPAPtherapy onsystolicdysfunctioninpatientswithOSA.Onestudyreportedanimprovementfrom 27%to36%inleftventricularejectionfraction(LVEF)in24patientsafter4weeksof CPAP therapy [25]. The second study reported an improvement in LVEF from 35% to 40%,areductioninurinarycatecholamines,andimprovedqualityoflifein55patients withCPAPtherapyfor3months[26].Amulticenterrandomizedstudyexploredtheef cacyofCPAPin60OSApatientswithheartfailure(LVEF<45%)[27].Therewasasigni cantimprovementintheLVEFinthegroupofpatientstreatedwithCPAPbutnosuch
126
A.S. BaHammam and M.K.A. Chaudhry
improvementintheshamCPAPgroup.Theimprovementwasmoremarkedinpatients with a LVEF above 30% [27]. On the contrary, a randomized, double-blind, crossover study did not elicit a signi cant change in LVEF after 6 weeks of CPAP use [28]. Nevertheless,CPAPusagewaslow(3.5hpernight)[28].OSAhasbeenassociatedwith highermortalityinpatientswithheartfailure[29].TheimpactofCPAPtherapyonmortalityinpatientswithheartfailurehasnotbeenshown.Currently,therearenoguidelinesfor treatmentofsleepapneainheartfailure.Well-designed,long-termstudiesareneededto seeiftreatmentwithCPAPprolongssurvival.
18.3.4 Pulmonary Arterial Hypertension TheWorldHealthOrganizationrecognizedSDBasasecondarycauseofpulmonaryarterial hypertension (PAH) in its second conference on PAH in 1998 [30]. Studies have shown that mild PAH (mean pulmonary artery pressure of 20 30 mmHg) is relatively commoninpatientswithOSA.Aprevalenceof17 43%hasbeenreportedindifferent studies.HighAHI,lowPao2,highPaco2,lowFEV1,andincreasedBMIhavebeenassociated with PAH in patients with OSA [31]. The clinical signi cance of this mild OSArelatedPAHisnotknown. Thepulmonaryvasculature,incontrasttothesystemicvasculature,respondstohypoxia withvasoconstrictiontomaintainmatchedventilationandperfusion.Sustainedlong-term hypoxiaresultsinchronicallypresentvasoconstrictionthatvariesamongindividuals.Over time,thisleadstoremodelingofpulmonaryvasculature.Experimentalintermittenthypoxia forpartofthedayforafewweekscausedPAH,pulmonaryarterialremodeling,andright ventricularhypertrophyinrodents[32].
18.3.5 CPAP Therapy Effects TreatmentofpatientswithOSAwithCPAPhasbeenshowntoreducepulmonaryartery pressure.Ariasandcolleagues[31]havestudiedpulmonaryhemodynamicsandOSAin their randomized crossover study and found that CPAP treatment compared with sham CPAPsigni cantlyreducedpulmonarysystolicpressure(from29to24mmHg).Patients whorespondedwellweretheoneswhohadPAHatbaselineorwithleftventriculardysfunction.Anumberofstudiesreportedasigni cantdecreaseinpulmonaryarterypressure inpatientswithOSAwithPAHafter3 6monthsofCPAPtherapy[31,33].Onestudy demonstrated reduction in the reactivity of the pulmonary circulation to hypoxia after CPAPtherapy[33].Nevertheless,itisimportanttomentionherethatsomestudiesshowed negativeresults[34]. Basedonavailabledata,itseemsthatadropinpulmonaryarterypressureislikelyto occurinpatientswithsevereOSA;thoseinwhomPAHiscausedbyOSAnotbycomorbid
18
Efficacy of Continuous Positive Airway Pressure in Cardiovascular Complications of Obstructive Sleep Apnea
127
conditions;thosewithleftventriculardysfunction;andthosewhoareadherenttotherapeuticCPAP.
18.3.6 Stroke Cross-sectionalstudiesshowedstrongassociationbetweenOSAandstroke.Thestrength ofassociationwassimilartotraditionalriskfactorsforstrokelikehypertensionandsmoking. In addition, even after adjustment for known confounding factors like obesity and hypertension, SDB remains an independent association [3]. Large observational cohort prospectivestudieshaveshownthatOSAincreasestheriskofstrokeandall-causemortalityindependentofknownconfounders[35,36].Moreover,severityofOSAwasassociated withahigherriskofstrokeanddeath[35 37].ThosewithanAHIabove36hadamore thanthreefoldincreasedriskofstrokeanddeath.AstudythatfollowedpatientswithOSA for10yearsshowedthatOSAwassigni cantlyassociatedwithahigherriskofstrokein patientswithCADwhowerebeingevaluatedforcoronaryintervention[38].
18.3.6.1 CPAP Therapy Effects ThereisalwaysaconcernthatindividualswithOSAandstrokemaynottolerateCPAPdue to their acute illness. Studies addressing CPAP tolerance in this group of patients have reportedcon ictingresults.Whilesomeinvestigatorsreportedasimilarimprovementand acceptanceofCPAPtherapyasinpatientswithOSAwithoutstroke[39],othersreported poortoleranceandlackofbene t[40]. AprospectiveobservationalstudyexploredSDBin166patientswithacutestroke [41].CPAPtherapywasofferedwhenAHIwas20/horhigher,andthenpatientswere followedfor5years.PatientswithanAHIof20orhigherwhodidnottolerateCPAP (n=68)showedanincreasedadjustedriskofmortality(hazardsratio[HR]2.69)comparedwithpatientswithanAHIbelow20(n=70)andanincreasedadjustedriskof mortality(HR1.58)comparedwithpatientswithmoderate-to-severeOSAwhotolerated CPAP (n = 28). There were no differences in mortality among patients without OSA, patients with mild disease, and patients who tolerated CPAP therapy [41]. Furthermore,CPAPtherapymayreducetheriskforstrokeindirectlythroughdifferent mechanisms.CPAPtherapyhasbeenshowntoreducebloodpressure;eliminateintermittent hypoxia; decrease platelet aggregation and brinogen levels; reduce risk of atrial brillation; reduce sympathetic nerve activity, ambulatory blood pressure, and arterialwallstiffness;andincreasesensitivityofthearterialbarore exinpatientswith OSA[12,42].TheseeffectsmayreducetheriskofCADandstrokeinthisgroupof patients.
128
A.S. BaHammam and M.K.A. Chaudhry
Key Recommendations
› ›
› › ›
OSAisaseriousmedicaldisorderthatmaycauseandincreasetheriskformany cardiovasculardisorders. Severalmechanismsmayaccountforthisrisk,includingintermittenthypoxia, sympatheticoveractivity,oxidativestress,endothelialdysfunction,in ammation cascadeoveractivity,intrathoracicpressureswings,metabolicdysregulation,and thrombosis. EarlytreatmentofOSApatientswithCPAPtherapymaypreventcardiovascular complications. CPAPtherapyhasbeeneffectiveinreducinganumberofcardiovascular complicationsandcardiac-relatedmortalityinpatientswithOSA. CliniciansshouldbeawareoftheseriousnessofOSAandhenceshould recognizethisdisorderinitsearlystages,initiateCPAPtherapy,andstressthe importanceofadherencetotheirpatients.
References 1. YoungT,PaltaM,DempseyJ,SkatrudJ,WeberS,BadrS(1993)Theoccurrenceofsleepdisorderedbreathingamongmiddle-agedadults.NEnglJMed328(17):1230 1235 2. NietoFJ,YoungTB,LindBK,ShaharE,SametJM,RedlineSetal(2000)Associationof sleep-disorderedbreathing,sleepapnea,andhypertensioninalargecommunity-basedstudy. SleepHeartHealthStudy.JAMA283(14):1829 1836 3. ShaharE,WhitneyCW,RedlineS,LeeET,NewmanAB,JavierNietoFetal(2001)Sleepdisordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart HealthStudy.AmJRespirCritCareMed163(1):19 25 4. LavieL(2003)Obstructivesleepapnoeasyndrome anoxidativestressdisorder.SleepMed Rev7(1):35 51 5. SomersV,JavaheriS(2005)Cardiovasculareffectsofsleep-relatedbreathingdisorders.In: KrygerMH,RothT,DementWC(eds)Principlesandpracticesofsleepmedicine,4thedn. Saunders,Philadelphia,pp1180 1191 6. ZieglerMG,MillsPJ,LoredoJS,Ancoli-IsraelS,DimsdaleJE(2001)Effectofcontinuous positiveairwaypressureandplacebotreatmentonsympatheticnervousactivityinpatients withobstructivesleepapnea.Chest120(3):887 893 7. RyanS,TaylorCT,McNicholasWT(2005)Selectiveactivationofin ammatorypathwaysby intermittenthypoxiainobstructivesleepapneasyndrome.Circulation112(17):2660 2667 8. IpMS,TseHF,LamB,TsangKW,LamWK(2004)Endothelialfunctioninobstructivesleep apneaandresponsetotreatment.AmJRespirCritCareMed169(3):348 353 9. YoungT,JavaheriS(2005)Systemicandpulmonaryhypertensioninobstructivesleepapnea. In:KrygerMH,RothT,DementWC(eds)Principlesandpracticesofsleepmedicine,4thedn. Saunders,Philadelphia,pp1192 1202 10. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B et al (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157(15): 1746–1752 11. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384
18
Efficacy of Continuous Positive Airway Pressure in Cardiovascular Complications of Obstructive Sleep Apnea
129
12. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR et al (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359(9302):204–210 13. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73 14. Gami AS, Howard DE, Olson EJ, Somers VK (2005) Day–night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352(12):1206–1214 15. BaHammam A, Al-Mobeireek A, Al-Nozha M, Al-Tahan A, Binsaeed A (2005) Behaviour and time-course of sleep disordered breathing in patients with acute coronary syndromes. Int J Clin Pract 59(8):874–880 16. Hanly P, Sasson Z, Zuberi N, Lunn K (1993) ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71(15):1341–1345 17. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P (1996) Sleep-disordered breathing in men with coronary artery disease. Chest 109(3):659–663 18. Franklin KA, Nilsson JB, Sahlin C, Naslund U (1995) Sleep apnoea and nocturnal angina. Lancet 345(8957):1085–1087 19. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712 20. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053 21. Doherty LS, Kiely JL, Swan V, McNicholas WT (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127(6):2076–2084 22. Bradley TD, Floras JS (2003) Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 107(12):1671–1678 23. Vazir A, Hastings PC, Dayer M, McIntyre HF, Henein MY, Poole-Wilson PA et al (2007) A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 9(3):243–250 24. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J (2005) Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112(3):375–383 25. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241 26. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169(3):361–366 27. Egea CJ, Aizpuru F, Pinto JA, Ayuela JM, Ballester E, Zamarron C et al (2008) Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med 9(6):660–666 28. Smith LA, Vennelle M, Gardner RS, McDonagh TA, Denvir MA, Douglas NJ et al (2007) Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 28(10):1221–1227 29. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL et al (2007) Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49(15): 1625–1631 30. Rich S (ed) (1998) Primary pulmonary hypertension: executive summary from the world symposium on primary pulmonary hypertension. World Health Organization, Geneva 31. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J (2006) Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 27(9):1106–1113
130
A.S. BaHammam and M.K.A. Chaudhry
32. Campen MJ, Shimoda LA, O’Donnell CP (2005) Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol 99(5):2028–2035 33. Sajkov D, Wang T, Saunders NA, Bune AJ, McEvoy RD (2002) Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 165(2):152–158 34. Sforza E, Krieger J, Weitzenblum E, Apprill M, Lampert E, Ratamaharo J (1990) Long-term effects of treatment with nasal continuous positive airway pressure on daytime lung function and pulmonary hemodynamics in patients with obstructive sleep apnea. Am Rev Respir Dis 141(4 Pt 1):866–870 35. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD (2005) Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172(11):1447–1451 36. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041 37. Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H et al (2008 Feb 11) Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 168(3):297–301 38. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA (2008) Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation 118(9):955–960 39. Scala R, Turkington PM, Wanklyn P, Bamford J, Elliott MW (2009 Jan) Acceptance, effectiveness and safety of continuous positive airway pressure in acute stroke: a pilot study. Respir Med 103(1):59–66 40. Palombini L, Guilleminault C (2006 Feb) Stroke and treatment with nasal CPAP. Eur J Neurol 13(2):198–200 41. Martinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L, Soriano Y, Roman-Sanchez P, Illa FB et al (2009) Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 180(1):36–41 42. Kohler M, Pepperell JC, Casadei B, Craig S, Crosthwaite N, Stradling JR et al (2008) CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 32(6):1488–1496
Obstructive Sleep Apnea and Atherosclerosis
19
RichardSchulz,FrankReichenberger,andKonstantinMayer
19.1 Introduction Atherosclerosisisaprogressive,chronicdiseaseoflargearteriesinwhichvariousstagesof vascularremodeling nallyleadtosigni cantnarrowingofthevessellumen.Intheearly phase of atherosclerosis, cholesterol particles are incorporated into the vascular wall (i.e.,foamcellformation,developmentoffattystreaks).Later,plaquesoccurthatareprone torupturewithconsecutivethrombosisandcompletevesselocclusion.Inthiscase,acute clinicalsyndromessuchasmyocardialinfarctionmayresult.Atherosclerosisisviewedasan in ammatoryprocessinwhichcirculatingleukocytesareattachedtotheendothelium,penetrateintothesubendothelialspace,andreleaseawidespectrumofcytokines.Knownrisk factorsforatherosclerosisare,forinstance,smoking,diabetesmellitus,andhyperlipidemia.
19.2 Relation of Obstructive Sleep Apnea to Atherosclerosis Large-scaleepidemiologicalstudiessuchastheSleepHeartHealthStudyandtheWisconsin SleepCohortStudyhaveshownthatpatientswithobstructivesleepapnea(OSA)havean increasedriskforatheroscleroticsequelaesuchasischemicheartandcerebrovasculardisease[1,2].Ofnote,thiseffectwasfoundtobeindependentofconfoundingfactorssuchas obesity,metabolicdisorders(i.e.,diabetesmellitusandhyperlipidemia),andsmoking. MultiplepathwaysmaybeinvolvedinthepathogenesisofatherosclerosisinOSA.First, oxidativestressprobablyplaysanimportantrole.Inthiscontext,neutrophilsfrompatients with OSA have been found to display an enhanced release of free oxygen radicals after invitrostimulationbyvariouscompounds.Theradical uxassociatedwithOSAmaytrigger
R.Schulz(),F.Reichenberger,andK.Mayer, UniversityofGiessen,LungCenter,Giessen,Germany e-mail:
[email protected];
[email protected];
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_19,©Springer-VerlagBerlinHeidelberg2010
131
132
R. Schulz et al.
lipid peroxidation and reduce nitric oxide bioavailability. Second, vascular in ammation maycontributetoOSA-associatedatherosclerosis.Thisisre ectedbyanupregulationof in ammatory biomarkers such as C-reactive protein (CRP), interleukin 6 (IL-6), tumor necrosis factor a (TNF-a), and soluble adhesion molecules in the blood of patients with OSA.Furthermore,differentleukocytesubpopulationsareactivatedinthesesubjectsand mayprovokeinjurytothevascularendothelium.Likewise,ratsundergoingrepetitiveair ow limitationsarecharacterizedbyincreasedleukocyte endothelialcellinteractions.Thesame hasbeenfoundinmicesubjectedtochronicintermittenthypoxia(CIH).Third,untreated OSAislinkedwithincreasedinsulinresistanceorimpairedglucosetolerance,whichmaybe equallyimportantfortheemergenceofatherosclerosis.Takentogether,thesechangesprovokeashiftofvascularhomeostasistovasoconstriction,in ammation,andthrombosis(i.e., endothelial dysfunction). This impairment of endothelial-dependent vasorelaxation is an established precursor lesion for atherosclerosis. Vasoreactivity studies employing venous occlusionplethysmographyand ow-mediatedvasodilationhaveclearlyshownthatendothelialdysfunctioncanbeobservedinotherwisehealthy,nonsmokingpatientswithOSA[3]. DirectevidencethatOSAmayinduceatherosclerosiscomesfromstudiesinvestigating subclinicalmarkersofatherosclerosisinpatientswithversuswithoutOSA.Thebestestablishedofthesemarkersisintimamediathickness(IMT).Itisdeterminedbyhigh-resolution ultrasonography,usuallyatthelevelofthecommoncarotidartery,andre ectstheearly phasesofatherosclerosis.VariousstudieshaveshownthatpatientswithOSAhavesigni cantlyincreasedIMTwhencomparedtosubjectswithoutsleep-disorderedbreathing,and thatthisisalsotrueforthosepatientswithoutanycomorbidities[4].Furthermore,itwas observedthatIMTinOSAisrelatedtothedegreeofnocturnalhypoxiaandtheapnea hypopneaindex(AHI).Inaddition,onestudyfoundthatIMTcorrelatedwithserumconcentrationsofin ammatorymarkers(i.e.,CRP,IL-6,andIL-18).Itshouldbenotedthat the ndingsfromthesesleeplab-basedstudieswerenotreplicatedinthepopulation-based SleepHeartHealthStudy.However,inthisstudy,patientswithmoderate-to-severeOSA inwhomanincreaseofIMTcanbeexpectedtooccurwereunderrepresented. Coronaryarteryatherosclerosiscanbevisualizedbyelectronbeamcomputedtomography.Usingthistechnique,Sorajjaandcolleaguesreportedthat,inpatientswithoutclinically overtcoronaryarterydisease,thepresenceandseverityofOSAwasindependentlyassociatedwiththepresenceandextentofcoronaryvesselcalci cations.Afurtherstudyinwhich coronary vessel architecture was evaluated by three-dimensional intravascular ultrasound foundthat,inpatientswithstablecoronaryarterydisease,therewasasigni cantrelationship betweenthefrequencyofapneasorhypopneasandcoronaryatheroscleroticplaquevolume. Theratioofankle-to-brachialsystolicbloodpressure(i.e.,theankle brachialindex)can beusedtoscreenforthepresenceofperipheralvaso-occlusivedisease.Inpatientswith OSA,thisindexhasbeenfoundtobehigherthaninpatientswithoutOSA.Atherosclerosis is characterized by enhanced arterial stiffness, which can be determined by carotid-tofemoralpulsewavevelocitymeasurement.PatientswithOSAhaveincreasedpulsewave velocitiesincomparisonwithmatchedcontrolswithoutsleep-disorderedbreathing. Inadditiontothesehumandata,ananimalexperimentfoundthatratsexposedtoCIH andfedwithahigh-cholesteroldietdevelopedacceleratedatherosclerosis[5].Interestingly, inthismodel,CIHalonewasnotsuf cienttoinduceatherosclerosis,thuspointingtoa ratherpermissiveroleofOSAinthepathogenesisofatherosclerosis.
19
Obstructive Sleep Apnea and Atherosclerosis
133
P=0.02 P=0.04 Intima-media thickness (µm)
Intima-media thickness (µm)
NS 1200 1100 1000 900 800 700 600 500 400 Baseline 4 months Control group
1200 1100 1000 900 800 700 600 500 400 Baseline 4 months Group receiving CPAP
Fig. 19.1 Effectsof4monthsofcontinuouspositiveairwaypressure(CPAP)therapyonintimamedia thickness(IMT)inobstructivesleepapnea(OSA)intreatedversusuntreatedpatients(n=12ineach group(From[6])
Continuouspositiveairwaypressure(CPAP)therapycanrestorethevascularmicromilieu, improve endothelial function, and prevent deaths from myocardial infarction and strokeinpatientswithOSAwithanAHIabove30/h.Therefore,oneshouldexpectthat thisformoftreatmentisabletoinhibitorevenreverseatherosclerosis.Indeed,onegroup fromBrazilfoundthatshort-termCPAPtherapyledtoamodestdecreaseofIMTinasmall sampleofpatientswithOSA([6];Fig.19.1).However,substantiallymorepatientsshould beinvestigatedoverlongertimeperiodstodetermineifCPAPreallycanreverseatheroscleroticremodelingofthevascularwall.
Key Recommendations
› › › › › ›
The vemajorkeymessagesofthisreviewareasfollows: PatientswithuntreatedOSAhaveanincreasedriskforatherosclerosisandits relateddiseasesindependentofconfoundingfactors. Presumably,theunderlyingmechanismisadisturbanceofthevascularmicromilieu (i.e.,endothelialdysfunction)inresponsetotheintermittentnocturnalhypoxia. Studieslookingatdifferentsubclinicalmarkersofatherosclerosishaveclearly shownthatpatientswithOSAhaveacceleratedatherosclerosiswhencompared withcontrolswithoutsleep-disorderedbreathing. RatsexposedtoCIHandfedwithahigh-cholesteroldietdevelopaccelerated atherosclerosis. CPAPtherapyislikelytodecreaseatherosclerosisinOSA;however,long-term studiesenrollinglargernumbersofpatientsarenecessarytode nitivelyprove thisassumption.
134
R. Schulz et al.
References 1. ShaharE,WhitneyCW,RedlineSetal(2001)Sleep-disorderedbreathingandcardiovascular disease.Cross-sectionalresultsoftheSleepHeartHealthStudy.AmJRespirCritCareMed 163:19 25 2. ArztM,YoungT,FinnLetal(2005)Associationofsleep-disorderedbreathingandtheoccurrenceofstroke.AmJRespirCritCareMed172:1447 1451 3. IpMS,TseHF,LamBetal(2004)Endothelialfunctioninobstructivesleepapneaandresponse totreatment.AmJRespirCritCareMed169:348 353 4. SchulzR,SeegerW,FegbeutelCetal(2005)Changesinextracranialarteriesinobstructive sleepapnoea.EurRespirJ25:69 74 5. SavranskyV,NanayakkaraA,LiJetal(2007)Chronicintermittenthypoxiainducesatherosclerosis.AmJRespirCritCareMed175:1290 1297 6. DragerLF,BortolottoLA,FigueiredoACetal(2007)Effectsofcontinuouspositiveairway pressureonearlysignsofatherosclerosisinobstructivesleepapnea.AmJRespirCritCare Med176:706 712
Transnasal Insufflation — A New Approach in the Treatment of OSAs
20
GeorgNilius,BrianMcGinley,andHartmutSchneider
20.1 Introduction Obstructive sleep apnea (OSA) syndrome leads to intermittent hypoxemia, sleep fragmentation,metabolicdysfunction,andincreasedcardiovascularmorbidityandmortality.Currenttreatmentoptions,includingcontinuouspositiveairwaypressure(CPAP),oral appliances,andsurgicalprocedures,areoftenintrusiveorinvasiveandnotwelltolerated, leavingavastnumberofsubjectsuntreated.Therefore,improvedtherapeuticstrategiesare requiredtotreatsleepapneasandhypopneasandtheirassociatedmorbidityandmortality. Currently,CPAPismosteffectiveineliminatingapneasandhypopneas,althoughlongtermeffectivenessiscompromisedbylowadherence,whichisestimatedatonly50 60% andevenlowerinchildrenorpatientswithcomorbidconditionslikechronicobstructive pulmonarydisease(COPD),stroke,orheartfailure.Anopennasalcannulasystem ThestudywassponsoredbyHL72126,P50HL084945-01,SeleonInc.,NHMRC353705. Con ictofInterestDr.SchneiderreceivedconsultingfeesfromTNImedicalin2006 2009andis entitledtoroyaltypaymentsonthefuturesalesofproductsdescribedinthisarticle.UnderaseparatelicensingagreementbetweenDr.SchneiderandTNImedicalandJohnsHopkinsUniversity, Dr. Schneider is entitled to a share of royalty received by the university on sales of products described in this article. The terms of this agreement are being managed by Johns Hopkins Universityinaccordancewithitscon ict-of-interestpolicies.Fundingforthestudydescribedin thisarticlewaspartiallyprovidedbyTNImedical. H.Schneider() DivisionofPulmonaryandCriticalCareMedicine,JohnsHopkinsSleepDisordersCenter, JohnsHopkinsUniversity,5501BayviewBlvd,Baltimore,MD224,USA e-mail:
[email protected] G.Nilius HELIOS-Klinik,Hagen-Ambrock,Germany e-mail:
[email protected] B.McGinley DivisionofPediatricPulmonary,JohnsHopkinsPediatricSleepDisordersCenter, JohnsHopkinsUniversity,Baltimore,MD,USA e-mail:
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_20,©Springer-VerlagBerlinHeidelberg2010
135
136
G. Nilius et al.
Fig. 20.1 Studyparticipant wearingthetreatmentwith nasalinsuf ation(TNI) cannula(cannulalengthis 1,800mm,5-mmouter diametercannulaandnasal prongs,3.4-mminner diameter)
deliveringwarmandhumidi edair(Fig.20.1)hasbeenintroducedasamethodforincreasingpharyngealpressure[1].Thischaptersummarizesthestudiesthatwereconductedwith treatment with nasal insuf ation (TNI) in adults and children with OSA and hypopnea acrossaspectrumofdiseaseseverity.
20.2 Mechanism of Actions of Nasal Insufflations 20.2.1 Effect on Upper Airway Upper airway obstruction is due to increased pharyngeal collapsibility, which decreases inspiratoryair ow,asmanifestedbysnoring,obstructivehypopneas,andapnea.Thisdefect inupperairwaycollapsibilitycanbeovercomebyelevatingnasalpressure.Infact,somewhatgreaterlevelsofnasalpressurearerequiredtoabolishapneasthanhypopneasandto restorenormallevelsofinspiratoryair ow.Viceversa,inpatientswithmildformsofupper airwayobstruction,lowlevelsofnasalpressurethroughanasalcannulamaybesuf cient torelievesleep-disorderedbreathing.Severalstudieshavebeenpublishedtocon rmthis hypothesis. ThemechanismofactionofTNIonupperairwayfunctionwas rstdeterminedinadult patientswithvaryingdegreesofupperairwayobstruction[1].Air owdynamicsandsupraglotticpressureresponsestoTNIwereexamined.Atarateof20L/min,TNIincreases nasalpressurebyapproximately2cmH2Oandincreasesinspiratoryair owbyapproximately100mL/s.Thisincreaseinpharyngealpressureandair owcanexplaintheimprovementofsnoringandhypopneasasfollows:Thepeakinspiratoryair owforhypopneasand
20 Transnasal Insufflation — A New Approach in the Treatment of OSAs
137
TNI Off 200
TNI 20
Expiration
Airflow (ml/s)
-200
Inspiration
2
5
1 0 PSG (cm H2O) -15
3
4
Fig. 20.2 Mechanismofaction.Air owandsupraglotticpressureareshownduringthetransition from ow-limited breathing with TNI off to non- ow-limited breathing with TNI 20 L/min. PSG supraglottic catheter pressure (cmH2O). (1) Increase in end-expiratory PSG, (2) increase in meaninspiratoryair ow,(3)decreaseinsupraglotticpressureswingsonabreath-by-breathbasis, (4)PSGthresholdforinspiratory owlimitation,(5)around,non- ow-limitedinspiratorypattern
for ow-limitedbreathsaveragesapproximately150 200mL/s.Theadditional owfrom TNIwillincreasetheinspiratoryair owto250 300mL/s,alevelpreviouslyassociated withstabilizationofbreathingpatterns(seeFig.20.2).However,unexpectedly,someindividuals also showed improvements in the event rate of obstructive apneas. The mechanismsfortheseresponsesarenotfullyunderstood.Additionalnonquanti ablefactorsmay havecontributedtothisresponse.First,smallincreasesinpharyngealpressuremayhave increasedlungvolume,whichmayimprovebothoxygenstoresandupperairwaypatency. Second,asventilationimprovesduringsleep,enhancedsleepcontinuity(decreasedarousal frequency)mayfurtherstabilizebreathingandreducetheeventrateofapneasandhypopneas.Finally,additionalbene tsmayhaveaccruedfrominsuf atingairdirectlyintothe nose,producingconcomitantreductionsindeadspaceventilation.
20.2.2 Effect on Ventilation NewevidenceexiststhatTNImayimproveventilationevenintheabsenceofupperairway obstruction.InonestudyinpatientswithamilddegreeofCOPD(GOLDI II:FEV1/FVC= 70%predictedandFEV1 <80%and>50%predicted),theuseofTNIduringsleepwas associatedwithareductioninarterialCO2comparedtoroomair[3].Inanotherstudy[4], TNIwasusedduringwakefulnessinadditiontosupplementaloxygensincepatientshad severeCOPD(GOLDIV-FEV1/FVC<70%predictedandFEV1<30%predicted)requiring oxygen treatment. In these patients, TNI and supplemental oxygen also reduced the respiratoryrate,whichwasassociatedwithareductioninarterialCO2from58to49mmHg, indicatingthatalveolarventilationhadimproved,andventilationhadbecomemoreeffective with TNI. Additional data for ventilator support independent of inspiratory ow
138
G. Nilius et al.
Expiration
Baseline
Nasal Insufflation
Baseline
Artflow Inspration
Thorax Abdomen 95
SaO2 (%)
80 110
Heart Rate (b/min)
70
Expiration
Air flow Inspiration
Thorax abdomen 95
SaO2 (%)
80 110
Heart Rate (b/min)
70
Respiratory Rate = 36/min, TI / TT=0.75 VM = 12 L/min Heart Rate: 90/min
Respiratory Rate = 23/min, TI /TT=0.45 VM = 4 L/min Heart Rate: 75 /min
Fig. 20.3 Polysomnographicrecordingshowingacuteeffectsofnasalinsuf ations(TNI20L/min) onventilationandbreathingpatterninachildwithobesityhypoventilationsyndromeandinspiratory owlimitationduringnon-rapid-eye-movement(NREM)sleep.Atbaseline,arapidshallow breathing pattern was present that was abolished with nasal insuf ations. Note that inspiratory owlimitationwasnotabolished,indicatingthatimprovementsinventilationareindependentof inspiratory owlimitation
limitation were given by the data in children [5]. McGinley et al. demonstrated that, in patients with rapid, shallow breathing, TNI markedly reduced the respiratory rate and inspiratory duty cycle, even if inspiratory ow limitation was not fully restored (see Fig.20.3).Theprecisemechanismforimprovinggasexchangeandef cacyofventilation isnotfullyunderstood.ItispossiblethatTNImayhavereducedCO2productionbyloweringtheworkofbreathing,orithasreducedthedeadspaceventilationbywashingoutthe anatomicdeadspaceofthenasalcavity.Alternatively,TNImayhavereducedintrapulmonarydeadspacebyopeningupatelectasisthroughtheslightincreaseinpositiveend-expiratorypressure(PEEP).Regardlessofthemechanism,thedatainchildrenandinindividuals withCOPDindicatedthatnasalinsuf ationsreducedtheloadofbreathing,particularlyin patientswitharapid,shallowbreathingpattern.Nevertheless,clinicaldataarewarrantedto determinetheeffectivenessofTNIinthesepatients.
20 Transnasal Insufflation — A New Approach in the Treatment of OSAs
139
20.3 Predictors for Therapeutic Responses to TNI in Adults with OSA PolysomnographicresponsestoTNIwereexaminedinalargerclinicalsampleofpatients[5]. Theprimarypurposewastoidentifypolysomnographiccharacteristicsinabaselinesleep studythatmaybeusedtopredictTNItreatmentresponses.Inthisstudy,wecon rmedthat TNIreducedtheoverallsleep-disorderedbreathingeventratebelowaclinicallyacceptable thresholdin30 50%ofpatientsreferredtoasleeplaboratoryforCPAPtherapy.Patientswith awiderangeofsleep-disorderedbreathingeventrate(rangingfrom10to80events/h)had similarresponserates,indicatingthattreatmentresponsestoTNIwereindependentofthe sleepapneadiseaseseverity.Moreover,theresponseratewasmarkedlyincreasedinpatients withpredominantlyhypopneasandpatientswithmildupperairwayobstruction.Inaddition, thepresenceofmorethan10%centralapneaspredictedpoorresponse.Thus,TNItreatment responsesdependedontheseveritybutnotthefrequencyofupperairwayobstruction(see Fig.20.4).ThemainconclusionfromthisstudywasthatTNImayofferanalternativetothe standard CPAP therapy in patients with predominantly obstructive hypopneas. In patients withapneas,TNImayalsoincreaseair ow,butthatincreasemaybeinsuf cient.Asaresult, in apneic patients TNI may shift apneas to hypopneas, leaving the overall event rate unchanged.Sincetheef cacyofTNIcanbeeasilyassessedwithinasinglenight,initiation of this treatment should be monitored to ensure treatment ef cacy before recommending hometreatment.Nevertheless,itcanbepredictedthattreatmentef cacyishigherinpatients whosesleep-disorderedbreathingeventsconsistofatleast90%hypopneaandRERAs.Itis ofnotethattheseeventsarepredominantlyseeninchildren,women,andpatientswithcomorbidconditions.Therefore,thesepopulationsmaybeidealforthisformoftherapy.Todate, theeffectofTNIwasdeterminedinchildren.
20.4 Therapeutic Responses in Children with OSA Childrenwithupperairwayobstructionduringsleepdiffermarkedlyinregardtothedistributionofobstructiveevents.Theyhaveobstructiveapneaspredominantlyduringrapideye-movement(REM)comparedtonon-rapid-eye-movement(NREM)sleep.Incontrast toadults,childrencommonlyexhibitperiodsofprolongedstableupperairwayobstruction orhypopneasduringNREMsleep.Thus,theapplicationoflowlevelsofpharyngealpressuremayhavegreatertherapeuticeffectsinchildren.TNIresponseswerecomparedto CPAPandbaselinein12morbidlyobese,otherwisehealthy,childrenwithsleepapnea,for whomadherenceratestoCPAPweresolowthatmostchildreninthisstudywereineffectivelytreated[2].TNItreatedsleepapneaacrossawidespectrumofdiseaseseverityinall buttwochildren(seeFig.20.5).Second,inthemajorityofchildren,thereductioninthe sleep-disordered breathing event rate with TNI was comparable to CPAP. The authors concludedthatTNImayofferanalternativetoCPAPinsomechildrenforwhomstandard treatmentapproachesarenotsuccessful.Thegreatertherapeuticresponserateinchildren maybeduetothemilderdegreeofupperairwayobstructioninchildren.Alternatively,
140
G. Nilius et al.
Sleep Apnea Disease Severity
Proportion of Hypopneas/RERAS *
Therapeutic 50 Response Rate (%) 40
* *
30
20
10
0 3rd 2nd RDI Tertile 1st event rate/hour 10-22 22-42 42-63
Percent Hypopnea & RERAS >50% >66% >90%
Fig. 20.4 Polysomnographic characteristics of the baseline sleep study that predict therapeutic response rates to TNI. A therapeutic response was de ned by a fall in RDI below 10 events/h associated with a 50% reduction in the RDI from baseline sleep study. *Denotes a statistically signi cantdifference(P<0.05)totheexpectednight-to-nightvariabilityinsleepapneaseverity of13%:Leftpanel:sleepapneadiseaseseveritywascategorizedintomild,moderate,andsevere bycalculatingtertilesoftheRDIatthebaselinesleepstudy.Rightpanel:fordegreeofhypopneas, theproportionsofobstructivehypopneastoallobstructiveevents(apneas,hypopneas,andRERAs) foreachpatientduringNREMsleepwerecalculated,andtherapeuticresponseratestoTNIare givenforsubgroupsofpatientswhohadmorethan50%(n=34),morethan2/3(n=23),andmore than90%(n=11)hypopneas.Notethatsubgroupsofpatientsoverlap(e.g.,thosewith>90%are alsorepresentedinthosewith>50%and>66%)
TNImighthaveincreasedpharyngealpressuremoreinchildrenthanadultsduetotherelativelylargersizeofthenasalcannulacomparedtothesizeofthenares. The greater therapeutic response rate in children may be due to the milder degree of upperairwayobstructioninchildren.Alternatively,TNImighthaveincreasedpharyngeal pressuremoreinchildrenthanadultsduetotherelativelylargersizeofthenasalcannula comparedtothesizeofthenares.Perhapsaslightincreaseinpharyngealpressuremight haveincreasedlungvolumestoagreaterdegreeinchildrenasaresultofhigherchestwall andlungcompliance,particularlyduringREMsleepwhenthechestwallmusculatureis hypotonic.Increasesinlungvolumemighthaveimprovedbothoxygenstoresandupper airwaypatency.Finally,itisalsopossiblethatchildren sre exresponsestoinsuf ationof airaregreaterthaninadults,leadingtoimprovementsinupperairwaypatency.Theauthors [2] concluded that, for the majority of children, the response to TNI was comparable to CPAP,thatTNImightultimatelybeamoreeffectivetreatmentoptionthanCPAP,andthat TNImayhaveaparticularroleinyoungerchildren,forwhomtheuseofCPAPcarriesconcernforthepotentialofcompressionofbonyfacialstructures.TNIisanopensystemthatis notdependentonatightlysealednasalmask,obviatingconcernsoffacialcompression.
20 Transnasal Insufflation — A New Approach in the Treatment of OSAs
NREM (n = 12)
141
REM (n = 8)
Total (n = 12)
80 p < 0.01
p = 0.01
p < 0.01
AHI
(events/hr)
60
40
*
* *
20
† †
0 Baseline
TNI
Baseline
TNI
Baseline
TNI
Fig. 20.5 Theapnea hypopneaindices(AHIs)aredisplayedforthebaselinecomparedtoTNItreatment night during non-rapid eye movement (NREM; left panel), rapid eye movement (REM; middlepanel),andfortheentirenight(rightpanel).Datapresentedaremean±standarderrorof themean(SEM).*ParticipantswithresidualsleepapneaonTNI, participantswithsuboptimal AHIresponsesonTNIcomparedtocontinuouspositiveairwaypressure(CPAP), childrenwithoutadenotonsillectomy
20.5 Summary An open nasal cannula system delivering warm and humidi ed air at a ow rate of 20L/min(TNI)caneffectivelytreatsleep-disorderedbreathinginasubsetofadultpatients andinamajorityofchildren.TNItreatmentresponsesdependedontheseverity(hypopneasratherthanapneas)butnotthefrequency(eventrate/h)ofupperairwayobstruction. TNImayalsoplayaroleinprotectingpatientswithrespiratoryfailureasitcanreducearterialCO2andalleviaterapid,shallowbreathing,therebyincreasingef cacyofbreathing. Thus,TNImightbeanalternativefornon-invasiveventilationforpatientsatriskfordevelopingrespiratoryfailure.
References 1. McGinleyB,PatilSP,DeRosaPA,KirknessJP,SmithC,SmithPL,SchwartzAR,Schneider H(2007)Anoveltherapeuticapproachforobstructedsleepdisorderedbreathing treatment withnasalinsuf ation(TNI).AmJRespirCritCareMed176:194 200 2. McGinleyB,HalbauerA,PatilSP,SmithC,SmithPL,SchwartzAR,SchneiderH(2009)An opennasalcannulatreatsobstructivesleepapneainchildren.Pediatrics124(1):179 188
142
G. Nilius et al.
3. BrownCD,HerpelLB,GoringKL,SmithPL,WiseRA,SchneiderH,SchwartzAR(2007) Treatmentofsleep-disorderedbreathinginchronicobstructivepulmonarydiseasewithnocturnalnasalinsuf ation.AJRCCM175(AbstractsIssue)A709 4. NiliusG,DomanskiU,van tHogT,FrankeKJ,RuhleKH,SchwartzAR,SchneiderH(2009) Nasalinsuf ationofair(TNI)decreaseshypoventilationinoxygendependentpatientswith COPD[abstract].ERJ2009;53(Suppl):P842 5. Nilius G, Wessendorf T, Maurer J, Stoohs RA, Patil SP, Schubert N, Schneider H (2009) Predictors for treating obstructive sleep apnea with an open nasal cannula system (TNI) [publishedonlineaheadofprint].Chest2010Mar;137(3):521 528
Cardiopulmonary Interventions to Prolong Survival in Patients with Duchenne Muscular Dystrophy
21
YukaIshikawa
21.1 Introduction Duchennemusculardystrophy(DMD)iscausedbymutationsinthedystrophingeneon theXchromosomeatXp21.DMDaffects1ofevery3,500livemalebirths.Progressionof muscularweaknessleadstolossofambulationby12yearsofage,andthedevelopmentof scoliosisismarkedbytheearlyteenageyears. Prior to the availability of effective ventilatory support and cardiac management, in DMDpatientsintheirlateteensorearly20stheleadingcauseofdeathwasrespiratory insuf ciency,andthoseintheirearlytomiddleteensdiedfromcardiaccomplicationssuch asdilatedcardiomyopathyandconductionabnormality. Currenttherapies,includingnoninvasiveventilation(NIV)andcardioprotectionhave improvedsurvivalandqualityoflifeforpatientswithDMD.
21.2 Respiratory Management 21.2.1 NIV for Chronic Respiratory Failure Pulmonaryfunctionisevaluatedannuallyorwhensigns rstappear(Table21.1). Whenthevitalcapacity(VC)decreases,anysymptomofchronicalveolarhypoventilation ismanifested,orhypoxemiaorhypercapniaisnoted,useofhigh-spanbilevelpositiveairway pressure(PAP)oravolume-cycledventilator(withcontrolmode)atnightisconsidered. Forpatientswhodevelopsymptomatichypercapniaandhypoxemiawhenawake,daytimeNIVisgraduallyincreased.Whenthepatientusesamotorizedwheelchair,theventilatorismountedonthewheelchairwitha exibletube,andanasalplugormouthpieceis xed.SomepatientscanhaveamealwhileusingNIV(desirablyusingcontrolmodewith avolume-cycledventilatororthepositiveend-expiratorypressure[PEEP]setatzero). Y.Ishikawa NationalHospitalOrganization,YakumoNationalHospital,Hokkaido,Japan e-mail:
[email protected] A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_21,©Springer-VerlagBerlinHeidelberg2010
143
144
Y. Ishikawa
Table 21.1 CardiopulmonaryevaluationinpatientswithDMD 1.Generalexamination Height(armspan) Weight Scoliosis Chestdeformity Abdominaldistention Symptomsofchronicalveolarhypoventilationorcardiacdysfunction Respiratorysoundandheartsound 2.Pulmonaryfunction Respiratoryrate Abnormalbreathingpattern:Row-a-boatphenomenon,glossopharyngealbreathing,etc. Vitalcapacity(VC) Saturationofpulse-oximetryoxygen(SpO2):daytimeandnighttime TranscutaneousCO2gastension(PtcCO2) orend-tidalCO2gastension(PetCO2):daytimeandnighttime orPaCO2 Coughpeak ow(CPF):unassistedCPF CPFassistedbyairstackingtodeeplungvolumes(CPFair) CPFassistedbyabdominalthrusts(CPFthrust) CPFassistedbybothairstackingandabdominalthrust(aCPF) Maximuminsuf ationcapacity(MIC)when%VCis<50% 3.Cardiacfunction Heartrate Bloodpressure ChestX-ray:CTR ECG,HolterECG Brainnatriureticpeptide(BNP) Echocardiography
21.2.2 Airway Clearance Childrenaged12yearsorolderaretaughthowtoperformmanuallyassistedcoughing when the cough peak ow (CPF) decreases to less than 270 L/min. Children under 12yearsaretaughthowtoperformmanuallyassistedcoughingifanepisodeofdif cult airwayclearanceoccurs.Coughingisperformedafterairstackingwithassistedprocedures
21
Cardiopulmonary Interventions to Prolong Survival in Patients with Duchenne Muscular Dystrophy
145
such as the use of a resuscitator bag, by inhaling several tidal volumes delivered by a volume-cycled ventilator under NIV, by performing glossopharyngeal breathing, or by raisingtheinspiratorypositiveairwaypressure(IPAP)by2 4cmH2O[1]. Once maximum assisted CPF becomes less than 270 L/min or ineffective for airway clearance,patientswithDMDrequiremechanicallyassistedcoughing(MAC)toprevent pneumoniaandacuterespiratoryfailure.MAChasbeende nedastheuseofmechanical insuf ation exsuf ation(CoughAssist,Phillips,Netherlands).Itisusedinconjunctionwith exsuf ation-timedabdominalthruststofurtheraugmentcough owsaspartofMAC.
21.2.3 Management of Chest Colds OncedecreasedVCorCPFisrecognizedinchildrenwithDMD,thosepatientsandfamilies shouldlearnhowtomaintainanSpO2(saturationofpulse-oximetryoxygen)greaterthan 94%usingassistedcoughingandprolongedhoursofNIVifthechildhasachestcold. NIVincombinationwithassistedcoughinghasbeenreportedtoreduceconsultations withageneralpractitionerforrespiratorytractinfections(RTIs),thenumberofantibiotic treatmentsforRTIs,andthenumberofhospitaladmissionsforRTIs[2].
21.2.4 Long-Term Continuous NIV ManypatientswithDMDusingcontinuousNIVfordecadeswithouttracheostomyhave beenreported.NIVhasalwaysbeeneffectiveforcontinuousventilatorysupportaslongas theventilatorsettingsorinterfacesareappropriate,evenwhenpatientsaretoomentally impairedtocooperatewithitorbulbar-innervatedmusculatureistooimpairedtoprotect theairwayfromcontinuoussalivaaspirationthatresultsinoxyhemoglobindesaturation.
21.3 Cardioprotection 21.3.1 Cardiac Evaluation Byadulthood,almostallpatientswithDMDhavecardiacinvolvement,includingcardiomyopathyandarrhythmia.ForpatientswithDMD,cardiacevaluationbyechocardiogram, serumbrainnatriureticpeptide(BNP),andelectrocardiogram(ECG)shouldbeobtained onceortwiceayear(Table21.1). Due to impaired motor function, patients with DMD are less likely to experience inspiratoryloadingandthusinspiratorydif culty.However,whenaloadslightlyhigher than usual is imposed, symptoms are suddenly manifested. Cardiac symptoms include dyspnea,cyanosis,paleness,cough,fatigue,palpitations,sweating,chestandabdominal discomfortorpain,nausea,lossofappetite,headache,frequentnocturnalarousal,frequent
146
Y. Ishikawa
changesinneedforturningatnight,arthralgias,chills,decreasedurinaryoutput,irritability,dif cultyinconcentration,andedema(weightgain).
21.3.2 Combined Drugs and NIV Preventive management of cardiac involvement with ACEi and beta-blockade in DMD is effective when standard respiratory management with NIV and assisted coughing are also applied.Fifty-twoDMDpatientsreceivedtreatmentforheartfailureduetocardiomyopathy orasymptomaticleftventricular(LV)dysfunctionwithACEiandbeta-blockadeduringthe periodfrom1992to2005[3].The5-and7-yearsurvivalratesofallpatientswere93%and 84%,respectively.Inthetreatmentgroup(n=12,symptomaticheartfailuredueto cardiomyopathy),5-and7-yearsurvivalrateswere81%and71%,respectively.Theprevention group(n=40,asymptomaticLVdysfunction,leftventricularejectionfraction[LVEF]<45%), 5-and7-yearsurvivalrateswere97%and84%,respectively,andthe10-yearsurvivalratewas 72%.Thepreventiongroupshowedabettersurvivalratecomparedwiththetreatmentgroup. TheconsequencesofDMDcardiomyopathyareworsenedbysleep-disorderedbreathingwithhypoxemiaandhypercapnia.Inapatientwithcardiacfailure,reducedpharyngeal muscletoneduringperiodicbreathingandincreasedpharyngealedemaassociatedwith congestion can contribute to the obstructive apneas and hypopnea. Therefore, NIV can havedirectcardioprotectiveeffects.
21.4 Anesthesia and Sedation TherisksrelatedtoanesthesiaandsedationinpatientswithDMDincludepotentiallyfatal reactions to inhaled anesthetics and certain muscle relaxants, upper airway obstruction, hypoventilation,atelectasis,congestiveheartfailure,cardiacdysrhythmias,respiratoryfailure,anddif cultyweaningfrommechanicalventilation.Therefore,expertrecommendations arenecessaryregardingrespiratory,cardiac,gastrointestinal(GI),andanestheticmanagementofpatientswithDMDwhoundergogeneralanesthesiaorproceduralsedation. AccordingtoastatementbytheAmericanCollegeofChestPhysicians,preoperative pulmonaryassessmentshouldbeperformed(Table21.1).Iftheforcedvitalcapacity(FVC) isbelow30%,trainingintheuseofNIVisrecommended[4].IftheCPFislessthan270 L/min,traininginassistedcoughingandemphasisontheuseofMACisapplied. OptimizationofthepreoperativenutritionalstatusmayinvolvetheuseofNIVbecause patientswithuntreatedrespiratoryfailuremaybecomemalnourishedduetotheincreased workofbreathingortheymaybeunabletoeatduetodyspnea. Postoperatively,theSpO2shouldbemonitoredcontinuouslyuntilthecardiopulmonary statusbecomesstable.Wheneverpossible,assesscarbondioxidelevels(e.g.,PtcCO2[transcutaneous CO2 gas tension]). Assess carbon dioxide levels if hypoxemia is caused by hypoventilation,atelectasis,orairwaysecretionsandtreatimmediatelywithNIVandassisted coughing.Supplementaloxygentherapyshouldbeusedwithcautionbecauseoxygentherapy cancorrecthypoxemiawithouttreatingtheunderlyingcause(e.g.,hypoventilation,atelectasis,orairwaysecretions),andoxygentherapymayimpairthecentralrespiratorydrive.
21
Cardiopulmonary Interventions to Prolong Survival in Patients with Duchenne Muscular Dystrophy
147
Inaddition,patientswithDMDmayhavegastroparesis,intestinaldysmotility,andconstipation,allofwhichcanbeexacerbatedpostoperativelybypainmedications.GIdysfunction can impair breathing if abdominal distention and increased intra-abdominal pressure occur, hampering diaphragmatic excursion. Gut dysmotility also increases the likelihoodofgastricdistentionwhenNIVisapplied.Bowelregimensshouldbeemployed to avoid and treat constipation, and selected patients may bene t from pharmacologic therapy with GI smooth muscle prokinetic agents. Appropriate postural management, feedingaids,gastrostomyinsertion,orparenteralnutritionshouldbeindicated.
21.5 The Parent as the “Lifeline” for a Child’s Life Using NIV Individuals with muscular dystrophy had average medical expenditures 10 20 times greaterthanindividualswithoutmusculardystrophy(intheUnitedStatesin2004).But, mostfamiliesfeltthattheyhadmadetherightchoiceinusingNIV. Accordingtoonestudy[5],familylifechangessigni cantlywiththedecisiontoplace achildwithDMDonNIV.Despitebecomingexpertcaregivers,theparentsexperienceda recurrentsenseoflossanduncertainty.Thosewhoperceivedinsuf cientsupportfeltthe weightofresponsibilityassolecareprovidersfortheirchild.Sincetheparents experience wasasthe lifeline fortheirchild slifeandqualityoflife,moresupportbyhealthcare professionalsandthecommunityisneeded.
Key Recommendations
›
› › ›
›
AsstandardrespiratorycareforindividualswithDMDleadstogreaterlongevity, bothrecognitionandpreventivetreatmentofcardiacinvolvement,including cardiomyopathyandarrhythmia,becomemoreimportant.Thetrendtoward improvingsurvivaltimesofpatientswithDMDcouldberelatedtothesalutary effectofNIVoncardioprotectioninadditiontotheincreasinguseofACEiand beta-blockers[3]. ForchildrenwithDMDwithdecreasedVCorCPF,NIVincombinationwith assistedcoughingreducesthefrequencyandseverityofRTIs[2]. Airstackingwassigni cantlymoreeffectivethanabdominalthrustinincreasing CPF,butthecombinationwasthemosteffective[1]. AlthoughthestatementbytheAmericanCollegeofChestPhysicians[4]includes adviceregardingrespiratoryandcardiacmanagementofpatientswithDMD undergoinganesthesiaorsedation,speci cstudiesneededtodevelopbetter guidelinesthatincludethefollowing:studiesofthespeci csettingsthatoptimize theef cacyofnoninvasivepositivepressureventilation(NPPV)andMACand studiesthatclarifytheroleofalternativemucusmobilizationtechniques. AmultidisciplinaryteamthatworksforoptimalmanagementofDMDusing NIV-speci cmultisystemcomplicationsisessential,andcollaborationinthis speci cclinicalnetworkisrecommendedtosupportfamiliesinmakingtheir choicetouselife-sustainingtechnologies[5].
148
Y. Ishikawa
References 1. IshikawaY,BachJR,KomaroffE,MiuraT,Jackson-ParekhR(2008)Coughaugmentationin Duchennemusculardystrophy.AmJPhysMedRehabil87:726 730 2. Dohna-SchwakeC,PodlewskiP,VoitT,MelliusU(2008)Non-invasiveventilationreduces respiratory tract infections in children with neuromuscular disorders. Pediatr Pulmonol 43: 67 71 3. OgataH,IshikawaY,IshikawaY,MinamiR(2009)Bene cial effects of beta-blockers and angiotensin-converting enzyme inhibitor in Duchenne muscular dystrophy. J Cardiol 53: 72 78 4. BirnkrantDJ,PanitchHB,BendittJO,BoitanoLJ,CarterER,CwikVAetal(2007)American CollegeofChestPhysiciansconsensusstatementontherespiratoryandrelatedmanagementof patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest 132: 1977 1986 5. MahJK,ThannhauserJE,McNeilDA,DeweyD(2008)Beingthelifeline:theparentexperience of caring for a child with neuromuscular disease on home mechanical ventilation. NeuromuscDisord18:983 988
Noninvasive Ventilation Pressure Adjustments in Patients with Amyotrophic Lateral Sclerosis
22
KirstenL.Gruis
Amyotrophiclateralsclerosis(ALS)isaprogressiveneurodegenerativedisorderofmotor neurons.PatientswithALSdevelopdiffuseskeletalmuscleweaknessinadditiontorespiratory muscle weakness, and respiratory failure is the most common cause of death. Tolerancetointermittentuseofnoninvasiveventilation(NIV)for4hormoreadayis associatedwithimprovedsurvivalandqualityoflifeinpatientswithALS[1,5]. NIV decreases the work of breathing by providing bilevel positive airway pressure: inspiratorypositiveairwaypressure(IPAP)and,toalesserextent,expiratorypositiveairway pressure (EPAP). Typically, the positive airway pressure is administered noninvasivelyviaanasal-typemaskinterface.Theamountofsupportprovidedtoweakinspiratory musclesisthedifferencebetweenIPAPandEPAP,termedpressuresupport. AlthoughNIVprovidessupportforweakenedrespiratorymuscles,itdoesnotcompletely replacerespiratorymusclefunctionascanbedonewithairwaycannulationandmechanical ventilation.Inthesettingoffullyassistedmechanicalventilation,themedicalprovidercan titratetheventilatorsettingstocorrectgasexchangeimpairment.However,inadisorderwith progressiverespiratorymuscleweaknesstreatedwithintermittentsupportiveNIV,itisuncertainhowmuchpressuresupporttoprovideandwhentoalterthepressuresupportsettings. InitialstudiesofNIVthatdemonstratedasurvivalbene tinALSusedNIVtitratedto patientcomfortbutdidnotprovideinformationregardingpressuresettings[2].Asurvey ofALSclinicmedicaldirectorsintheUnitedStatesshowedthatthemostfrequentlyused protocolwastoinitiateNIVwith8cmH2OIPAPand4cmH2OEPAPandtoincreasethe IPAPby2 3cmH2Oasneededtoimprovesymptoms[3].Incontrast,otherexpertshave proposedthatallALSpatientsuse high-span NIVwithapressuresupportof10cmH2O orgreaterwithagoalIPAPof16 18cmH2O.
K.L.Gruis MotorNeuronDiseaseCenter,UniversityofMichiganHealthSystem, DepartmentofNeurology,1914/0316TaubmanCenter,1500EastMedicalCenterDrive, AnnArbor,MI48109-0316,USA e-mail:
[email protected]
A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_22,©Springer-VerlagBerlinHeidelberg2010
149
150
K.L. Gruis
Whileprovidinghighlevels(>10cmH2O)ofpressuresupportforallALSpatientsmay appearprudentinaprogressivedisorder,exposingpatientstohighairwaypressuresmay result in signi cant side effects that decrease NIV tolerance and subsequent bene ts of therapy.Inaddition,bythetimeNIVisstartedALSpatientshavelearnedtocompensate for respiratory muscle weakness and small tidal volumes with increased breathing frequency.Therefore,titratingallALSpatientstohighNIVpressurestocorrectreducedtidal volumes and increased breathing frequency may result in patient ventilator asynchrony andintolerancetoNIVtherapy. Importantly,thelackofguidanceinthemedicalliteratureregardingNIVpressuresettingsandadjustmentsforALSpatientsmaycontributetomedicalproviders unwillingness to prescribe NIV therapy. Therefore, we performed a retrospective, single-center, chart reviewassessmentofNIVpressuresettingsusedforsymptomatictreatmentofALSpatients. WeassessedNIVpressuresettingsovertimeandcomparedsurvivalbetweenthoseALS patientstolerant,de nedbymorethan4hofusepernight,andintoleranttoNIV[4]. TheALSpatientsinourstudywerestartedonNIV,andpressuresweretitratedinasimilar fashion to that described [3]. Therefore, the NIV pressures used were the minimum requiredtoimprovebreathingcomfort.Wecompared18patientswhoweretoleranttoNIV therapyand19patientswhowereintolerant.Themajorityoftolerantpatients(67%)used pressuresupport(IPAP EPAP)oflessthan10cmH2Ountiltheirdeaths,whiletheremainingthirdofpatientsrequiredpressuresupportgreaterthan10cmH2Otoimprovesymptoms.Themaximumpressureneededwas19/5cmH2O,while4of18patients(22%)found theoriginalNIVsettingsof8/3cmH2Osuf cienttoimproverespiratorysymptoms[4]. These ndings are similar to a prospective, randomized study of NIV therapy in ALS patientsthatdemonstratedanaveragepressuresupportofonly11cmH2O[5].Awiderange ofNIVpressures(8.2 22.4cmH2O)hasbeenassociatedwithimprovedALSpatientventilationasmeasuredbygasexchange[6].Takentogether,these ndingsdemonstratethat notallALSpatientsneedapressuresupportgreaterthan10cmH2Otoimproveventilation withNIVtherapy. Inourstudy,mostNIVpressurechangesoccurredwithinthe rstyearofNIVtherapy, andonly2of18patients(11%)requiredmorethantwochangesinNIVpressuresettings[4]. ThisiscontrarytothebeliefthatALSpatientswillneedmorefrequentNIVpressure increasesasthediseaseprogresses.Instead,whatlikelyoccurswithprogressiverespiratory muscleweaknessisincreasedhoursofusageofNIVtherapyratherthanmarkedincreasesin NIVpressuresupport.Asigni cantincreaseinNIVusagedurationhasbeendescribedina prospectivestudyofALSpatients,withNIVusagehoursincreasing98 277%,withsome patientseventuallyusingNIVcontinuously[5]. Patients who tolerated NIV had a nearly 1-year increase in survival compared with thosewhowerenottolerantofNIV.Thesurvivalassociationremainedwhenadjustingfor ageandsymptomonsetlocation(bulbarvs.limb) clinicalcharacteristicsassociatedwith poor ALS survival with a hazard ratio of 0.23 (95% con dence interval 0.10, 0.54). These ndingsaresimilartothebene tfoundinaprospective,randomizedclinicaltrial thatdemonstratedamediansurvivalbene tofnearly7monthsinthosepatientstreated withNIVtherapycomparedtothosewhoreceivedstandardmedicalcarewithoutNIV[5]. Thus,ourdatasuggestthatevenrelativelylowNIVpressuresupportisassociatedwithan improvementinsurvival.
22
Noninvasive Ventilation Pressure Adjustments in Patients with Amyotrophic Lateral Sclerosis
151
References 1. Kleopa KA, Sherman M, Neal B, Romano GJ (1999) Heiman Patterson T Bipap improves survivalandrateofpulmonaryfunctiondeclineinpatientswithALS.JNeurolSci164:82 88 2. AboussouanLS,KhanSU,BanerjeeM,ArroligaAC,MitsumotoH(2001)Objectivemeasures of the ef cacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. MuscleNerve24:403 409 3. MeloJ,HommaA,IturriagaEetal(1999)Pulmonaryevaluationandprevalenceofnon- invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposalofapulmonaryprotocol.JNeurolSci169:114 117 4. GruisKL,BrownDL,LisabethLD,ZebarahVA,ChervinRD,FeldmanEL(2006)Longitudinal assessmentofnoninvasivepositivepressureventilationadjustmentsinALSpatients.JNeurol Sci247(1):59 63 5. BourkeSC,TomlinsonM,WilliamsTL,BullockRE,ShawPJ,GibsonGJ(2006)Effectsof non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis:arandomisedcontrolledtrial.LancetNeurol5:140 147 6. ButzM,WollinskyKH,Wiedemuth-CatrinescuUetal(2003)Longitudinaleffectsofnoninvasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys MedRehabil82:597 604
Noninvasive Positive Pressure Ventilation in Amyotrophic Lateral Sclerosis
23
DanieleLoCoco,SantinoMarchese,andAlbinoLoCoco
23.1 Introduction Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of unknown origin that affects approximately 1.5 individuals per 100,000 every year; usually,theseindividualsarebetween55and75yearsofage[1].ALScausesprogressiveweaknessofvoluntarymusclegroups,includingrespiratoryones,andrespiratory failureorpneumoniarelatedtorespiratorymuscleweaknessisthemostfrequentcause ofdeath. However,onlyafewpatientspresentwithrespiratorymuscledysfunction,whereas themajorityofthemmaintainanalmostnormalrespiratoryfunctionforlongperiodsof time. Patients thus need to be regularly and progressively evaluated to identify early signs of respiratory muscle weakness so that adequate treatment can be implemented. Furthermore,itisgoodpracticetodiscussrespiratoryissueswellinadvancewiththe patientsandtheirfamilytoavoidemergencydecisionsorunwantedtreatmentsincaseof acrisis.
D.LoCoco() ALSClinicalResearchCenter,DipartimentoUniversitariodiNeuroscienzeCliniche(DiNeC), UniversityofPalermo,ViaG.LaLoggia,1,90129Palermo,Italy e-mail:
[email protected] S.Marchese RespiratoryIntensiveCareUnit,OspedaleCivicoeBenfratelli,ARNAS,ViaC.Lazzaro, 2,90127Palermo,Italy A.LoCoco PulmonaryDepartmentandRespiratoryIntensiveCareUnit,OspedaleCivicoeBenfratelli, ARNAS,ViaC.Lazzaro,2,90127Palermo,Italy
A.M.Esquinas(ed.),NoninvasiveMechanicalVentilation, DOI:10.1007/978-3-642-11365-9_23,©Springer-VerlagBerlinHeidelberg2010
153
154
D. Lo Coco et al.
23.2 Respiratory Function Evaluation Usually,whenpatientswithALSseekmedicalattention,pulmonaryevaluationiswithinthe normalrange,andpatientsdonotreferrespiratorycomplaints.However,duringtheprogressionofthediseaseallpatientseventuallycomplainofdyspneawithexertion,orthopnea, andpoorsleepqualitywithfrequentawakenings,nightmares,earlymorningheadaches,or excessivedaytimesleepiness[2,3].Aclinicalexaminationatthispointmightshowrespiratoryparadox,rapidshallowbreathing,oraccessorymusclecontraction.Nevertheless,the observation that many patients may remain asymptomatic even when there is a marked reductionofvitalcapacitylimitsthereliabilityofthesesignsandsymptoms. Inadditiontorespiratorysymptomsandsigns,manyexamsareusedintheevaluation ofpulmonaryfunctioninALSpatients(Table23.1)[2,3].Themostwidelyavailablemeasurefordetectingrespiratorydeclineisforcedvitalcapacity(FVC)whensittingorsupine. FVCiscorrelatedwithsurvivalandusuallypresentsanalmostlineardecreaseduringthe courseofthedisease,butwithamarkedvariabilityfrompatienttopatient(within2 4%of predictedvaluepermonth). Well-knownlimitationsofFVCarethelowsensitivityinpatientswithbulbarinvolvement,becauseofreducedbuccalstrength,orcognitiveinvolvement,andtherelativeinsensitivitytodetectmildormoderatediaphragmaticdysfunction. Maximal inspiratory and expiratory pressure (MIP and MEP, respectively) are other sensitive measurements, but in many centers these are not routinely executed because manypatientsareunabletoperformthetestwiththeprogressionofdisease. ArterialbloodgasanalysismayalsobeofhelpintheevaluationofpatientswithALS, especiallyinthosewithseverebulbarinvolvementsinceitcouldrevealrestinghypercapnia(Paco2>6.5kPa)orhypoxemia(Pao2<90mmHg).However,theseareusuallyvery latesignsofrespiratoryfailureinALS. Increasing attention has been drawn to measurement of sniff nasal inspiratory pressure (SNIP),whichisregardedasagoodmeasureofdiaphragmaticstrength.SNIPisprobablymore accuratethanFVC,althoughevenSNIPmayunderestimaterespiratoryfunctioninpatients withbulbarinvolvementbecauseofupperairwaycollapse.However,asniffnasalpressuretest below40%ofpredictedvalueisasigni cantpredictorofnocturnalhypoxemiaandmortality. Finally,nocturnalhypoventilationandsleep-disorderedbreathingarealsocommonin ALS with the progression of the disease and can occur even when respiratory muscle functionisonlymildlyaffectedanddaytimegasexchangeremainsnormal.Then,since Table 23.1 Objective measurements of pulmonary function of patients with amyotrophic lateral sclerosis(ALS)inadditiontorespiratorysymptomsandsigns Forcedvitalcapacity(FVC;bothuprightandsupine) Maximalinspiratoryandexpiratorypressure(MIPandMEP,respectively) Sniffnasalinspiratorypressure(SINP) Nocturnaloximetry Arterialbloodgasanalysis
23
Noninvasive Positive Pressure Ventilation in Amyotrophic Lateral Sclerosis
155
nocturnaloximetryiseasytoperformandcanbeexecutedinthehome,ithasbecome frequentlyusedinclinicalpracticefortheevaluationofrespiratoryinvolvementinALS patients.Polysomnographyisnotroutinelyrecommended.
23.3 Noninvasive Positive Pressure Ventilation Inthelast10years,therehasbeenarevolutioninrespiratoryassistanceandventilatory supportinALSthathashadasigni cantimpactonthenaturalhistoryofthedisorder.The application of ventilatory assistance, most frequently noninvasively, has been shown to alleviaterespiratorysymptoms,toextendsurvivalconsiderably,andtoimprovequalityof lifeandcognitivefunctionsinmostpatients[1 3].Atpresent,noninvasivepositivepressure ventilation (NIPPV), usually via nasal mask with bilevel positive airway pressure (BiPAP)machines,isthemosteffectivetreatmentavailableforpatientswithALS[4].A proposedrespiratorymanagementalgorithmforpatientswithALSisshowninFig.23.1. AllpatientswithALScanbene tfromNIPPVtherapy,andatrialwiththisappliance should never be discouraged, but marked bulbar involvement could be associated with reducedtoleranceandmaybesurvival.Indeed,theincreasedriskofaspirationinpatients withbulbaronsetandproblemsbecauseofdif cultiesinclearingsecretionsorobstructions, such as those related to abnormal function of the vocal cords, should be considered.
offer NIPPV
periodic respiratory evaluations (FVC, SNIP, nocturnal oxymetry)
ALS onset
- Respiratory symptoms - FVC < 80% - SNIP < 40cmH2O - nocturnal desaturation - morning pCO2 > 6.5 kPa
monitor NIPPV compliance and coughing efficacy
progressive skeletal muscles weakness and atrophy
diagnosis
chronic hypoventilation
respiratory insufficiency
tracheostomy ventilation
death
Fig. 23.1 Schematicrepresentationoftheprogressiverespiratorydysfunctioninamyotrophiclateral sclerosis (ALS) over time and recommended respiratory management. FVC forced vital capacity,NIPPVnoninvasivepositivepressureventilation,SNIPsniffnasalinspiratorypressure
156
D. Lo Coco et al.
Inourexperience,NIPPVcanbewelltoleratedbybothpatientsandcaregivers,evenin patientswithbulbarinvolvement[5].Specialimportanceshouldbegiventoadaptation andcomplianceduringthe rstfewweeksofNIPPVusesincethiscouldbeacrucialstep indeterminingtheef cacyofthetreatment. Factors predicting survival following NIPPV include advanced age, airway mucus accumulation,andlowerbodymassindex. The mechanisms by which NIPPV therapy could affect survival in ALS are not perfectlyknown,andithasbeensuggestedthatmostofitseffectscouldberelatedto aslowingoftherateofrespiratoryimpairment,thusmodifyingthenaturalcourseof thedisease.Amongthehypothesesthathavebeengeneratedtoexplainthesustained improvementinrespiratoryfunctionandgradualresolutionofsymptomsassociated withNIPPV,ithasbeenpostulatedthatNIPPVrestschronicallyfatiguedrespiratory muscles,therebyimprovingdaytimerespiratorymusclefunction.Anotherhypothesis suggeststhatNIPPVimprovesrespiratorysystemcompliancebyreversingmicroatelectasis, thus diminishing daytime work of breathing. Finally, a third theory proposes that NIPPV improves central respiratory drive and the arousal mechanism (chronically depressed by habitual exposure to hypoventilation), leading to better ventilationduringbothwakingandsleepinghours.Allthesetheoriesarenotmutually exclusive,witheachpossiblycontributingtotheameliorationsobservedinpatients undergoingNIPPV. Notwithstanding the effects on respiratory symptoms, quality of life, and survival, manystudiessuggestedthattheemploymentofNIPPVinALSispoorworldwide,witha needformoreeducationofcliniciansandpatientsregardingthebene tsofNIPPVearlier inthecourseofthedisease[6].ThereasonsforsuchlowuptakeofNIPPVaremultifactorialbutarein uencedbydifferencesintheexperienceofphysicians,itsavailabilityand cost,uncertaintyofthebene tsandtimingforstartingventilation,andconcernsthatventilatorysupportmightprolongsuffering,renderhomecarelessfeasible,andleadtodependencyorventilatorentrapment[1]. Moreover, there is still debate about the optimal timing to introduce ventilation in thesepatientsandwhetherearlyNIPPVinitiationcouldactuallyleadtoincreasedsurvivalrates. Atpresent,worldwideacceptedguidelinesproposeNIPPVinitiationinthepresence of respiratory symptoms or evidence of respiratory muscle weakness (FVC £ 80% of predictedorSNIP£40cmH2O),evidenceofsigni cantnocturnaldesaturationonovernightoximetry(<90%for>5%ofthetimeasleep),oramorningarterialPaco2above6.5 kPa[1]. NIPPVisusuallyinitiallyusedforintermittentnocturnalsupporttoalleviatesymptoms of nocturnal hypoventilation, although as respiratory function worsens, patients tend to requireincreasingdaytimesupportandeventuallycontinuoussupport.However,thedisorderwilleventuallyprogresstothestageatwhichNIPPVwillnotbeabletocompensate forrespiratoryimpairment,andinthesecircumstancesonlyinvasiveventilationbytracheostomyisabletoprolongsurvival[1 3]. Whenplacedoninvasiveventilation,patientsaresupportedfromarespiratorypoint ofview;however,thelossofmotorneuronsgoesonprogressively,leadingtocomplete paralysis and muscular atrophy. Some patients may eventually reach a locked-in
23
Noninvasive Positive Pressure Ventilation in Amyotrophic Lateral Sclerosis
157
stateinwhichtheycannotcommunicateatallbecausethereisalsototalparalysisof theextraocularmuscles.Despitethis,whenconnectedtotracheostomytubespatients maysurviveformanyyears,withrespiratorytractinfectionsthemostfrequentcause ofdeath. Notwithstandingitseffectonsurvival,onlyaminorityofALSpatientsreceiveinvasive mechanical ventilation, at least in the Western countries. On the contrary, in Japan the frequencyofinvasiveventilationisconsiderablyhigher. Furthermore, many patients undergo tracheostomy in emergency without advance planningbecauseofarespiratorycrisis,whereasthenumberofpatientswhoelectively choosethistreatmentislow.SocioeconomicreasonsmaybeoneofthepossibleexplanationsforthelowprevalenceofinvasiveventilationinALSsincethetreatmentiscostly. Moreover,thereisaneedfor24-hcaregiving,whichcouldbeperceivedasextremely burdensomeforthewholefamily.Theattitudesofthetreatingphysicianhavealsogreat in uence,andthereisconcernthattracheostomyventilationwillprolonglifebeyondthe pointthatthepatientcancommunicateorinteractwithothersorabouttheprocedureto withdrawcare. Despitethesemanydoubtsandconcerns,themajorityofpatientswhounderwentinvasiveventilationwerepositiveabouttheirchoice,reportedasatisfyingqualityoflife,and indicated that they would repeat the choice again in the same situation. Caregivers weremorefrequentlyburdenedanddistressedbythisintervention,andtheyfrequently witnessedamarkedreductionofsociallifeactivities[1 3]. It is important to underline that unplanned and unwanted tracheotomy could beavoidedbyearlydiscussionoftheoptionsforrespiratorysupportandthroughadvance directives.Indeed,onceintubated,patientsarerarelyfreefromtheventilator.Advance directives should also be reviewed periodically during the course of the disease. On thecontrary,emergencyintubationandtracheostomyshouldbeavoided[1 3].
23.4 Supportive Care Apartfromsustainingrespirationwithmechanicaldevices,specialconsiderationhasto begiventopreventionofaspirationanddevelopmentofpneumonia[1 3].Inthisregard, itisoffundamentalimportancetoreducetheamountofsalivarysecretionsthroughthe use of several medications (such as amitriptyline and botulinum toxin injections), to devoteadequatetimeinteachingproperswallowingtechnique,andtomaintainhydration.Itisalsousefultoprovideaportablemechanicalhomesuctiondevice.Inaddition, when dysphagia worsens, placement of a percutaneous endoscopic gastrostomy tube shouldbethepreferredoption,especiallywhentherespiratoryfunctionisnottoomuch compromised. Anotheraspectofthepatient scarethatneedsspecialattentionisphysiotherapy,which is a useful aid for the management of respiratory secretions [1 3]. Indeed, during the courseofthedisease,progressiveinspiratoryandexpiratorymuscleweaknessandbulbar innervated muscle dysfunction result in the cough re ex becoming ineffective, causing
158
D. Lo Coco et al.
dif cultiesintheclearanceofmucus.Thisislargelydependentonthemagnitudeofpeak cough ows(PCFs),andaPCFbelow2.7L/sindicatesanineffectivecough.However, sincePCFdecreasesduringrespiratorytractinfections,whenthepressuregeneratedby expiratorymusclesisreduced,ithasbeensuggestedthatonceapatient sPCFisbelow4.5 L/s,particularlyinthepresenceofbulbardysfunction,thereisariskforpulmonarycomplications,andthatthresholdcouldbeanappropriatetimetoimplementassistedcough techniques. Methodstotreatofrespiratorysecretionsincludebreathingexercises,posturaldrainage,exerciseregimens,andtheuseofassistedcoughtechniques.However,ithastobe pointedoutthatpatientswithlimitedmobilityandmuscleweaknesshavedif cultywith postural drainage and generally do not bene t from chest physical therapy. Moreover, intensivecyclesofphysiotherapymaybeexhaustingformanypatients,particularlythose withadvanceddisease,andmaycausearterialdesaturation. Amongnoninvasiveexpiratoryaids,manuallyassistedcoughingtechniques,suchas anteriorchestcompression and abdominal thrust, have been effective in facilitating the elimination of airway secretions in patients with neuromuscular diseases, even if these maneuversarelaborintensiveandoftendif cultfornonprofessionalcaregivers. Themechanicalin-exsuf ator(MI-E)isadevicethatassistspatientsclearbronchial secretions. It consists of a two-stage axial compressor that provides positive pressure (whichcausesadeepinsuf ation),therebygeneratingaforcedexpirationinwhichhigh expiratory owratesandahighexpiratorypressuregradientaregeneratedbetweenthe mouthandthealveoli.Itisusuallyappliedviaafacemask.TheuseofMI-Eissimple andsafeenoughforapplicationbynonprofessionalcaregiversandisconsideredacomplement to manually assisted coughing in the prevention of pulmonary morbidity in patientswithneuromusculardiseases.Moreover,theuseofMI-Eprolongsnoninvasive respiratoryaidsanddelaystheneedfortracheostomyinpatientswithALS.However, thisdeviceseemstobeineffectiveinpatientswithseverebulbardysfunction,perhaps becausetheapplicationoftheexsuf ationcycleofMI-Eforthosepatientswithweaknessofthegenioglossusmusclemightproduceadynamic,total,orpartialcollapseofthe upperairway. Itcanbeusefultorememberthat,forpatientswhosevitalcapacitiesarelessthannormal,manuallyassistedcoughingisnotoptimallyeffectiveunlessprecededbymaximal lunginsuf ation,andMI-Eisnotoptimalunlessanabdominalthrustisappliedduringthe exsuf ation.AbdominalthrustsandMI-Earenotmutuallyexclusive,andtheyshouldbe combined for effective prevention of lower respiratory tract infection and respiratory insuf ciency. Failure to correctly administer physical medicine aids continues to make respiratory failure inevitable for the great majority of people with neuromuscular diseases. Finally, high-frequency chest wall oscillation (HFCWO) is another airway-clearance technique that has been tested on ALS patients. HFCWO is a technique that, throughgenerationofhigh owinthesmallairways,isthoughttomobilizesecretions from the distal airways to the larger airways, from where they can be more easily removed.Althoughwedonothavespeci cknowledgeaboutit,HFCWOseemstobe well tolerated and helpful to a great proportion of patients, decreasing symptoms of breathlessness.
23
Noninvasive Positive Pressure Ventilation in Amyotrophic Lateral Sclerosis
159
Conclusion and Key Recommendations
› ›
›
›
› ›
Recentpublicationshavemadeimportantcontributionsinparticulartosome aspectsofrespiratorycareforpatientswithALS,suchasnoninvasiveventilation andassistedcough. Thereisaneedforregularassessmentandfollow-upofrespiratoryfunction,and investigationsshouldincludedaytimeassessmentofrespiratoryfunction (includingFVCandSNIP)aswellasasleepstudiestoensureearlyrecognition ofpatientswithrespiratorymuscleimpairment. NIPPVtreatmentalleviatesrespiratorysymptoms,prolongssurvivalforlonger thananyavailablepharmaceuticalagent,improvesqualityoflife,andmay probablymodifythediseasecourse.Forthisreason,NIPPVshouldbeconsidered mandatoryinanypatientatriskofhypoventilationorinwhomrespiratoryfailure hasbecomeevidentduringsleepdespitenormaldiurnalrespiration. ThedegreeofhypoventilationthatshouldpromptintroductionofNIPPVmustbe de nedfurther,evenifthereisgrowingevidencefromliteratureshiftingthe evidence-basedindicationforNIPPVtowardearlierintervention.Nocturnal hypoventilationcouldbeparticularlyusefulforthispurpose. EveryeffortshouldbemadetoimproveNIPPVimplementationinthe managementworldwideofpatientswithALSsinceitisstillunderutilized. Preventionofaspirationandpneumoniaandadequatemanagementofbronchial secretionsaretwoimportantissues.Adequatetreatmentofsialorrheaand dysphagiaisimportantinthereductionofpneumoniarisk.Insuf cientcough isaconditionthatcanbediagnosedbymeasuringpeakcough owandshould, wheneverpresent,betreatedinpatientswithALS.Thereissomeevidencethat mechanicalcough-assistingdevicescouldbeofhelpincoughassistance,except forpatientswithseverebulbardysfunction,butfurtherresearchisneeded.
References 1. RadunovićA,MitsumotoH,LeighPN(2007)Clinicalcareofpatientswithamyotrophiclateral sclerosis.LancetNeurol6:913 925 2. Beneditt JO, Boitano L (2008) Respiratory treatment of amyotrophic lateral sclerosis. Phys MedRehabilClinNAm19:559 572 3. Heffernan C, Jenkinson C, Holmes T et al (2006) Mangement of respiration in MND/ALS patients:anevidencebasedreview.AmyotrophLateralScler7:5 15 4. Heiman-PattersonTD,MillerRG(2006)NIPPV:atreatmentforALSwhosetimehascome. Neurology67:736 737 5. LoCocoD,MarcheseS,PescoMC,LaBellaV,PiccoliF,LoCocoA(2006)Noninvasivepositive-pressureventilationinALS.Predictorsoftoleranceandsurvival.Neurology67:761 765 6. MillerRG,AndersonF,BrooksBR,MitsumotoH,BradleyWG,RingelSP,ALSCAREStudy Group(2009).Outcomesresearchinamyotrophiclateralsclerosis:lessonslearnedfromthe amyotrophiclateralsclerosisclinicalassessment,research,andeducationdatabase.AnnNeurol 65(Suppl1):S24 S28
Noninvasive Mechanical Ventilation as an Alternative to Endotracheal Intubation During Tracheotomy in Advanced Neuromuscular Disease
24
DavidOrlikowski,HélènePrigent,andJésusGonzalez-Bermejo
24.1 Introduction 24.1.1 Difficulties for intubation and invasive procedures in neuromuscular disease Tracheotomyisamajorstepforpatientswithneuromusculardiseaseasitrequiresahigher levelofcare,whichaffectsqualityoflifeandincreasesdependence.Intoleranceornonfeasibilityofnoninvasiveventilation(NIV)isthemostcommonreasonfortracheotomyof patientswithneuromusculardisease.Otherreasonsincludeworseningofrespiratoryfailurewithalowvitalcapacity(VC),persistenthypercarbia,andtheneedtoincreaseventilationtime.Onemajorconditiontorealizetracheotomyistobeabletomaintainef cient ventilation throughout a procedure while providing efficient analgesia. Due to their severely impaired pulmonary function, respiratory management of patients with neuromusculardif cultiesisverychallenging.Theseindividualsareatriskofseverecomplicationswhentheyrequiredeepsedationoranesthesiawithendotrachealintubation.They present many factors that can lead to dif cult intubation: skeletal deformities, tracheal deviationrelatedtokyphoscoliosis,reducedneckmobilityduetocervicalfusionormyopathy,tonguehypertrophy